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	Abstract	
	
To	date,	computed	tomography	and	nuclear	medicine	techniques	are	still	the	reference	standard	
for	 lung	 imaging,	but	 radiation	exposure	 is	a	major	concern;	especially	 in	case	of	 longitudinal	
examinations	and	in	children.	Therefore,	radiation-free	imaging	is	an	urgent	necessity.	Pulmo-
nary	magnetic	 resonance	 imaging	 (MRI)	 is	 radiation-free,	 but	 poses	 challenges	 since	 the	 low	
proton	density	and	the	presence	of	strong	mesoscopic	susceptibility	variations	considerably	re-
duce	 the	 detectable	MR	 signal.	 As	 a	 result,	 the	 lung	 typically	 appears	 as	 a	 “black	 hole”	with	
conventional	MRI	techniques.	Recently,	ultra-fast	balanced	steady-state	free	precession	(ufSSFP)	
methods	were	proposed	 for	ameliorated	 lung	morphological	 imaging.	 In	 this	 thesis,	ufSSFP	 is	
employed	to	develop	and	improve	several	pulmonary	functional	imaging	methods,	which	can	be	
used	in	clinical	settings	using	standard	MR	scanners	and	equipment.	
	
At	every	breath,	the	lung	expands	and	contracts,	and	at	every	heartbeat,	the	blood	is	pumped	
through	the	arteries	to	reach	the	lung	parenchyma.	This	creates	signal	modulations	associated	
with	pulmonary	blood	perfusion	and	ventilation	that	are	detectable	by	MRI.	The	second	chapter	
of	this	thesis	focuses	on	the	optimization	of	time-resolved	two-dimensional	(2D)	ufSSFP	for	per-
fusion-weighted	 and	 ventilation-weighted	 imaging	 of	 the	 lung.	 Subsequently,	 in	 the	 third	
chapter,	three-dimensional	(3D)	multi-volumetric	ufSSFP	breath-hold	imaging	is	used	to	develop	
a	lung	model	and	retrieve	the	measure	α,	a	novel	ventilation-weighted	quantitative	parameter.	
	
Oxygen-enhanced	MRI	exploits	the	paramagnetic	properties	of	oxygen	dissolved	in	the	blood,	
acting	as	a	weak	T1-shortening	contrast	agent.	When	breathing	pure	oxygen,	it	reaches	only	ven-
tilated	alveoli	of	 the	parenchyma	and	dissolves	only	 in	 functional	and	perfused	 regions.	How	
ufSSFP	 imaging	 in	combination	with	a	 lung	model	can	be	used	 to	calculate	 robust	3D	oxygen	
enhancement	maps	is	described	in	the	fourth	chapter.	In	addition,	in	the	fifth	chapter,	2D	inver-
sion	recovery	ufSSFP	imaging	is	employed	to	map	the	T1	and	T2	relaxation	times	of	the	lung,	the	
change	of	 the	relaxation	times	after	hyperoxic	conditions,	as	well	as	 the	physiological	oxygen	
wash-in	and	wash-out	time	(related	to	the	time	needed	to	shorten	T1	after	oxygen	breathing).	
	
The	objective	of	the	last	chapter	of	this	thesis	is	the	application	of	3D	ufSSFP	imaging	before	and	
after	intravenous	gadolinium-based	contrast	agent	administration	for	the	investigation	of	signal	
enhancement	ratio	(SER)	mapping:	a	rapid	technique	to	visualize	perfusion-related	diseases	of	
the	lung	parenchyma.	
	
The	techniques	presented	in	this	thesis	using	optimized	ufSSFP	pulse	sequences	demonstrated	
potential	to	reveal	new	insights	on	pulmonary	function	as	well	as	quantification,	and	might	be-
come	part	of	the	future	standard	for	the	evaluation	and	follow-up	of	several	lung	pathologies.	
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CHAPTER	1	
	 3	
1.1	 An	improved	respiratory	medicine	thanks	to	lung	MRI	
	
Pulmonary	diseases	are	among	the	leading	causes	of	morbidity	and	mortality	worldwide	[1,	2].	
The	lung	has	a	delicate	structure	and	limited	regenerative	capacity	[3],	and	consequently,	early	
diagnosis,	illness	quantification,	and	follow-up	examinations	play	a	pivotal	role	in	patient	man-
agement	as	well	as	interventions	to	avoid	life-long	alterations	[2,	4,	5].		
	
A	medical	examination	combined	with	 lung	stethoscope	auscultation	 is	 the	 first	and	simplest	
diagnostic	method	to	evaluate	morpho-functional	alterations	of	the	thorax	[6].	Pulmonary	func-
tion	 tests	 (PFTs)	 such	 as	 spirometry,	 plethysmography,	 and	 multiple-breath	 washout	
measurements	provide	a	global	measure	of	the	lung	disease	severity	and	progression	[7].	The	
strength	of	the	PFTs	relies	on	their	low	costs	and	the	standardization	of	normative	results	(e.g.,	
gender,	body	size,	age)	[8].	However,	PTFs	are	highly	effort-dependent	and	can	therefore	not	be	
performed	in	young	children	(e.g.,	<	5	years	old),	creating	a	diagnostic	gap	within	this	age	group	
[9].	Furthermore,	the	diagnostic	value	of	PFTs	and	stethoscope	auscultation	is	limited	as	they	are	
not	able	to	give	any	insight	on	exact	morphological	alterations	and	do	not	provide	quantification	
of	 regional	 lung	 function	or	 pathophysiological	mechanisms	 [10,	 11].	 In	 addition,	 these	 tech-
niques	are	often	not	sensitive	enough	to	detect	the	disease	in	its	early	stages	[12–14],	limiting	
opportunities	for	personalized	and	targeted	interventions	which	are	the	cornerstones	for	a	suc-
cessful	modern	respiratory	medicine.		
	
To	overcome	these	 limitations,	 several	 imaging	modalities	have	been	developed	 for	 the	non-
invasive	assessment	of	lung	morphology	and	function.	Currently,	the	clinical	gold	standard	meth-
ods	 for	 morphological	 investigations	 are	 chest	 X-ray	 and	 three-dimensional	 (3D)	 computed	
tomography	(CT)	[15,	16].	X-ray	examinations	offer	planar	images	with	a	low	radiation	dose	de-
livered	to	the	body,	while	CT,	at	the	cost	of	higher	radiation,	allows	electron	density	weighted	
3D	imaging	up	to	an	isotropic	resolution	of	about	0.3	mm.		
	
For	functional	measurements	of	the	lung,	nuclear	medicine	modalities	are	regarded	as	a	clinical	
gold	standard:	single-photon	emission	computed	tomography	(SPECT)	for	pulmonary	perfusion	
and	ventilation	assessment,	planar	scintigraphy	for	ventilation,	and	positron	emission	tomogra-
phy	 (PET)	 for	metabolic	 tissue	 imaging	 [5,	16–20].	These	techniques	are	based	on	radioactive	
nuclides	intravenously	injected	or	inhaled	(e.g.,	macroaggregates	or	aerosols	labelled	with	99mTc,	
81mKr,	133Xe,	18F),	have	a	relatively	low	spatial	and	temporal	resolution,	and	difficulties	to	obtain	
quantitative	outcomes	[21].	Figure	1.1	shows	representative	imagines	of	the	chest	obtained	with	
X-ray,	CT,	and	SPECT/CT.	
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Even	though	nuclear	medicine	and	CT	scientists	have	invested	continuously	significant	effort	in	
reducing	radiation	doses,	any	exposure	to	ionizing	particles	is	still	of	concern	[22–24];	especially	
for	 children	and	pregnant	women.	Furthermore,	 for	patients	who	 require	 frequent	 follow-up	
examinations	 for	monitoring	 the	disease	progression	and	 the	 response	 to	 therapeutic	 proce-
dures	(e.g.,	pharmacological	treatments	and	targeted	physiotherapy),	the	cumulative	radiation	
dose	would	be	a	hazard	[25].	
	
A	viable	solution	is	offered	by	magnetic	resonance	imaging	(MRI),	which	does	not	involve	any	
harmful	ionizing-radiation	but	employs	strong	electromagnetic	fields	and	radiofrequency	pulses.	
MRI	is	categorized	as	safe	and	is	unlikely	to	have	biological	effects	or	to	be	genotoxic	[26,	27].	
For	this	reason,	MRI	 is	well	suited	for	 long-term	structural	as	well	as	functional	monitoring	of	
lung	pathologies	[4,	28–33].	It	has	the	potential	to	accelerate	targeted	interventions,	thus	pre-
venting	severe	pulmonary	disease	exacerbation	and	permanent	alterations	(e.g.,	atelectasis)	that	
might	impair	the	life	of	patients	and	adversely	affect	the	growth	and	development	of	the	lung	in	
children.	
	
In	contrast	to	CT	where	the	measured	signal	intensity	is	proportional	to	electron	density,	in	pro-
ton	MRI,	the	signal	is	generated	by	the	density	and	magnetic	properties	of	hydrogen	nuclei	(1H)	
in	the	tissues,	i.e.,	spin-spin	(T2)	or	spin-lattice	(T1)	relaxation	times.	These	parameters	lead	to	a	
large	variety	of	contrasts,	 theoretically	 improving	the	distinctions	of	various	soft	 tissues	com-
pared	 to	 CT.	 Furthermore,	 with	 MRI,	 higher	 spatial	 and	 temporal	 resolutions	 are	 reached	
compared	to	nuclear	medicine	imaging	techniques,	offering	quantitative	insights	on	rapid	func-
tional	changes	and	physiology	[4,	28–33].	
	
	
	
Figure	1.1.	 X-ray	 (a),	CT	 (b),	 and	SPECT/CT	 (c)	 in	a	patient	with	 chronic	obstructive	pulmonary	disease	
(COPD).	Emphysema	and	bullae	are	indicated	by	the	arrowheads.		
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Until	recently,	however,	the	application	of	proton	MRI	to	study	lung	anatomy	and	function	was	
limited	due	to	technical	imaging	difficulties	arising	from	the	unique	biophysical	characteristics	of	
the	 lung	[28,	29,	34].	The	pulmonary	parenchyma	is	primarily	composed	of	blood	vessels	and	
alveoli,	creating	a	sponge-like	structure,	mainly	filled	with	air,	and	thus	characterized	by	a	proton	
density	that	is	5	to	20	times	lower	compared	to	other	human	organs.	Furthermore,	the	sponge-
like	structure	of	the	parenchyma	contains	macroscopic	and	microscopic	air	cavities	(e.g.,	bron-
chial	tree	and	alveoli)	as	well	as	dense	regions	of	lung	tissue	and	vessels.	These	air-tissue	and	air-
water	interfaces	create	high	susceptibility	differences	which	lead	to	intravoxel	phase	dispersion	
of	spins	and	a	rapid	MR	signal	decay,	challenging	MRI.	Lung	imaging	is	further	complicated	by	
the	continuous	respiratory	and	cardiac	motion,	blood	flow,	and	pulsation;	impairing	image	qual-
ity.	For	these	reasons,	the	lung	typically	appears	as	a	“black	hole”	with	conventional	proton	MRI	
[28]	as	evident	from	Figure	1.2a.	As	a	result,	non-proton	based	MRI	with	inhaled	hyperpolarized	
gaseous	tracers	(e.g.,	3He,	129Xe,	19F)	was	proposed	and	has	demonstrated	the	ability	to	measure	
various	pulmonary	functional	biomarkers	[11,	35–41].	However,	as	it	requires	specific	equipment	
and	trained	personnel,	broad	clinical	application	of	hyperpolarized	gas	MRI	is	not	feasible.	
	
In	the	last	decade,	dedicated	and	optimized	pulse	sequences	have	significantly	improved	proton	
MRI	of	the	lung	[4,	28,	29],	which	nowadays	is	broadly	available.	Recently,	rapid	acquisition	tech-
niques	with	very	short	echo	time	(TE)	or	repetition	time	(TR),	such	as	ultra-short	echo	time	(UTE)	
and	 ultra-fast	 steady-state	 free	 precession	 (ufSSFP)	 pulse	 sequences	 have	 shown	 promise	 to	
tackle	present	 limitations	of	 imaging	the	pulmonary	parenchyma	and	lung	structures	[42–47].	
The	speed	of	these	techniques	is	further	driven	by	optimized	data	acquisition	trajectories	com-
bined	with	multichannel	phased	array	coils	for	parallel	imaging	[48–50].	Specifically,	a	short	echo	
time	for	UTE	or	a	short	repetition	time	for	ufSSFP,	combined	with	parallel	imaging	and	specific	
acquisition	trajectories,	reduces	the	acquisition	time	while	increasing	the	detected	spin	signal,	
mitigating	motion-related	artifacts,	and	allowing	for	higher	temporal	and	spatial	resolution.	Rep-
resentative	UTE	and	ufSSFP	images	are	shown	in	Figure	1.2.		
	
Nowadays,	thanks	to	the	continuous	commitment	of	scientists	and	advances	in	pulmonary	MRI,	
various	methods	have	been	developed	to	explore	the	lung	morphology,	the	tissue	characteris-
tics,	and	function	[4,	28–33,	40,	41,	46,	47,	51].	Importantly,	to	date,	these	novel	MR	methods	
are	investigated	in	patients,	allowing	for	new	insights	on	pathophysiological	processes	and	tar-
geted	therapy,	as	well	as	longitudinal	monitoring	of	the	disease	and	treatments	outcome	[14,	33,	
47,	52–56].	Lung	MRI	is	laying	fundamental	building	blocks	for	a	successful	modern	respiratory	
medicine.		
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1.2	 The	human	lung	
	
1.2.1	 Anatomy	
	
The	respiratory	apparatus	comprises	all	the	organs	involved	in	breathing,	and	its	cardinal	func-
tion	is	to	ensure	a	balanced	blood	oxygenation	and	removal	of	carbon	dioxide	(CO2)	produced	by	
the	cellular	respiration	[8,	57–59].	The	respiratory	system,	as	exemplarily	shown	in	Figure	1.3,	is	
divided	into	an	upper	and	lower	tract.	The	upper	tract	includes	the	nose,	nasal	passage,	sinuses,	
pharynx,	and	a	portion	of	the	larynx	above	the	vocal	cords;	the	lower	tract	 include	the	larynx	
(below	the	vocal	cords),	trachea,	bronchi,	bronchioles,	terminal	bronchioles,	respiratory	bron-
chioles,	alveolar	ducts,	and	alveolar	sacs.	Alveolar	sacs	contain	a	collection	of	alveoli,	densely	
surrounded	by	blood	capillaries	in	which	the	gas	exchange	takes	place	by	diffusion.	The	lower	
respiratory	tract	is	lined	with	the	respiratory	epithelium.	This	ciliated	epithelium,	covered	by	mu-
cus	secreted	by	mucous	glands	and	by	the	bronchial	walls,	removes	endogenous	particles	(e.g.,	
dust,	bacteria)	from	the	lung	thanks	to	the	movement	of	the	cilia.		
	
Humans	have	two	lungs	that	are	embedded	in	the	thorax.	The	lung	comprises	bronchi,	bronchi-
oles,	 terminal	 bronchioles,	 respiratory	 bronchioles,	 alveolar	 ducts,	 alveoli,	 blood	 vessels,	 and	
	
Figure	1.2.	MRI	of	a	healthy	 subject.	 In	(a),	a	gradient	echo	sequence	with	 long	TE	 is	used	for	 imaging	
resulting	in	a	very	weak	pulmonary	tissue	signal	such	that	the	lung	appears	as	a	“black	hole”.	UTE	[43]	(b)	
and	ufSSFP	[45]	(c)	imaging	allow	capturing	the	signal	of	the	pulmonary	tissue.		
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pulmonary	interstitium.	The	pulmonary	interstitium	is	a	collection	of	connective	tissues	within	
the	 lung	 that	 includes	 the	 alveolar	 epithelium,	 pulmonary	 capillary	 endothelium,	 basement	
membrane,	perivascular	and	perilymphatic	tissues.	The	lung	parenchyma	consists	of	mixed	struc-
tures	involved	in	the	gas	transfer,	such	as	respiratory	bronchioles,	alveolar	ducts,	alveoli,	blood	
vessels,	and	pulmonary	interstitium.	
	
Both	lungs	are	covered	by	a	visceral	pleura;	the	interstitium	between	the	visceral	pleurae	and	
the	parietal	pleura	attached	to	the	thoracic	cavity	is	filled	with	lubricant	serous	fluids	to	increase	
the	sliding	of	the	lung	inside	the	thorax	during	respiration.	The	visceral	pleura	covers	the	lungs	
	
Figure	1.3.	Left:	schematic	of	the	respiratory	system.	Top	right:	acinus	region	and	a	cutaway	of	the	alveoli.	
Bottom	right:	gas	exchange	by	diffusion	through	the	alveolar-capillary	membrane.	To	note	the	different	
partial	pressures	of	O2	and	CO2	 in	the	 inspired	/	expired	air	 (top	 left),	 in	the	alveolar	air,	and	arterial	/	
venous	capillaries	(bottom	right).	Adapted	from	[60]	(licensed	under	Creative	Commons).	
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and	divides	the	right	lung	into	three	lobes,	and	the	left	lung	into	two	lobes.	The	pleural	separa-
tions	between	the	lobes	are	known	as	fissures	(see	Fig.	1.3).	The	lobes	are	supplied	by	secondary	
bronchi.	The	lobes	are	further	divided	into	segments	defined	as	the	lung	regions	supplied	by	any	
tertiary	bronchus.	The	right	lung	is	divided	into	10	segments,	and	the	left	into	8-9	segments	(i.e.,	
depending	on	the	subject,	two	segments	might	result	fused	together).	The	segments	are	subdi-
vided	 into	pulmonary	 lobules,	defined	as	 the	most	distal	 lung	units	 served	by	 the	 respiratory	
bronchioles.		
	
The	tracheobronchial	tree	is	an	intricate	system	that	transports	gases	from	the	trachea	to	the	
alveoli,	as	illustrated	in	Figure	1.4.	It	is	divided	into	23	generations	of	dichotomous	branching,	
from	the	trachea	(generation	0)	to	the	alveolar	sacs	(generation	23).	The	initial	16	generations,	
(bronchi	to	terminal	bronchioles)	form	the	conducting	zone	of	the	airways	that	transport	gases	
from	and	to	the	exterior.	The	remaining	7	generations	(respiratory	bronchioles	to	alveolar	sacs)	
form	the	respiratory	zone,	where	the	gas	exchange	takes	place	[57,	59,	61–63].		
	
The	tree	structure	of	the	lung	allows	increasing	the	number	of	the	alveoli	considerably	and	there-
fore	the	gas	exchange	surface	(cf.	Fig.	1.4).	The	human	lung	has	almost	300-500	million	alveoli,	
which	make	the	lung	appear	like	a	sponge.	The	total	area	of	the	alveolar	wall	is	about	70-140	m2	
(similarly	to	the	size	of	a	tennis	court).	The	alveoli	have	a	diameter	of	about	0.1-0.3	mm	(Fig.	
1.4d)	and	are	densely	surrounded	by	capillaries	of	ca.	7-10	μm	in	diameter	(Fig.	1.4e).	The	capil-
laries	have	a	similar	size	to	a	red	blood	cell,	ca.	6-8	μm	(cf.	Fig	1.4e).	Alveolar	air	and	capillary	
blood	are	separated	only	by	the	alveolar	epithelium	and	capillary	endothelium,	which	form	a	0.5	
μm	thin	wall	(known	as	alveolar-capillary	membrane)	that	allows	the	gas	exchanges	(cf.	Fig.	1.4e).	
	
The	lung	tissue	has	a	total	mass	of	about	500	g,	and	its	density	is	about	0.25-0.1	g/cm3,	depending	
on	the	respiratory	phase	(i.e.,	lung	volume	for	a	specific	inspiratory	level).	In	contrast,	other	hu-
man	tissues	and	organs	have	a	density	of	about	1	g/cm3.	
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Figure	1.4.	(a)	Cast	of	the	human	lung	revealing	the	complexity	of	the	bronchial	and	circulatory	system.	(b)	
A	close-up	of	the	distal	arteries	(red)	and	veins	(blue)	that	are	closely	attached	to	the	airways	(yellow).	(c)	
Electron	microscope	scan	showing	small	respiratory	bronchioles	and	alveoli.	(d)	A	zoom-in	of	the	alveolar	
duct	surrounded	by	alveoli.	(e)	A	further	zoom-in	of	the	alveolar	wall	composed	primarily	by	blood	capillaries	
(tubular	structures	as	marked	by	the	green	arrowhead);	air	and	blood	are	separated	by	the	very	thin	alveo-
lar-capillary	membrane	(yellow	arrowhead),	allowing	gas	diffusion;	a	red	blood	cell	in	a	capillary	is	indicated	
by	the	red	arrowhead.	 (f)	Schematic	of	the	airway	branching	according	to	the	model	of	Weibel	[62]	and	
approximate	dimensions	of	the	respective	structures.	(a-e)	and	(f)	are	adapted	from	[63]	(licensed	under	
Creative	Commons)	and	[59],	respectively.	
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1.2.2	 Pulmonary	circulatory	system	
	
The	blood	flow	in	the	lung	is	supplied	by	both	the	pulmonary	and	bronchial	circulation.	The	pul-
monary	 circulation	 is	 responsible	 for	 the	 blood	 re-oxygenation.	 The	 deoxygenated	 blood	 in	
return	from	the	body	(systemic	circulation),	is	pumped	by	the	right	ventricle	into	the	pulmonary	
arteries.	Similarly	to	the	tracheobronchial	tree,	the	arteries	branch	off	until	the	respiratory	bron-
chioles.	The	blood	then	passes	through	the	dense	network	of	the	capillary	bed	that	lies	in	the	
wall	of	the	alveoli,	where	it	gets	oxygenated,	to	finally	flow	back	to	the	left	atrium	via	the	pul-
monary	veins.	An	illustration	of	the	lung	anatomy	with	a	depiction	of	the	main	pulmonary	vessels	
is	shown	in	Figure	1.5.	The	bronchial	circulation	nourishes	the	lung	tissue.	A	part	of	the	oxygen-
ated	blood	from	the	aorta	passes	through	the	bronchial	arteries	to	supply	the	bronchi	and	the	
pulmonary	parenchymal	connective	tissue.	The	majority	of	the	deoxygenated	blood	of	the	bron-
chial	circulation	returns	directly	 into	the	pulmonary	vein,	and	a	part	returns	via	the	bronchial	
veins	to	the	circulatory	system.	
	
	
		
Figure	1.5.	Anatomy	of	the	thorax	depicting	the	tangled	structure	of	the	pulmonary	circulatory	system.	
Adapted	from	[64]	(licensed	under	Creative	Commons).	
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1.3	 Physiology	of	the	lung	
	
1.3.1	 Ventilation	and	gas	diffusion	
	
The	respiratory	tract	works	as	a	system	of	pipes	 in	which	air	 is	 funneled	 into	the	 lung.	 In	this	
tract,	the	air	gets	warmed,	filtered,	and	moistened	until	it	reaches	the	alveoli	where	the	gas	ex-
changes	 take	place	by	diffusion:	 the	oxygen	 (O2)	enters	 the	 red	blood	cells	 in	 the	pulmonary	
capillaries	while	the	CO2	exits	the	blood	and	enters	the	alveoli.	Diffusion	takes	place	across	the	
alveolar-capillary	membrane	due	to	gradients	in	the	partial	pressure	of	gases	(Fick’s	Law),	as	de-
picted	in	Figure	1.3	on	the	right.	The	airflow	in	and	out	of	the	lung	(inspiration	and	expiration)	is	
generated	by	the	respiratory	muscles	(chest	wall	and	diaphragm),	which	increase	and	decrease	
the	size	of	the	thoracic	cavity.	During	this	process,	the	lung	parenchyma	expands	and	contracts.	
	
The	size	of	the	lung	depends	on	many	physiological	factors,	such	as	height,	body	weight,	gender,	
age,	ethnicity,	and	health	condition.	The	volume	of	air	 in	 the	 lung	during	respiration	changes	
continuously,	and	consequently,	the	lung	volume	is	varying	as	well.	Figure	1.6	shows	typical	lung	
volumes	and	capacities	for	a	70	kg	healthy	adult	male.	During	quiet	breathing,	the	lung	volume	
at	end	expiration	is	about	2400	ml	(Functional	Residual	Capacity,	FRC)	and	500	ml	of	air	are	in-
spired/expired	per	breath	(Tidal	Volume,	TV).	Assuming	that	12	to	15	breaths	occur	per	minute,	
a	total	of	6-8	L	of	air	is	inspired/expired	per	minute.	At	maximal	possible	inspiration,	the	volume	
of	the	lung	reaches	6000	ml	(Total	Lung	Capacity,	TLC);	at	maximal	expiration,	1200	ml	(Residual	
Volume,	 RV).	 Various	 parameters	 regarding	 lung	 ventilation	 can	 be	 quantified	 by	 pulmonary	
function	tests	(PFTs)	such	as	spirometry,	plethysmography,	and	multiple-breath	nitrogen	wash-
out	measurements.	 Since	 pulmonary	 pathologies	 can	 alter	 lung	 capacities	 and	 global	 values	
related	to	ventilation,	PFTs	are	the	first	clinical	measurement	for	pulmonary	investigation.	
	
1.3.2	 Perfusion	
	
Alveolar	ventilation	combined	with	blood	supply	in	the	capillaries	of	the	alveolar	wall	is	required	
for	adequate	gas	exchange.	To	this	end,	the	heart	pumps	continuously	blood	through	the	pul-
monary	artery	at	a	rate	of	almost	70	ml	per	heart-beat	(at	rest,	for	a	70	kg	healthy	adult	male).	
Considering	a	heart	rate	of	70	beats/min,	the	cardiac	output	is	about	5	L/min.	The	blood	in	the	
pulmonary	artery	flows	at	a	velocity	of	about	70	cm/s,	but	due	to	the	 large	capillary	bed	and	
vascular	 resistance,	 the	 speed	 of	 blood	 falls	 rapidly	 when	 it	 passes	 through	 the	 capillaries	
(<1cm/s).	A	red	blood	cell	takes	about	4	to	5	seconds	to	travel	through	the	pulmonary	circulation,	
spending	about	0.75	seconds	in	the	pulmonary	capillaries.	The	blood	volume	in	the	lung	(pulmo-
nary	circulation)	is	about	300	ml,	amongst	which	75	ml	are	found	in	the	capillaries.		
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1.3.3	 Regional	distribution	of	pulmonary	ventilation	and	perfusion	
	
The	dorsal	(dependent)	part	of	the	lung	is	denser	of	vessels,	capillaries,	and	parenchyma	com-
pared	to	the	ventral	part	[65,	66].	Furthermore,	the	supine	position	conventionally	employed	for	
imaging	affects	the	lung	density,	the	ventilation,	and	the	perfusion.	When	lying	on	the	back,	the	
gravitational	force	lets	the	lung	collapse	under	its	own	weight,	compressing	the	lung	structure,	
particularly	in	the	dorsal	part	(see	Fig.	3.1).	Furthermore,	the	gravitational	force	acts	on	the	pul-
monary	 blood,	 which	 is	 consequently	 increased	 in	 the	 posterior	 lung	 as	 well	 (see	 Fig	 6.4).	
Therefore,	 in	supine	position,	compared	to	 the	ventral	 region,	 the	posterior	 region	 is	denser,	
more	ventilated	(cf.	Fig.	3.4),	and	more	perfused	[66–73].		
	
1.3.4	 Ventilation-perfusion	ratio	in	the	lung	
	
An	adequate	balance	between	ventilation	and	perfusion	is	crucial	for	efficient	exchange	within	
the	lung.	It	would	be	unfavorable	to	have	a	region	of	the	lung	that	is	ventilated	but	not	perfused,	
since	in	this	case	no	flowing	blood	could	be	oxygenated.	Or	on	the	contrary,	it	would	be	disad-
vantageous	to	have	a	perfused	part	of	the	lung	which	is	not	ventilated.	
	
Figure	1.6.	Representative	breathing	pattern	 indicating	typical	lung	volumes	and	capacities	for	an	adult	
male.	1)	 Tidal	 volume	 (TV):	 air	 inspired/expired	during	quiet	breathing.	2)	 Functional	 residual	 capacity	
(FRC):	volume	of	air	in	the	lung	at	the	end	of	tidal	expiration.	3)	Expiratory	reserve	volume	(ERV):	maximal	
expired	air	from	the	end	of	tidal	expiration.	4)	Residual	volume	(RV):	volume	of	air	in	the	lung	after	a	forced	
expiratory	manoeuver.	5)	Inspiratory	capacity	(IC):	maximal	volume	of	air	inspired	from	the	end	of	tidal	
expiration.	6)	Inspiratory	reserve	volume	(IRV):	maximal	volume	of	air	inspired	from	the	end	of	tidal	inspi-
ration.	7)	Vital	capacity	(VC):	maximal	amount	of	air	that	can	be	expired	after	a	forced	inspiration.	8)	Total	
lung	capacity	(TLC):	volume	of	air	in	the	lung	after	maximal	inspiration.	
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The	lung	ventilation	(V',	in	ml	of	air	per	minute	and	per	100	ml	of	tissue)	to	perfusion	(Q',	in	ml	
of	blood	per	minute	and	per	100	ml	of	tissue)	ratio	(V'/Q')	assesses	the	efficiency	of	gas	exchange	
and	pulmonary	perfusion,	i.e.,	the	air	ventilating	the	alveoli	and	the	blood	flowing	in	the	capil-
laries.	The	average	ventilation-perfusion	ratio	in	the	whole	lung	at	rest	is	ranging	from	0.8	to	1.2.	
In	a	healthy	lung,	due	to	the	natural	inhomogeneities	of	the	organ,	regional	values	of	V'/Q'	can	
slightly	differ	from	the	average	[74].	Furthermore,	since	the	ventral-to-dorsal	perfusion	gradient	
is	greater	than	the	ventilation	gradient,	dorsal	(dependent)	lung	regions	have	lower	V'/Q'	(~0.8)	
than	ventral	regions	(~1.2).	Pulmonary	pathologies	can	substantially	alter	these	values.	Hence,	
methods	to	measure	ventilation,	perfusion,	and	ventilation-perfusion	ratio	are	clinically	relevant.	
	
The	 ventilation-perfusion	 ratio	 in	 the	 lung	 is	 regulated	 by	 vasoconstriction	 and	 bronchocon-
striction.	 In	 case	of	 local	 alveolar	 hypoxia	 (reduced	 ventilation,	 e.g.,	 caused	by	obstructions),	
vasoconstriction	occurs	 in	that	area,	diverting	the	blood	to	other	ventilated	lung	regions.	This	
physiological	phenomenon	is	named	Euler-Liljestrand	mechanism	[75].	Similarly,	 in	case	of	re-
duced	perfusion	(e.g.,	embolism),	bronchoconstriction	reduces	ventilation	in	the	affected	area,	
automatically	shifting	ventilation	away	from	the	poorly	perfused	regions	[58,	76,	77].	
	
The	Euler-Liljestrand	mechanism	is	driven	by	the	partial	pressures	of	O2	and	CO2in	the	alveoli.	In	
case	of	ventilation	obstructions,	in	the	alveoli	PO2	will	drop	since	less	air	is	entering,	and	PCO2	
will	rise	because	less	CO2	can	be	expired.	On	the	contrary,	when	perfusion	is	reduced,	the	alveo-
lar	PCO2	will	drop	(hypocapnia)	because	less	CO2	exits	the	blood,	and	since	less	O2	dissolves	into	
blood,	PO2	will	be	higher	than	healthy	lung	units	(alveolar	PO2	is	determined	by	a	balance	be-
tween	O2	delivered	by	the	ventilation	and	O2	removal	by	the	blood	flow)	[57,	58].	
	
	
1.4	 Pulmonary	disorders	
	
Many	pathologies	can	change	the	tissue	characteristics	and	mechanical	properties	of	the	lung,	
affecting	its	function.	Lung	pathologies	might	result	in	an	increase	of	the	lung	density,	referred	
to	as	“plus-pathologies”,	or	in	a	decreased	lung	density,	referred	to	as	“minus-pathologies”	[4,	
15,	30].	
	
Plus-pathologies	are	characterized	by	an	increase	of	cellular	tissue	(nodules,	masses,	fibrosis),	
fluid	accumulation	(mucus,	effusion,	oedema),	or	collapse	of	the	existing	pulmonary	structures	
(atelectasis).	These	pathological	conditions	often	have	consequences	on	pulmonary	perfusion	
and	ventilation.	For	example,	 in	subjects	with	cystic	fibrosis,	reduced	ventilation	as	caused	by	
mucus	 plugs	 frequently	 occurs,	 and	 hypoxia	 will	 automatically	 decrease	 perfusion	 (Euler-
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Liljestrand	mechanism).	Similarly,	in	subjects	with	lung	tumor,	direct	occlusions	of	arteries	and	
airways	might	take	place	and	hamper	pulmonary	ventilation	as	well	as	perfusion.	
	
Minus-pathologies	manifest	as	hyperinflation,	enlargement	and	destruction	of	air	spaces	with	
emphysema,	tissue	elasticity	decline,	as	well	as	air-trapping;	for	instance,	in	chronic	obstructive	
pulmonary	disease	(COPD)	and	asthma.	Due	to	alveolar	hypoxia,	minus-pathologies	are	also	char-
acterized	by	a	reduction	in	blood	volume	as	caused	by	hypoxic	vasoconstriction	as	well	as	chronic	
inflammations.	 These	 factors	 can	 lead	 to	 airway	 function	decline	 and	 tissue	 remodeling	 (i.e.,	
bronchoconstriction,	bronchial	wall	thickening,	fibrosis).	Further	extension	of	the	minus-pathol-
ogies	 group	 might	 include	 vascular	 disorders	 caused	 by	 emboli	 and	 cardiac	 diseases	 (e.g.,	
congestive	heart	failure),	which	directly	result	in	reduced	lung	perfusion	and	might	cause	perma-
nent	damages	of	the	pulmonary	tissue	and	function.	
	
Representative	MR	images	of	subjects	with	plus-pathologies	can	be	found	in	Chapters	1,	3	and	6	
(Figs.	1.7,	1.8,	A3.3,	6.9,	and	6.11),	and	with	minus-pathologies	in	Chapters	3	and	6	(Figs.	3.6,	6.7,	
and	6.8).	
	
	
1.5	 What	do	we	wish	to	measure?	
	
Pulmonary	disorders	are	represented	by	alterations	of	tissue	structures	and	functions.	To	assess	
these	subtle	changes,	non-invasive,	radiation-free,	robust,	and	rapid	imaging	modalities	are	re-
quired,	 offering	 high	 resolution	 as	 well	 as	 high	 sensitivity	 and	 specificity	 for	 clinical	
interpretation.	For	morphological	diagnostics,	we	thus	aim	for	quantitative	visualization	of	bio-
physical	 characteristics	 such	as	electron	density,	proton	density,	 the	concentration	of	various	
metabolites,	transversal	and	longitudinal	relaxation	times,	alveolar	size,	and	characterization	of	
biological	cells.	For	functional	assessment	of	the	lung,	ideally,	we	would	need	quantitative	imag-
ing	of	haemodynamics,	ventilation	and	air-flow	dynamics,	mechanics	of	breathing,	gas	diffusion	
(i.e.,	gas	exchange),	tissue	elasticity,	and	metabolic	imaging.	
	
Nowadays,	it	is	possible	to	image	many	of	these	biomarkers.	Magnetic	resonance	imaging	is	such	
an	imaging	modality,	which	is	not	only	widely	available	in	the	clinical	setting,	but	also	essentially	
radiation-free.	Over	the	years	various	MRI	techniques	have	been	developed	for	the	assessment	
of	 lung	 morphology,	 tissue	 characteristics	 (T1,	 T2,	 T2*),	 perfusion	 (commonly	 using	 contrast	
agents),	ventilation,	and	the	dynamics	of	breathing	[4,	28–33,	40,	41,	46,	47,	51].	Pulmonary	MRI,	
however,	is	complicated	by	many	factors	[28,	29,	34],	and	there	is	much	room	for	further	meth-
ods	development.		
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1.6	 The	challenges	of	lung	MRI	
	
Pulmonary	imaging	with	MR	is	complex	[28,	29,	34].	First,	the	lung	has	a	proton	density	that	is	5	
to	20	times	lower	compared	to	other	organs.	Since	the	acquired	MR	signal	is	directly	proportional	
to	the	proton	density,	lung	tissue	suffers	from	a	considerably	reduced	signal-to-noise	ratio.		
	
Second,	the	lung	has	an	extremely	short	apparent	relaxation	time	(T2*),	since	it	is	exceptionally	
heterogeneous	and	contains	a	multitude	of	air-tissue	and	air-blood	interfaces.	The	lung	is	com-
posed	of	tissue	and	blood,	which	are	diamagnetic	[78].	But	it	is	also	filled	with	air,	which	contains	
oxygen	and	 is	paramagnetic.	These	 interfaces	cause	microscopic	susceptibility	effects,	 i.e.,	 in-
travoxel	magnetic	field	variations	and	varying	field	gradients,	which	perturb	the	local	MR	main	
magnetic	field	(B0).	The	local	magnetic	field	inhomogeneity	creates	a	wide	frequency	distribution	
in	the	voxels	and	a	frequency	shift,	leading	to	a	broad	distribution	of	Larmor	frequencies.	As	a	
result,	the	air-tissue	and	air-blood	interfaces	effect	a	strong	dephasing	of	the	net	transverse	mag-
netization.	The	induced	fast	signal	decay	challenges	lung	MRI.	The	apparent	relaxation	rate	(T2*)	
is	extremely	short,	approximately	1-2	ms	at	1.5	Tesla	(T)		[79].	Contrarily,	the	T2	relaxation	rate	
originating	by	spin-spin	dephasing	is	approximately	66	ms	for	lung	tissue	at	1.5T	and	the	T1	relax-
ation	time	is	relatively	long,	about	1375	ms	[46];	similarly	to	other	tissues	of	the	human	body.	
Importantly,	increasing	the	MR	field	strength	(e.g.,	from	1.5T	to	3T)	results	in	a	higher	observable	
MR	signal	 for	 imaging	 (and	 theoretically	a	higher	 signal-to-noise	 ratio).	However,	higher	 field	
strengths	come	along	with	generally	decreased	tissue	T2	relaxation	times	as	well	as	enhanced	
susceptibilities	effects	 leading	to	an	even	 faster	T2*	signal	decay.	Thus,	a	higher	 field	strength	
poses	additional	challenges	for	lung	MR.		
	
Third,	MRI	can	be	hampered	by	organ	motion	caused	by	breathing,	cardiac	and	blood	pulsation.	
The	respiratory	movement	has	two	consequences:	imaging	has	to	be	performed	either	with	rapid	
acquisitions	that	are	robust	in	the	presence	of	breathing	motion	(e.g.,	time-resolved,	triggered,	
or	self-navigated);	or	with	feasible	breath-holding	maneuvers	(<20	seconds).	Moreover,	imaging	
has	to	be	insensitive	to	cardiac	pulsation	and	blood	flow,	since	these	effects	can	substantially	
impair	the	image	quality.	
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1.7	 What	lung	MRI	offers	
	
Despite	physical	and	 technical	 complexities,	 several	 imaging	 sequences	have	been	developed	
and	optimized	specifically	for	lung	MRI.	To	address	the	difficulties	given	by	the	extremely	fast	
dephasing	of	the	spins	in	the	lung	tissue	(T2*	decay),	specific	gradient	echo	(GRE)	and	fast	spin-
echo	(SE)	MR	sequences	with	very	short	echo	time	(TE)	and	repetition	time	(TR)	have	been	pro-
posed	[42–47].	The	strength	of	MRI	is	its	versatility	in	visualizing	both	morphology	and	functions	
in	one	single	examination.	In	this	section,	selected	methods	for	lung	MRI	are	described.	
	
1.7.1	 Morphological	imaging	
	
1.7.1.1	 Clinical	protocols	
In	the	past	years,	several	comprehensive	diagnostic	protocols	have	been	suggested	for	the	as-
sessment	of	a	wide	range	of	pulmonary	disorders	[4,	15,	28–30,	80].	For	diagnostic	imaging	of	
the	chest	in	less	than	15	minutes,	standard	non-contrast	enhanced	protocols	include:	
	
• T2-weighted	 fast	 spin	 echo	 (e.g.,	 half-Fourier	 acquisition	 single-shot	 turbo	 spin	 echo,	
HASTE)	[81]	in	breath-holding	for	imaging	fluids,	mucus,	infections,	blood,	thickening	of	
bronchial	walls,	nodules,	masses,	and	lymph	node.	Acquisition	time	20	seconds,	TE	of	
20-40	ms	and	TR	of	500	ms,	coronal	orientation,	resolution	2.3	×	2.3	×	6	mm3.	Compare;	
Figure	1.7a.	
	
• T2-weighted	fast	spin	echo	(e.g.,	PROPELLER	or	BLADE)	[82]	respiratory	triggered	(navi-
gator)	in	free-breathing	for	subjects	unable	to	perform	breath-holding.	Acquisition	time	
5-8	min,	TE	of	80-120	ms	and	TR	of	800-2500	ms,	transverse	orientation,	resolution	2	×	
2	×	5	mm3.	Compare;	Figure	1.7b.	Alternatively,	T2-weighted	fat	saturated	short	TI	inver-
sion	recovery	(STIR)	[83]	in	multiple	breath-holdings.	Acquisition	time	~4	min,	TE	110	of	
ms	and	TR	of	3500	ms,	transverse	orientation,	resolution	2.1	×	1.6	×	6	mm3.		
	
• Time-resolved	T2/T1-weighted	balanced	SSFP	[84]	 in	 free-breathing	for	visualizing	ves-
sels,	pulmonary	emboli,	nodules,	cardiac	dysfunctions,	as	well	as	respiratory	mechanics	
(e.g.,	adhesion	of	the	pleurae).	Acquisition	time	40	seconds	for	120	images,	TE	of	0.9	
ms,	TR	of	1.8	ms,	coronal	orientation,	resolution	2.4	×	2	×	4	mm3.	Compare;	Figure	1.7c.	
	
• 3D	T1-weighted	spoiled	gradient	echo	(e.g.,	volumetric	interpolated	breath-hold	exami-
nation,	VIBE)	[85]	in	breath-holding	for	the	assessment	of	chest	masses,	lymph	nodes,	
nodules,	and	consolidations.	Acquisition	time	~20	seconds,	TE	of	1ms	and	TR	of	2-3ms,	
transverse	orientation,	resolution	1.8	×	1.8	×	4	mm3.	Compare;	Figures	1.8a	and	6.3.	
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1.7.1.2	 Ultra-short	echo	time	
Ultra-short	echo	time	(UTE)	imaging	is	another	promising	sequence	for	imaging	tissues	with	rapid	
T2*	decay.	UTE	was	proposed	more	than	two	decades	ago	for	lung	parenchyma	visualization	[86].	
Technical	difficulties	and	 relatively	 long	 scan	 times	 limited	 its	 integration	 into	 the	pulmonary	
protocols	of	the	clinical	routine.	Nevertheless,	UTE	has	shown	promising	results	in	several	spe-
cific	lung	studies	[55,	87,	88].	
	
The	pulse	sequence	tackles	the	rapid	T2*	decay	in	the	lung	with	ultra-short	TE	of	about	50-100	μs	
(TR	=	3-8	ms).	To	reduce	motion	artifacts	and	increase	acquisition	speed,	UTE	uses	non-Cartesian	
trajectories	such	as	spiral	or	radial	centered-out,	accelerated	with	parallel	acquisitions	and	re-
constructions	[30,	89,	90].	Furthermore,	to	minimize	the	TE,	the	sampling	of	the	k-space	center	
starts	directly	after	the	RF	excitation	and	during	the	ramp-up	of	the	readout	gradient.	The	TE	of	
UTE	refers	to	the	acquisition	of	the	central	k-space,	while	the	TE	in	the	outer	k-space	is	length-
ened.	Due	 to	 the	 acquisition	 during	 various	 TE,	 the	 T2*	 (and	 T2)	 decay	 is	 considerable,	which	
results	in	a	spread	of	the	signal,	blurring	the	image;	the	resolution	of	UTE	thus	differs	from	the	
	
Figure	1.7.	HASTE	(a),	BLADE	(b),	coronal	time-resolved	2D	ufSSFP	(c),	and	3D	ufSSFP	(d)	acquired	in	a	child	
with	cystic	fibrosis.	Mucus	plugs	are	visible	on	both	the	superior	lobes	of	the	lung,	as	exemplarily	depicted	
by	the	arrowheads	in	(a).	While	HASTE,	BLADE,	and	2D	ufSSFP	belong	to	the	standard	protocols	suggested	
in	the	literature	for	lung	radiological	assessment,	3D	ufSSFP	was	only	recently	proposed	for	chest	imaging	
providing	volumetric	coverage	at	isotropic	resolution	[45,	47].	
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nominal	 one.	 Furthermore,	 streaking	 artifacts	 and	 blurring	 are	 also	 caused	 by	 the	 complex	
readout	trajectories.		
	
Since	the	signal	of	UTE	is	acquired	at	diverse	echo	time,	the	contrast	has	a	complex	behavior,	but	
optically	might	resemble	proton-density	and	is	visually	alike	to	CT	imaging.	Recent	implementa-
tions	allow	for	3D	imaging	of	about	2	×	2	×	5	mm3	in	16	seconds	breath-holding	[43]	(TE	of	0.06	
ms	and	TR	of	3.3	ms,	see	Figs.	1.2b	and	1.8b	for	representative	images),	or	for	free-breathing	
self-navigated	imaging	with	an	isotropic	resolution	of	1	mm	in	10-15	minutes’	acquisition	time	
[42,	44].	
	
	
	1.7.2	 Pulmonary	relaxometry	
	
Relaxometry	has	been	investigated	as	a	potential	quantitative	biomarker	for	the	assessment	of	
several	pathologies	 in	 the	human	body	 [91].	For	 the	 lung,	a	multitude	of	 technique	has	been	
proposed.	For	T1	quantification,	inversion	recovery	(IR)	half-Fourier	acquisition	single-shot	turbo	
spin	echo	(IR-HASTE)	and	snapshot-fast	low-angle	shot	(FLASH)	[92,	93].	For	simultaneous	meas-
urement	of	T1	and	T2*,	a	UTE	implementation	has	been	recently	introduced	for	3D	imaging	with	
scan	time	of	about	10	min	[94].	Clinical	transition	of	these	techniques	is	still	limited	by	relatively	
long	scan	times.	For	simultaneous	quantification	of	T1,	T2,	as	well	as	proton	density,	IR-ufSSFP	has	
	
Figure	1.8.	VIBE	 (a),	 UTE	 (b),	 and	3D	ufSSFP	 (c)	 imaging	 in	a	patient	with	a	non-small	 cell	 lung	 cancer	
(NSCLC)	invading	the	left	inferior	lobe	of	the	lung,	as	exemplarily	indicated	by	the	red	arrowheads	in	(a).	
The	yellow	arrowhead	in	(b)	point	to	a	typical	artifact	seen	with	UTE	related	to	the	spiral	trajectory,	espe-
cially	in	case	the	chest	is	very	large	or	not	perfectly	positioned	in	the	center	of	the	field-of-view.		
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recently	shown	compelling	results	for	rapid	and	robust	2D	acquisition	in	 less	than	10	seconds	
breath-holding	 for	a	 resolution	of	2.4	×	2.4	×	10	mm3	 [46].	Representative	quantitative	maps	
obtained	with	IR-ufSSFP	imaging	can	be	found	in	Chapter	5	(Fig.	5.1).		
	
1.7.3	 Functional	imaging	
	
The	fundamental	function	of	the	lung	is	to	ensure	blood	oxygenation	and	elimination	of	carbon	
dioxide,	which	 is	achieved	 through	pulmonary	ventilation,	gas	diffusion,	and	blood	perfusion.	
Measuring	qualitatively	and	quantitatively	these	complex	physiological	processes	is	a	necessity	
to	evaluate	the	disease	progression,	prognosis	and	treatment	outcomes.	Herewith,	chosen	MR	
functional	techniques	are	described.	
	
1.7.3.1	 Dynamic	contrast-enhanced	MRI	
Dynamic	contrast-enhanced	MRI	(DCE-MRI)	is	the	standard	clinical	technique	for	perfusion	im-
aging,	allowing	for	mapping	blood	flow	(i.e.,	perfusion,	 in	ml	of	blood	delivered	per	minute	in	
100	ml	of	tissue),	volume,	and	mean	transit	time	[28,	29].	DCE-MRI	allows	mapping	haemody-
namics	and	visualizing	perfusion-related	 impairments.	Nevertheless,	DCE-MRI	also	permits	an	
indirect	 insight	 into	ventilation	defects,	because	of	the	hypoxic	pulmonary	vasoconstriction	 in	
case	of	ventilation	obstructions.	
	
For	DCE-MRI,	time-resolved	T1-weighted	3D	spoiled	gradient	echo	datasets	with	short	acquisition	
times	(1-2	seconds)	are	continuously	acquired	after	intravenous	contrast	agent	administration.	
Imaging	is	performed	in	one	breath-hold	(15-20	seconds)	following	the	injection	of	a	paramag-
netic	contrast	agent	bolus	(e.g.,	gadolinium),	which	shortens	T1	(as	well	as	T2)	of	blood	and	tissues,	
increasing	the	detected	signal.	Three-dimensional	time-resolved	imaging	permits	to	visualize	the	
passage	of	the	contrast	agent	in	the	arterial	and	venous	blood	and	to	calculate	haemodynamic	
parameters.	The	imaging	speed	for	DCE-MRI	is	achieved	thanks	to	k-space	undersampling,	par-
allel	 imaging,	and	echo	sharing.	Typical	measurements	parameters	are:	resolution	is	4	×	4	×	5	
mm3,	TE	of	0.7-1	ms	and	TR	of	1.5-2.5	ms	[30].	Representative	perfusion	maps	derived	with	DCE-
MRI	are	shown	in	Chapter	3	(Fig.	3.6).	
	
1.7.3.2	 Oxygen-enhanced	MRI	
Oxygen-enhanced	(OE)	MRI	exploits	the	paramagnetic	properties	of	oxygen	which	can	serve	as	
a	weak	T1-shortening	contrast	agent	[95].	When	breathed,	oxygen	reaches	only	the	ventilated	
alveoli,	passes	only	through	the	functional	alveolar	walls	(i.e.,	alveolar	and	capillary	epithelia),	
and	dissolves	into	blood	only	in	perfused	capillaries.	If	one	of	the	three	functions	is	locally	com-
promised,	oxygen	does	not	dissolve	into	the	blood	and	no	regional	shortening	in	T1	takes	place.	
Introduction	 	
	20	
By	this	means,	OE-MRI	provides	functional	information	related	to	ventilation,	diffusion,	and	per-
fusion	[96].	
	
Oxygen	enhancement	maps	can	be	calculated	from	acquisitions	performed	in	normoxic	(air)	and	
hyperoxic	(e.g.,	100%	oxygen)	conditions.	For	semi-quantitative	OE-MRI	(i.e.,	relative	oxygen	en-
hancement),	T1-weighted	sequences	such	as	 IR-HASTE,	 IR-FLASH	or	UTE	are	usually	employed	
[56,	93,	97].	For	quantitative	oxygen	enhancement,	the	shortening	in	T1	is	commonly	calculated	
from	IR-FLASH	scans	(Look-Locker),	UTE	or	HASTE	[98–100].	In	the	work	presented	in	this	thesis,	
OE-MRI	was	performed	with	ufSSFP	sequences.	Representative	images	can	be	found	in	Chapters	
4	and	5	(Figs.	4.7	and	5.2).	
	
OE-MRI	was	also	proposed	to	measure	ventilation	with	a	spoiled	gradient	echo	(SPGR)	sequence:	
since	oxygen	is	paramagnetic,	it	increases	the	magnetic	susceptibilities	at	the	air-tissue	interfaces	
in	the	lung,	only	in	ventilated	regions.	Therefore,	a	change	in	T2*	allows	estimating	pulmonary	
ventilation	[101].		
	
OE-MRI	can	be	 implemented	easily	 for	commercial	 scanners	and	 is	 inexpensive;	 furthermore,	
breathing	oxygen	for	short	periods	of	time	has	usually	no	contraindications	in	several	patholo-
gies.	However,	the	shortening	of	T1	given	by	O2	is	weak	and	difficult	to	be	imaged.	In	addition,	
OE-MRI	requires	scanning	in	two	different	oxic	conditions,	doubling	the	scan	time	and	hampering	
the	transition	to	the	clinical	routine.		
	
1.7.3.3	 Fourier	decomposition	MRI	
The	signal	intensity	of	the	lung	during	respiration	exhibits	modulations	arising	from	the	paren-
chyma	density	changes	(compression/expansion)	and	from	the	inflow	of	blood	passing	through	
arteries	and	parenchymal	capillaries	at	every	cardiac	pulsation.	These	signal	modulations	can	be	
captured	by	time-resolved	2D	balanced	steady-state	free	precession	(bSSFP)	imaging	with	a	TE	
of	0.9	ms	and	a	TR	of	1.9	ms	(or	shorter)	in	coronal	or	sagittal	views	[102].	Typical	in-plane	reso-
lution	is	approximately	3.5	×	3.5	mm2	for	coronal	acquisitions,	with	a	slice	thickness	of	10	mm.	
	
The	acquisition	time	of	one	image	with	2D	bSSFP	is	118	ms,	therefore	imaging	is	performed	in	
the	transient	phase	of	the	magnetization	[103].	An	interval	time	of	180	ms	between	successive	
acquisitions	is	programmed	for	magnetization	recovery	(especially	of	blood),	resulting	in	an	ac-
quisition	frame	rate	of	3.33	images	/	second.	For	Fourier	decomposition	(FD)	MRI,	a	series	of	200	
images	is	acquired	in	1	minute	of	free-breathing.	After	specific	deformable	image	registration	to	
a	reference	image,	perfusion-weighted	and	ventilation-weighted	maps	are	calculated	by	integra-
tion	of	 cardiac	 (~1	Hz)	and	 respiratory	 (~0.2	Hz)	 spectral	 lines	obtained	after	Fourier	 analysis	
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[102].	Specifics	about	the	most	recent	Matrix	Pencil	(MP)	algorithm	employed	to	calculate	per-
fusion,	blood	arrival	time,	and	ventilation	in	FD-MRI	are	described	in	Ref.	[104].	
	
FD-MRI	has	been	validated	in	animal	studies	and	initial	results	in	patients	showed	clinical	rele-
vance	for	ventilation	and	perfusion	imaging	[33,	53,	102,	105,	106].	Since	the	technique	does	not	
require	any	contrast	agent,	nor	gaseous	media,	and	is	rapid	and	quantitative,	it	has	the	potential	
for	broad	clinical	application	and	longitudinal	monitoring	of	patients.	Representative	FD-MR	im-
ages	are	included	in	Chapter	2	(Fig.	2.4).		
	
	
1.8	 Imaging	with	balanced	steady-state	free	precession	
	
Balanced	steady-state	free	precession	(bSSFP)	sequences	belong	to	a	type	of	fast	gradient	echo	
sequences	employing	short	repetition	times	[107,	108].	The	echo	is	formed	after	every	RF	exci-
tation	 by	 a	 dephasing	 and	 rephasing	 gradient	 pattern	 along	 the	 frequency-encoding	 axis,	 as	
shown	in	the	sequence	scheme	in	Figure	1.9.	Within	each	TR,	the	gradient	moments	along	all	
three	orthogonal	axes	are	fully	rewound,	i.e.,	the	total	net	gradient	area	and	thus	the	net	dephas-
ing	(in	case	of	spins	not	in	motion)	are	zero	in	each	RF	cycle.	Due	to	the	short	TR	of	bSSFP	(TR	<<	
T2	<	T1),	the	longitudinal	magnetization	of	the	spins	has	not	sufficient	time	to	relax	back	to	the	
equilibrium	before	the	application	of	the	next	RF	pulse,	and	similarly,	the	transverse	magnetiza-
tion	 does	 not	 decay	 to	 zero.	 As	 a	 result,	 the	 continuous	 application	 of	 RF	 excitations	 allows	
generating	a	dynamic	equilibrium,	and	a	steady-state	signal	is	formed.	The	steady-state	condition	
is	reached	after	a	certain	number	of	excitation	pulses	and	can	be	established	rapidly	with	specific	
preparation	schemes	[109].		
	
At	on-resonance,	in	the	limit	TR	<<	T2	<	T1	and	for	echoes	occurring	in	the	center	of	TR	(i.e.,	TE	=	
TR/2),	the	bSSFP	signal	in	case	of	alternating	RF	pulses	(±𝛼)	is	given	by:	
	 𝑆bSSFP 𝛼, 𝑇*, 𝑇+,TR ≈ 	 𝑀1 ∙ sin 𝛼1 + cos 𝛼 + 1 − cos 𝛼 𝑇* 𝑇+ 	 ∙ 𝑒< TR+∙=>	,																											(1.1)	
	
where	𝑀1	is	the	equilibrium	magnetization	(proton	density),	and	𝛼	is	the	flip	angle.	
The	optimal	flip	angle	for	bSSFP	maximal	signal	intensity	can	be	derived	from	the	previous	Eq.	
(1.1)	as	
	 𝛼opt 	= 	 cos<* 𝑇* 𝑇+ − 1𝑇* 𝑇+ + 1 		,																																																												(1.2)	
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which	leads	a	maximal	signal	amplitude	of	
	
𝑆bSSFP,max 	= 	 𝑆bSSFP|J	K	Jopt 	= 	 12 	𝑀1 𝑇+𝑇* ∙ 𝑒< TR+∙=>		.																																										(1.3)	
	
From	Eq.	(1.3),	it	is	clear	that	the	signal	of	bSSFP	is	proportional	to	T2/T1.	Furthermore,	it	can	be	
noted	that	the	signal	of	bSSFP	at	TE	=	TR/2	 is	T2-weighted	(i.e.,	𝑒< TR>∙M> 	 ),	similarly	to	spin-echo	
sequences,	and	 it	 is	not	T2*-weighted	 (i.e.,	𝑒< TR>∙M>∗ )	as	common	gradient	echo	sequences	 [108–
111].	As	a	result,	especially	for	the	lung	tissue	which	is	governed	by	a	very	short	T2*,	bSSFP	can	
achieve	a	higher	signal	than	spoiled	gradient	echo	sequences.	Balanced	SSFP	sequences	offer	the	
highest	possible	signal-to-noise	ratio	(SNR)	per	unit	time	of	all	known	sequences	and	in	addition	
are	rather	insensitive	to	motion	and	flow	effects	[108].	However,	as	a	consequence	of	the	bal-
anced	 gradients,	 the	 signal	 of	 bSSFP	 is	 strongly	 sensitive	 to	 off-resonance	 effects	 (bandings),	
caused	by	 susceptibility	 variations,	 imperfections	of	 the	main	magnetic	 field	 (B0)	 or	 chemical	
shift.	Shimming	can	mitigate	inhomogeneities	of	B0,	but	the	susceptibility	effects	are	inevitable.	
An	efficient	way	to	eliminate	off-resonance	effects	is	the	use	of	a	very	short	TR,	e.g.,	<3-6	ms	for	
typical	imaging	targets	[108].		
	
Balanced	SSFP	is	suited	for	imaging	tissues	with	different	T2/T1	ratios:	the	signal	will	appear	very	
bright	for	blood,	vessels,	liquids,	and	fat,	and	darker	for	muscle	and	other	tissues.	The	rationale	
to	use	bSSFP	for	lung	MRI	is	quite	evident.	Balanced	SSFP	provides	fast	acquisitions,	is	robust	in	
the	presence	of	motion,	has	the	highest	SNR	per	unit	time	amongst	all	sequences	and	a	strong	
signal	from	blood	and	vessels.	These	factors	make	bSSFP	a	perfect	candidate	for	imaging	an	organ	
with	reduced	proton	density	such	as	the	lung,	in	free-breathing	or	with	rapid	breath-holding	ma-
neuvers.	Nevertheless,	the	application	of	bSSFP	for	lung	imaging	has	been	hindered	by	technical	
challenges.	Namely,	the	shortest	achievable	TR	with	conventional	bSSFP	sequences	at	commer-
cial	scanners	is	limited	to	about	2	ms,	still	causing	residual	off-resonance	related	banding	artifacts	
and	signal	voids	in	the	lung	(cf.	Fig.	1.9).	An	even	shorter	TR	is	thus	desirable	for	successful	lung	
bSSFP	imaging.	
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Figure	1.9.	Diagrams	(left)	of	a	2D	bSSFP	pulse	sequence	(top)	and	of	2D	ufSSFP	(bottom)	including	typical	
acquired	images	(right).	After	the	RF	excitation	pulse,	the	phase	and	frequency	encoding	is	started.	Within	
each	TR,	 the	net	 gradient	area	and	dephasing	are	 zeroed	 (fully	 refocused).	 Compared	 to	 conventional	
bSSFP,	ufSSFP	reaches	a	shorter	TR	due	to	shortened	RF	pulses,	asymmetric	readout	(i.e.,	C<B	in	the	dia-
gram),	and	sampling	on	the	ramp-down	readout	gradient	(marked	in	orange).	The	sequence	scheme	for	
3D	SSFP	sequences	is	similar,	including	additionally	a	phase-encoding	gradient	(and	a	rewinder	gradient)	
along	slice-selection	direction	(not	illustrated).	The	repetition	time	/	echo	time	for	the	presented	images	
acquired	with	2D	bSSFP	and	2D	ufSSFP	acquisition	were	1.9	ms	/	0.87	ms	and	1.46	ms	/	0.67	ms,	respec-
tively.	The	red	arrowheads	indicate	signal	voids	in	the	lung	using	bSSFP	(top	right),	which	are	mitigated	by	
ufSSFP	(bottom	right).	
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1.9	 Balanced-SSFP	with	minimal	TR:	ultra-fast	SSFP	
Recently,	a	novel	bSSFP	implementation	was	proposed	for	pulmonary	imaging	with	extremely	
short	TR,	termed	ultra-fast	SSFP	[45].	There	are	two	factors	that	need	to	be	considered	to	achieve	
a	TR	as	short	as	possible.	The	first	is	the	design	of	a	short	RF	pulse	and	the	second	to	ensure	a	
rapid	Cartesian	image	encoding	scheme.	Usually,	in	the	common	implementation	of	the	bSSFP	
sequence,	the	flip	angle	is	produced	by	a	SINC-shaped	RF	pulse	with	a	relatively	long	fixed	dura-
tion	that	allows	to	generate	flip	angles	that	are	even	larger	than	90°.	However,	as	derived	from	
Eq.	(1.3),	the	optimal	flip	angle	for	the	steady-state	signal	is	only	about	25°	in	the	lung	tissue	(T1 
≈ 1375	ms	and	T2 ≈ 66	ms)[46].	As	a	consequence,	the	following	minimal	RF	pulse	duration	can	
be	 obtained:	 for	 3D	 ufSSFP,	 non-selective	 rectangular-shaped	 pulses	 of	 70	 μs	 duration	 (hard	
pulses);	and	for	2D	ufSSFP,	Gaussian-shaped	pulses	of	240	μs	duration.	Moreover,	the	time	that	
is	required	for	image	encoding	is	mainly	determined	by	the	readout.	As	a	consequence,	ufSSFP	
combines	asymmetric	echoes	and	ramp	sampling	techniques	to	shorten	the	readout	time.	
	
A	scheme	of	the	optimized	ufSSFP	sequence	including	a	representative	image	is	shown	in	Figure	
1.9.	Using	an	asymmetric	echo,	the	TR	can	be	reduced	in	comparison	to	the	centered	echo	(TE	=	
TR/2).	Therefore,	in	this	optimized	ufSSFP	implementation,	the	echo	is	slightly	shifted	away	from	
TR/2.	Since	the	achieved	TR	is	extremely	short,	the	additionally	introduced	T2*	weighting	is	mar-
ginal.	Both,	theoretical	simulations	as	well	as	in-vivo	experiments	demonstrated	that	in	the	lung	
tissue,	a	truly	balanced	SSFP	is	obtained	only	with	TR	<	2	ms;	with	TR	>	2	ms,	due	to	intravoxel	
dephasing,	a	rather	unbalanced	SSFP	is	produced	with	signal	amplitudes	that	are	only	half	as	high	
in	comparison	to	bSSFP	[45].	
	
In	conclusion,	3D	ufSSFP	has	the	ability	to	achieve	for	example	TR/TE	as	short	as	1.08	ms	/	0.42	
ms	for	a	2.5	mm	isotropic	resolution,	allowing	imaging	of	the	whole	lung	in	18	seconds	with	3	
averages	(parallel	imaging,	Grappa	acceleration	factor	2).	In	2D	mode,	ufSSFP	can	achieve	TR/TE	
as	short	as	1.36	ms	/	0.52	ms	for	an	in-plane	resolution	of	1.8	×	1.8	mm2	and	a	slice	thickness	of	
8	mm	with	an	acquisition	time	of	110	ms	per	slice.	Representative	lung	images	obtained	with	3D	
ufSSFP	can	be	found,	e.g.,	in	Figures	1.2c,	1.7d,	1.8c,	and	in	Chapters	3	and	6	(Figs.	3.1	and	6.1).	
A	comparison	of	2D	bSSFP	and	2D	ufSSFP	is	presented	in	Chapter	2	(Fig.	2.4).		
	
The	optimized	ufSSFP	sequence	provides	diagnostic	lung	imaging	with	a	high	signal-to-noise	ra-
tio,	free	of	banding,	and	with	only	minor	motion	artifacts	and	image	degradation	[45,	47];	ideal	
to	develop	new	functional	imaging	techniques	and	to	improve	the	robustness	and	reliability	of	
existing	methods.	
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1.10	 Aim	of	the	thesis	
	
Morphological	and	functional	imaging	of	the	lung	is	of	high	clinical	importance.	The	main	draw-
back	of	current	clinical	standards,	such	as	CT	and	nuclear	medicine	techniques,	 is	 the	 implied	
radiation	dose,	particularly	when	 longitudinal	 imaging	 is	required	to	monitor	the	disease	pro-
gression	and	medical	interventions.	Especially	for	children,	where	pathologies	could	affect	the	
lung	development	and	reduce	their	quality	of	life,	radiation-free	imaging	modalities	are	an	ur-
gent	 necessity.	 Non-proton	 based	 MRI	 with	 inhaled	 hyperpolarized	 gas	 (i.e.,	 3He,	 129Xe,	 19F)	
showed	promise	for	measuring	several	functional	biomarkers	of	the	lung	(e.g.,	ventilation	and	
alveolar	size),	but	the	need	for	dedicated	equipment	and	specialized	staff	limit	its	transition	to	
the	clinics.		
	
On	the	other	hand,	proton	MRI	is	radiation-free	and	widely	available.	Nevertheless,	proton	lung	
MRI	is	challenging.	In	fact,	the	physical	characteristics	of	the	lung	tissue	that	are	unfavorable	for	
MRI	(i.e.,	low	proton	density	and	short	apparent	transverse	relaxation	time,	cf.	Section	1.6)	can	
lead	to	a	low	detected	signal;	not	sufficient	for	a	veritable	evaluation	of	pulmonary	structures	
and	 function.	These	present	 limitations	have	been	 recently	mitigated	with	accelerated	bSSFP	
schemes,	namely	with	ufSSFP	sequences	 that	are	characterized	by	an	extremely	 short	TR	 (cf.	
Section	1.9)	and	yield	an	improved	signal-to-noise	ratio	of	the	pulmonary	tissues	and	artifact-
free	images	[45].	Within	the	work	presented	in	this	thesis,	new	and	improved	techniques	were	
developed	with	ufSSFP	acquisition	 schemes	 for	accurate	pulmonary	 functional	 imaging	at	1.5	
Tesla.	
	
It	has	been	shown	previously	that	time-resolved	two-dimensional	bSSFP	imaging	of	the	lung	dur-
ing	free-breathing	and	Fourier	decomposition	(FD)	of	the	physiological	signal	modulations	allow	
calculating	quantitative	maps	related	to	pulmonary	perfusion	and	ventilation	[102].	The	purpose	
of	the	first	work	included	in	this	thesis	(Chapter	2)	is	to	adapt	ufSSFP	imaging	for	FD-MRI	with	an	
increased	signal	and	functional	image	quality.	Thanks	to	free-breathing	acquisitions,	FD-MRI	can	
easily	be	performed	in	clinical	settings.	As	a	major	drawback,	however,	FD-MRI	is	limited	to	2D	
imaging,	thus	covering	only	portions	of	the	thorax.	Furthermore,	FD-MRI	ventilation	measure-
ments	depend	on	the	breathing	amplitude	of	the	examined	subject.		
	
These	limitations	have	been	overcome	in	the	second	work	described	in	Chapter	3	where	rapid	
3D	multi-volumetric	ufSSFP	breath-hold	acquisitions	combined	with	a	model	of	the	lung	are	used	
to	retrieve	voxelwise	the	parameter	α,	a	new	ventilation-weighted	quantitative	measure	that	
describes	the	compression/expansion	of	the	lung.	The	index	α	is	independent	of	the	breathing	
amplitude	as	well	as	the	lung	density	and	capacity.	The	quantitative	parameter	α	strongly	differs	
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from	ventilation-related	biomarkers	presented	 in	 the	 literature,	such	as	simple	subtraction	of	
images	acquired	at	diverse	respiratory	level	[112,	113].	The	difference	between	the	derived	novel	
ventilation	parameter	α	and	contemporary	ventilation	measures	is	briefly	described	in	the	Ad-
dendum	 to	 Chapter	 3.	 Within	 the	 scope	 of	 the	 Addendum	 to	 Chapter	 3,	 the	 ventilation	
impairments	quantified	with	α-mapping	are	evaluated	in	a	cohort	of	children	with	cystic	fibrosis.	
	
Oxygen-enhanced	(OE)	MRI	allows	for	an	indirect	measure	of	ventilation,	diffusion,	and	perfu-
sion.	Usually,	OE-MRI	is	performed	with	T1-weighted	imaging	(IR-HASTE	or	UTE).	Since	the	signal	
enhancement	given	by	oxygen	is	weak,	the	measured	oxygen	enhancement	can	be	flawed	by	the	
signal	changes	 in	 the	parenchyma	caused	by	different	 inspiratory	 levels.	 In	 the	 third	work	 in-
cluded	in	Chapter	4,	3D	multi-volumetric	ufSSFP	breath-hold	 imaging	is	combined	with	a	 lung	
model	(as	described	in	Chapter	3)	to	take	into	account	these	density	variations	for	the	calculation	
of	robust	oxygen-enhancement	maps.		
	
Relaxation	time	measurements	(T1	and	T2)	have	demonstrated	clinical	value	for	various	patholo-
gies	 of	 the	 human	 body	 [91].	 Lung	 T1	 relaxometry	 in	 combination	 with	 oxygen	 breathing	 as	
contrast	 agent	has	been	explored	 for	physiological	 imaging	 in	 several	 studies	 and	has	 shown	
good	prospect	amongst	certain	patient	groups	[92,	93,	114,	115].	Usually,	inversion	recovery	GRE	
or	HASTE	sequences	are	employed	for	pulmonary	T1-relaxometry.	Recently	 inversion	recovery	
ufSSFP	has	shown	promise	for	robust	lung	T1	and	T2	relaxometry	[46].	Therefore,	the	objective	of	
the	fourth	work	(Chapter	5)	is	to	employ	2D	IR-ufSSFP	breath-hold	imaging	to	rapidly	and	simul-
taneously	 map	 thecT1	 and	 T2	 relaxation	 times	 of	 the	 lung	 under	 normoxic	 and	 hyperoxic	
conditions.	The	proposed	quantitative	OE-MRI	method	allows	mapping	 functional	biomarkers	
such	as	the	change	in	the	T1	and	T2	relaxation	time	after	hyperoxic	conditions	(i.e.,	∆T1	and	∆T2)	
or	the	physiological	oxygen	wash-in	and	wash-out	time	constants	(related	to	the	time	needed	to	
shorten	T1	after	oxygen	breathing).	
	
The	vascular	integrity	of	the	pulmonary	parenchyma	is	usually	assessed	by	SPECT/CT,	which	is	a	
time-consuming	imaging	modality	with	rather	low	spatial	resolution,	and	furthermore,	it	is	radi-
oactive.	Many	MR	radiological	protocols	include	contrast	agent,	e.g.,	for	lung	perfusion	with	DCE-
MRI,	cardiac	examinations,	or	the	evaluation	of	mediastinal	masses.	It	is	thus	appealing	to	add	
to	these	protocols	a	rapid	imaging	technique	optimized	for	parenchyma	functional	assessment	
to	ameliorate	the	diagnosis,	the	disease	characterization	as	well	as	to	quantify	the	pulmonary	
impairments	caused	by	the	pathology.	Even	though	bSSFP	sequences	are	considered	to	be	rather	
insensitive	to	contrast	agents,	they	have	shown	promise	to	detect	the	signal	increase	after	con-
trast	 agent	 administration	 [116,	 117].	 As	 a	 consequence,	 in	 the	 last	work	 (Chapter	 6),	 signal	
enhancement	ratio	(SER)	mapping	is	presented	–	a	rapid	technique	developed	for	specific	visu-
alization	of	disorders	altering	regional	lung	parenchyma	perfusion.	
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1.11	 Outline	of	the	thesis	
	
The	naturally	occurring	lung	signal	modulations	associated	with	pulmonary	blood	flow	and	res-
piration	are	used	to	recover	perfusion	and	ventilation	imaging	in	Chapter	2.	Similarly,	in	Chapter	
3	ventilation	maps	are	calculated	from	the	lung	signal	modulations	occurring	at	diverse	respira-
tory	levels.	In	Chapters	4	and	5,	pure	oxygen	is	breathed	and	acts	as	a	mild	contrast	agent,	thus	
enabling	pulmonary	 imaging	 that	contains	 information	about	ventilation,	diffusion,	as	well	as	
perfusion.	Finally,	Gadolinium	contrast	agent	is	employed	for	functional	imaging	related	to	pul-
monary	parenchyma	perfusion	in	Chapter	6.		
	
Chapter	2.	An	optimal	ufSSFP	sequence	scheme	with	minimal	TR	and	TE	is	presented	for	FD-MRI.	
Optimization	with	regard	to	the	achievement	of	a	short	TR	includes	shortening	of	the	RF	pulse	
duration	and	the	use	of	an	asymmetric	readout.	Furthermore,	ramp-up	and	ramp-down	radio-
frequency	(RF)	preparation	pulses	to	stabilize	the	magnetization	vector	are	introduced.	The	in-
fluence	of	the	flip	angle,	RF	pulse	length,	in-plane	resolution,	field-of-view,	and	image	acquisition	
rate	(i.e.,	the	temporal	resolution)	are	evaluated	to	optimize	the	FD-MRI	protocol	with	respect	
to	parenchyma	signal	intensity	and	image	quality.	FD-MRI	with	optimized	ufSSFP	acquisitions	is	
compared	to	conventional	bSSFP	in	healthy	volunteers	at	1.5T.	Furthermore,	the	optimized	FD-
MRI	protocol	is	also	evaluated	at	3T.		
	
Chapter	3.	Three-dimensional	multi-volumetric	ufSSFP	breath-hold	imaging	is	used	to	study	the	
lung	SI	modulations	at	diverse	respiratory	volumes	(i.e.,	capacities).	A	simple	compression	model	
of	the	lung	is	introduced	to	retrieve	voxelwise	the	measure	α;	a	novel	quantitative	parameter	for	
lung	ventilation	 imaging	that	 is	nearly	 independent	of	 the	breathing	phases,	 lung	density	and	
capacity.	Three-dimensional	α-mapping	is	evaluated	in	healthy	volunteers,	two	COPD	patients	
and	one	cystic	 fibrosis	patient,	and	compared	 to	DCE-MRI,	FD-MRI,	and	CT.	Moreover,	 in	 the	
Addendum	to	Chapter	3,	α-mapping	is	evaluated	in	24	pediatric	patients	with	cystic	fibrosis	(CF).	
The	ventilation	impairments	are	quantified	with	α-mapping	and	compared	to	the	lung	clearing	
index	(LCI),	a	functional	lung	parameter	resulting	from	nitrogen	multiple-breath	washout	meas-
urements	(N2-MBW)	[118].	
	
Chapter	4.	Three-dimensional	ufSSFP	breath-hold	 imaging	 is	employed	 for	OE-MRI.	After	 flip-
angle	optimization,	multi-volumetric	ufSSFP	lung	imaging	under	both	normoxic	(air,	21%	O2)	and	
hyperoxic	conditions	(100%	O2)	is	investigated	in	healthy	volunteers.	The	lung	model	retrieved	
in	Chapter	3	is	used	to	map	the	oxygen	enhancement	(percentage	of	signal	increase),	mitigating	
the	confounding	bias	inherent	to	common	OE-MRI	techniques	that	arises	from	residual	lung	den-
sity	modulations.	Even	when	the	imaging	is	performed	at	a	fixed	inspiratory	level	(e.g.,	FRC),	lung	
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density	variations	 lead	to	a	bias	 in	contemporary	OE-MRI	methods	since	 it	 is,	 in	practice,	not	
possible	to	exactly	reproduce	a	given	inspiratory	level.	
	
Chapter	5.	Pulmonary	OE-relaxometry	with	IR-ufSSFP	is	evaluated	in	healthy	volunteers.	Cardiac-
triggered	 breath-hold	 imaging	 with	 IR-ufSSFP	 is	 continuously	 performed	 every	 30	 s;	 first	 in	
normoxic	conditions	 for	5	min,	 then	 in	hyperoxic	conditions	 for	5	min	 (wash-in),	and	again	 in	
normoxic	conditions	for	5	min	(wash	out).	Quantitative	maps	of	T1	and	T2	change	between	the	
different	oxic	 conditions	 (∆T1	 and	∆T2),	 as	well	 as	maps	 representing	 the	oxygen	wash-in	and	
wash-out	time	constants	(i.e.,	the	characteristic	rate	of	T1	decrease	and	increase),	are	calculated.	
It	is	important	to	note	that	OE-relaxometry	does	not	require	density	corrections	(cf.	Chapter	4)	
since	it	provides	quantitative	measures	of	T1	and	T2	that	are	not	proton-density	weighted.	
	
Chapter	6.	Static	signal	enhancement	ratio	(SER)	maps	(percentage	of	signal	enhancement)	are	
calculated	from	3D	ufSSFP	breath-hold	imaging,	acquired	once	before	and	once	3	min	after	in-
travenous	 Gadolinium-based	 contrast	 administration.	 Post-contrast	 imaging	 for	 static	 SER	
mapping	is	performed	3	min	after	the	injection	of	Gadolinium	to	ensure	a	constant	dilution	and	
distribution	of	the	contrast	agent	in	the	blood	pool.	The	flip	angle	is	optimized	considering	the	
maximal	signal	intensities	of	ufSSFP	in	the	lung,	before	and	after	contrast	agent	administration,	
as	well	as	the	stability	of	the	signal	[117].	To	motivate	the	use	of	ufSSFP	for	lung	imaging,	the	
image	quality	and	the	signal	level	yielded	by	ufSSFP	imaging	are	compared	to	contemporary	vol-
ume-interpolated	breath-hold	examinations	(VIBE)	 in	10	subjects	with	healthy	 lung.	Secondly,	
ufSSFP-SER	 maps	 are	 evaluated	 in	 9	 patients	 with	 different	 pulmonary	 diseases	 (3	 COPD,	 4	
COPD+	lung	cancer,	1	pulmonary	fibrosis,	1	traumatic	lung	contusion).	For	the	COPD	cohort,	SER	
is	compared	to	99mTc-MAA-SPECT/CT	by	radiological	scoring	of	lung	deficits.		
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A	modified	version	of	this	chapter	has	been	published	as:	
Pusterla	O*,	Bauman	G*,	Bieri	O.	Ultra-fast	Steady-State	Free	Precession	Pulse	Sequence	for	Fou-
rier	Decomposition	Pulmonary	MRI.	Magn	Reson	Med,	2015,	75:1647-53.	
*Equally	contributed	to	this	work.	
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CHAPTER	ABSTRACT	
	
	
Purpose:	To	assess	whether	ultra-fast	steady-state	free	precession	(ufSSFP)	can	improve	
image	quality	in	Fourier	decomposition	(FD)	MRI	of	lung	ventilation	and	perfusion.	
	
Methods:	Series	of	two-dimensional	time-resolved	lung	images	were	acquired	in	healthy	
volunteers	at	1.5T	and	3T	using	an	FD	adapted	ufSSFP.	For	comparison,	the	imaging	pro-
tocol	was	complemented	by	a	standard	implementation	of	the	FD-MRI	technique	using	
balanced	steady-state	free	precession	(bSSFP).	 Imaging	parameters	were	evaluated	to	
optimize	the	ufSSFP	FD-MRI	protocol	with	respect	to	the	signal	intensity	of	the	lung	pa-
renchyma	and	the	severity	of	image	artifacts.	
	
Results:	FD-MRI	with	 the	adapted	ufSSFP	pulse	 sequence	 resulted	 in	 increased	signal	
intensity	in	the	lung	tissue	by	19%	and	significantly	decreased	banding	artifacts	due	to	
shorter	repetition	times:	1.46	ms	for	ufSSFP	and	1.90	ms	for	bSSFP.	Despite	improved	
image	quality	FD-MRI	is	still	problematic	at	3T.	
	
Conclusion:	MRI	of	the	lung	with	ufSSFP	performs	better	than	bSSFP	in	terms	of	signal	
and	banding	artifacts,	 and	can	be	used	 to	either	 increase	 resolution	or	overall	 image	
quality	of	FD	images.	
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2.1	 Introduction	
	
Nowadays,	radionuclide	planar	scintigraphy	and	single	photon	emission	computed	tomography	
(SPECT)	are	widely	accepted	as	a	clinical	standard	for	the	measurement	of	pulmonary	perfusion	
and	ventilation	[19,	20].	Nuclear	techniques,	however,	are	based	on	the	application	of	radioac-
tive	labeled	tracers	and	are	thus	limited	by	relatively	poor	spatial	and	temporal	resolution.	As	a	
result,	non-ionizing	methods,	such	as	magnetic	resonance	imaging	(MRI)	with	inhaled	hyperpo-
larized	noble	gases	(3He,	129Xe)	were	introduced	for	the	assessment	of	static	and	dynamic	lung	
ventilation	[38,	119].	Alternatively,	pulmonary	function	can	also	be	assessed	by	proton	MRI	using	
a	T1-shortening	contrast	agent,	such	as	oxygen,	for	ventilation	mapping	[95],	or	by	the	injection	
of	gadolinium-based	contrast	agents	for	the	evaluation	of	pulmonary	perfusion	[120,	121]	but	
not	without	the	possible	risk	of	acute	allergic	reactions	and	nephrogenic	systemic	fibrosis	in	pa-
tients	with	impaired	renal	function	[122].	Hence,	simple,	easy	and	non-invasive	MRI	techniques	
for	the	assessment	of	regional	pulmonary	function	are	highly	desirable.	
	
In	the	recent	years	a	novel,	native,	functional	lung	imaging	method,	known	as	Fourier	decompo-
sition	(FD)	MRI,	has	been	introduced	[102]	providing	ventilation-weighted	(Vw)	and	perfusion-
weighted	(Qw)	information	from	a	single	acquisition	series,	requiring	no	administration	of	con-
trast	 agent,	 as	 well	 as	 no	 further	 patient	 compliance	 such	 as	 repeated	 or	 prolonged	 breath	
holding.	FD-MRI	was	validated	in	animal	experiments	against	other	imaging	modalities	including	
SPECT/CT,	DCE-MRI	and	3He-MRI	[105,	123]	and	first	clinical	data	were	obtained	in	a	population	
of	cystic	fibrosis	patients	and	non-small	cell	lung	cancer	patients	for	assessment	of	regional	per-
fusion	 [106,	 124].	 Nevertheless,	 the	 application	 of	 FD-MRI	 in	 some	 groups	 of	 patients,	 e.g.,	
chronic	obstructive	pulmonary	disease	(COPD),	can	be	limited	from	the	presence	of	emphysem-
atous	lung	destruction	leading	to	very	low	regional	signal	intensity.	Here,	the	key	limitation	of	
FD-MRI	is	the	minimal	achievable	echo	time	(TE),	which	is	too	long	to	sufficiently	sample	very	
fast	decaying	signal.	
	
Only	recently,	some	major	methodological	advances	have	been	demonstrated	for	lung	imaging	
based	on	a	very	 fast	steady	state	 free	precession	 (SSFP)	 imaging	technique,	 termed	ultra-fast	
SSFP	(ufSSFP)	 [45].	For	ufSSFP,	excitation	pulses	and	gradient	switching	patterns	of	a	conven-
tional	 Cartesian	 SSFP	 imaging	 scheme	 were	 optimized,	 and	 further	 reduced	 by	 partial	 echo	
readouts	and	ramp	sampling	techniques.	As	a	result	 from	the	overall	 reduced	repetition	time	
(TR),	image	acquisition	is	shortened,	motion	and	banding	artifacts	are	reduced,	and	the	paren-
chyma	signal	is	increased.	
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Consequently,	the	purpose	of	this	work	is	to	fuse	two	recently	introduced	promising	concepts,	
namely	FD-MRI	and	ufSSFP	imaging,	for	improved	lung	imaging	in	the	clinical	setting.	
	
	
2.2	 Methods	
	
2.2.1	 Adaptation	and	optimization	of	ufSSFP	for	FD-MRI	
	
The	basis	of	FD-MRI	is	a	time-resolved	series	of	2D	balanced	SSFP	acquisitions	with	a	frame	rate	
of	about	3-4	images	per	second	to	assess	lung	function	from	signal	modulations	caused	by	res-
piratory	and	cardiac	cycles.	Overall,	due	to	the	very	short	T2*	relaxation	times	of	lung	tissue	at	
1.5T	[34],	the	key	factor	driving	balanced	SSFP	image	quality	and	visibility	of	the	lung	parenchyma	
is	TR.	
	
Figure	2.1	shows	a	schematic	of	the	acquisition	using	a	balanced	ufSSFP	scheme.	Generally,	the	
2D	image	acquisition	blocks	are	interleaved	by	a	time	interval	(TW)	for	magnetization	recovery	
and	imaging	is	thus	performed	mainly	during	the	transient	state.	Overall,	TR	is	reduced	using	a	
tailored	duration	of	the	radio-frequency	(RF)	excitation	pulse	adjusted	to	the	limit	given	by	the	
specific	absorption	rate	(SAR)	and	by	partial	echoes	[45].	The	readout	asymmetry	was	set	to	75%	
of	 the	 full	echo	and	combined	with	POCS	[125]	 reconstruction	of	 the	missing	k-space	data.	A	
ramp	of	10	RF	pulses	increasing	linearly	from	a/10	to	a	was	used	to	stabilize	the	magnetization	
vector	[126].	An	optional	post	scanning	linear	ramp	down	scheme	of	10	subsequent	RF	pulses	
for	magnetization	refocusing	was	also	implemented	and	a	linear	k-space	reordering	was	chosen	
to	mitigate	eddy	currents	[127].	
	
	
	
	
Figure	2.1.	Schematics	of	the	FD-MRI	adapted	ultra-fast	steady-state	free-precession	(ufSSFP)	imaging	se-
quence	 comprising	 an	 optional	 fat	 saturation	 block	 (FS),	 ramp-up	 and	 ramp	 down	 magnetization	
preparation	steps	for	stabilization	of	the	magnetization	vector,	image	acquisition	block	(TA),	and	time	in-
terval	(waiting	time:	TW)	between	consecutive	image	acquisitions.		
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2.2.2	 MRI	data	acquisitions	
	
Experiments	were	performed	on	a	1.5T	MR-scanner	(MAGNETOM	Avanto,	Siemens	Healthineers,	
Erlangen,	Germany)	using	a	12-channel	 thorax	and	a	24-channel	 spine	coil	 receive-array.	Five	
healthy	volunteers	were	examined	with	both	a	time-resolved	2D	ufSSFP	sequence,	as	well	as	a	
standard	2D	bSSFP	used	in	previous	publications	on	the	FD-MRI	[102,	105,	106,	123,	124].	Gen-
erally,	scans	were	performed	with	predefined	default	shim	settings	and	on	the	same	volunteer	
on	the	same	day.	
	
The	dependence	between	the	signal	intensity	(SI)	in	the	lung	parenchyma	and	the	flip	angle	(a),	
the	duration	(t)	of	sinc-shaped	RF	pulses,	the	interval	time	(TW)	between	each	image	acquisition	
and	spatial	resolution	was	analyzed	in	expiratory	breath	hold	with	variable	parameters:	a	=	5°–
75°,	t	=	 250–500	μs,	TE	=	0.61–0.75	ms,	TR	=	1.37–1.61	ms,	TW	=	0–280	ms,	leading	to	variable	
acquisition	times	TA	=	80–160	ms	for	spatial	resolutions	ranging	from	4.7´4.7	mm2	(96´96	ma-
trix)	to	2.6´2.6	mm2	(176´176	matrix).	The	acquisition	rate	was	kept	constant	at	3.33	images/s	
by	adapting	the	interval	length	TW,	with	and	without	the	post-scan	linear	RF	ramp,	for	a	fixed	
field-of-view	(FOV)	=	450´450	mm2,	slice	thickness	=	12	mm,	bandwidth	in	a	range	2003-2056	
Hz/px,	64	images	per	slice,	parallel	imaging	GRAPPA	[128]	factor	2.	Additionally,	simple	numerical	
simulations	of	 the	magnetization	vector	evolution	using	Bloch	equations	 (taking	 into	account	
relaxation	but	neglecting	pulmonary	perfusion	and	susceptibility	effects)	were	performed	to	ex-
plore	 the	 relationship	 between	 flip	 angle	 and	 signal	 intensity	 in	 the	 lung	 parenchyma	 to	
qualitatively	check	whether	the	calculations	supported	the	experimental	data	[129].	In	the	sim-
ulation	we	assumed	that	the	lung	tissue	is	characterized	by	T1	=	1000	ms	and	T2	=	60	ms	(15).	
	
For	ventilation	and	perfusion	imaging,	sets	of	time-resolved	images	were	acquired	in	free-breath-
ing	with	a	fixed	flip	angle	and	RF	pulse	length	of	a	=	65°	and	t	=	360	μs,	but	otherwise	identical	
imaging	parameters	to	the	breath	hold	scans.	Two	hundred	images	were	acquired	per	slice	with	
a	total	acquisition	time	of	66	seconds	per	slice.	A	supplemental	acquisition	with	a	fat	saturation	
RF	pulse	was	performed,	for	possible	beneficial	suppression	of	ghost	artifacts	from	oscillations	
of	the	magnetization	occurring	in	the	transient	state.	For	comparison,	scans	using	the	standard	
bSSFP	sequence	was	performed	[102].	The	main	sequence	parameters	were	as	follows:	TE/TR/TA	
=	0.8/1.9/118	ms,	TW	=	180,	acquisition	rate	=	3.33	images	per	second,	a	=	75°,	FOV	=	450´450	
mm2,	slice	thickness	=	12	mm,	matrix	=	128´128	(resolutions	of	3.5´3.5	mm2),	GRAPPA	factor	3.	
	
Additionally,	we	scanned	one	healthy	volunteer	at	a	3T	clinical	MR-scanner	(MAGNETOM	Prisma,	
Siemens	Healthineers,	Erlangen,	Germany)	using	an	18-channel	thorax	and	a	32-channel	spine	
coil	 receive-array.	 The	 parameters	 of	 the	 ufSSFP	 sequence	 were	 as	 follows:	 TE/TR/TA/TW	 =	
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0.61/1.36/100/170	ms,	flip	angle	a	=	36°,	FOV	=	450´450	mm2,	matrix	=	128´128,	200	images	
per	slice,	slice	thickness	=	12	mm,	bandwidth	=	2055	Hz/px,	GRAPPA	factor	3.	
	
2.2.3	 Image	post-processing	and	analysis	
	
Respiratory	motion	in	time-resolved	ufSSFP	data	was	compensated	with	a	two-dimensional	non-
rigid	image	registration	algorithm	[130].	Vw	and	Qw	images	were	created	by	integration	of	res-
piratory	and	cardiac	spectral	lines	obtained	after	Fourier	analysis	of	the	registered	data.	The	non-
rigid	registration	algorithm	as	well	as	Fourier	decomposition	routine	was	implemented	in	a	ded-
icated	software	program	(fMRLung	4.5,	Siemens	Corporate	Research,	Princeton,	NJ).	A	general	
description	of	image	post-processing	can	be	found	in	Bauman	et	al	[102].	
 
Subsequently,	the	lung	parenchyma	was	segmented	in	both	lungs	separately	with	exclusion	of	
large	vessels	using	a	region	growing	algorithm	[131]	(see	Figure	2.2).	Segmentation	masks	were	
propagated	along	the	temporal	dimension	of	the	registered	data	sets	for	calculation	of	the	mean	
signal	intensity	in	each	time	frame.	Furthermore,	the	mean	over	time	μt(SI)	as	well	as	the	stand-
ard	deviation	over	time	σt(SI)	from	the	averaged	signal	intensity	in	the	segmented	region	were	
computed.	The	standard	deviation	σt(SI)	reflects	the	sensitivity	of	the	FD-MRI	technique	for	de-
tection	of	signal	fluctuations	caused	by	physiological	processes,	i.e.,	cardiac	cycle	in	breath-hold	
acquisitions.	Dedicated	software	(The	Medical	Imaging	Interaction	Toolkit	2014.03.0,	Heidelberg,	
Germany)	was	used	for	the	segmentation.	The	signal	intensity	analysis	and	visualization	of	the	
data	was	performed	using	Python	2.7	(Anaconda	Python	distribution,	Continuum	Analytics,	ver-
sion	2.0).	
	
	
2.3	 Results	
	
Illustrative	cuts	of	2D	coronal	chest	images	acquired	at	1.5T	with	a	FD	adapted	ufSSFP	sequence	
are	shown	in	Figure	2.2.	From	the	short	TR	of	1.46	ms	used,	essentially	no	banding	is	present	
within	the	lung	parenchyma.	For	a	flip	angle	of	a	=	50°,	as	compared	to	a 	=	25°,	lung	tissue	signal	
increases	by	about	66%	from	29	±	1	[a.u.]	to	48	±	1	[a.u.]	(see	Fig.	2.2a).	Similarly,	an	increase	in	
TW	between	subsequent	image	acquisitions	from	0	ms	to	280	ms	increases	the	signal	in	the	lung	
parenchyma	by	almost	100%	from	28	±	1	[a.u.]	to	54	±	1	[a.u.]	(Fig.	2.2b).	Generally,	delays	(TW)	
allow	for	partial	recovery	of	the	magnetization	and	for	inflow	of	fresh	blood	in	the	slice	being	
imaged.	Moreover,	the	implementation	of	a	reversed	RF	pulse	ramp	(see	Fig.	2.1)	at	the	end	of	
the	ufSSFP	acquisition	block	resulted	in	a	further	slight	increase	in	the	signal	intensity	of	the	lung	
parenchyma	by	about	14%	from	42	±	1	[a.u.]	to	48	±	1	[a.u.].		
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For	optimization	purposes,	the	mean	signal	intensity,	μt(SI),	in	the	lung	parenchyma	and	its	vari-
ation	over	 time,	 σt(SI),	 are	 now	analyzed	 in	 detail	 as	 a	 function	of	 the	 flip	 angle	a,	 the	 time	
interval	TW	between	consecutive	images,	the	RF	pulse	length	t,	as	well	as	the	spatial	resolution	
(see	Fig.	2.3).	
As	can	be	expected,	the	lung	signal	as	well	as	the	sensitivity	for	detection	of	signal	fluctuations	
increases	with	increasing	flip	angle	(see	Fig.	2.3a)	but	starts	to	level	off	only	for	a	»	60-65°.	For	
the	chosen	waiting	time	(TW	=	180	ms)	and	pulse	length	(t	=	360	μs),	any	further	increase	in	the	
flip	angle,	however,	is	limited	due	to	SAR.	Similarly,	the	simulation	of	the	SSFP	behavior	in	the	
transient	state	of	the	magnetization	shows	an	increase	in	the	signal	with	increasing	the	flip	angle.		
A	similar	strong	influence	on	the	parenchymal	signal	level	is	found	for	TW	(see	Fig.	2.3b).	Within	
the	accessible	range	(for	appropriate	sampling	of	the	cardiac	frequency,	3	to	4	images	per	second	
	
Figure	2.2.	(a)	Time-resolved	2D	ufSSFP	coronal	sample	images	of	the	chest	acquired	at	1.5T	in	an	expira-
tory	 breath	 hold	 for	 two	 different	 flip	 angle	 values	 α	 =	 25°	 (left)	 and	 α	 =	 50°	 (right).	 Other	 sequence	
parameters	were:	TE/TR/TA/TW	=	0.67/1.46/110/180	ms	and	RF	pulse	length	t	=	360	μs,	resolution	=	3.5	
´	3.5	mm2	(128	´	128	matrix).	(b)	Coronal	sample	images	acquired	with	a	fixed	flip	angle	α	=	60°	but	using	
different	time	interval	values	(TW)	between	consecutive	image	acquisitions:	0	ms	(left)	and	280	ms	(right).	
Regions	of	interest	for	the	assessment	of	parenchymal	signal	intensity	are	indicated	by	the	yellow	outline.	
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need	to	be	acquired),	a	near	linear	relationship	is	observed.	Almost	no	effect	of	the	TW	length	
on	σt(SI)	was	measured.	Thus,	TW	should	be	chosen	to	be	maximal.		
The	mean	signal	intensity	over	time	maximizes	for	RF	pulse	lengths	(t)	around	350–400	μs	(see	
Fig.	2.3c),	whereas	the	standard	variation	over	time	increases	with	a	prolongation	of	the	RF	du-
ration (see	Fig.	2.3c).	A	pulse	length	of	360	μs	was	chosen,	providing	flip	angle	settings	within	
the	optimal	range	(see	Fig.	2.3a).		
As	can	be	expected,	the	lung	signal	intensity	decreases	with	increasing	resolution	(see	Fig.	2.3d):	
for	example,	for	an	increase	in	the	matrix	size	from	96´96	to	176´176,	μt(SI)	decreases	from	57	
±	2	[a.u]	to	36	±	1	[a.u].	Similarly,	as	a	result	of	the	prolonged	image	acquisition	times	and	re-
duced	waiting	times	(TW),	σt(SI)	decreases	with	increasing	spatial	resolution.	
	
Contemporary	bSSFP	FD	imaging,	performed	with	an	in-plane	resolution	of	3.5´3.5	mm2	for	a	
matrix	size	of	128´128	[123],	is	now	compared	to	FD	imaging	using	an	optimal	ufSSFP	setup,	and	
the	corresponding	results	are	shown	in	Fig.	2.4.	Residual	banding	artifacts,	especially	in	regions	
near	 spine,	 ribs	and	mediastinum	persist	with	bSSFP,	 resulting	 in	 local	defects	 in	Vw	and	Qw	
images	(as	indicated	in	Fig.	2.4a).	This	is	in	contrast	to	ufSSFP	imaging,	where	no	residual	banding	
can	be	perceived	(Fig.	2.4b).	For	healthy	lung	tissue,	this	essentially	results	 in	artifact-free	Vw	
and	Qw	images	of	notable	homogeneous	intensity.	As	compared	to	bSSFP,	lung	tissue	signal	from	
ufSSFP	signal	was	increased	by	21%:	the	mean	signal	intensity	and	corresponding	standard	devi-
ation	in	free	breathing	acquisitions	was:	34	±	4	for	bSSFP	and	41	±	3	for	ufSSFP.	As	demonstrated	
	
	
	
Figure	2.3.	The	diagrams	present	measurements	of	the	mean	signal	 intensity	over	time	μt(SI)	 (top	row)	
and	the	standard	deviation	over	time	σt(SI)	(bottom	row)	in	the	lung	parenchyma	(for	definition	of	ROI,	
see	Fig.	2.2a)	of	a	healthy	volunteer	in	expiration	at	1.5T	using	the	2D+t	ufSSFP	imaging	as	a	function	of	
the	flip	angle	and	signal	intensity	values	obtained	from	the	numerical	simulation	of	the	signal	behavior	(a),	
the	time	interval	(TW)	between	consecutive	image	acquisitions	(b),	the	RF	pulse	length	t	(c),	and	the	matrix	
size	(d).	The	standard	deviation	over	time	estimated	in	the	lung	parenchyma	reflects	the	sensitivity	of	the	
FD	technique	for	detection	of	signal	modulations	mainly	induced	by	blood	pulsation	in	the	data	acquired	
in	breath	hold.	
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in	Fig.	2.4c,	fat-saturation	(FS)	can	be	applied	without	notable	lung	tissue	signal	loss	(38	±	4	[a.u.]).	
Despite	the	methodological	advances	of	ufSSFP,	FD	 imaging	 is	still	problematic	at	3T	(see	Fig.	
2.4d)	as	a	result	of	pronounced	banding	artifacts	and	overall	reduced	signal	 levels	 in	the	 lung	
parenchyma	(16	±	2	[a.u.])	due	to	SAR	constraints	requiring	considerably	lower	flip	angles	(see	
also	Fig.	2.3a).		
	
From	the	increased	lung	signal	in	the	FD	adapted	ufSSFP	sequence	at	1.5T	(19	±	5%	measured	for	
five	 volunteers)	 in	 combination	with	 the	 reduced	TR	 (~23%),	 FD-MRI	of	 the	 lung	 can	be	per-
formed	 with	 increased	 spatial	 resolution.	 Native	 ufSSFP	 images	 acquired	 at	 1.5T	 and	
corresponding	Vw	and	Qw	images	are	shown	in	Fig.	2.5	for	three	different	spatial	resolutions	of	
4.0´4.0	mm2,	3.5´3.5	mm2,	and	2.8´2.8	mm2.		
	
	
	
Figure	2.4.	Illustrative	2D	FD	ufSSFP	imaging	results	at	1.5T	in	a	healthy	volunteer:	(a)	native	ufSSFP	images	
of	the	 chest	 from	time	 resolved	data	 sets,	 (b)	ventilation-weighted	and	(c)	perfusion-weighted	 images.	
Yellow	 arrows	 indicate	 location	 of	 the	 banding	 artifacts.	 Imaging	 sequence	 parameters	 at	 1.5T	 were:	
TE/TR/TA/TW	=	0.87/1.9/110/180,	and	α	=	75°,	for	standard	bSSFP;	TE/TR/TA/TW	=	0.67/1.46/110/180	ms	
and	α	=	65°	for	ufSSFP;	TE/TR/TA/TW	=	0.67/1.46/110/170	ms	and	α	=	65°	for	ufSSFP	with	fat	saturation	
(FS-ufSSFP);	and	TE/TR/TA/TW	=	0.61/1.36/100/170	ms	and	α	=	26°	with	ufSSFP	at	3T.	The	in-plane	reso-
lution	and	matrix	of	the	presented	images	were	3.5	´	3.5	mm2	and	128	´	128,	respectively.	
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Figure	2.5.	Native	ufSSFP	images	(a)	obtained	(from	left	to	right)	with	following	matrix	sizes,	spatial	reso-
lutions	and	imaging	parameters:	112	´	112	(4.0	´	4.0	mm2),	TE/TR/TA/TW	=	0.64/1.41/90/195	ms;	128	´	
128	(3.5	´	3.5	mm2),	TE/TR/TA/TW	=	0.67/1.46/110/180	ms;	and	160	´	160	(2.8	´	2.8	mm2),	TE/TR/TA/TW	
=	0.73/1.55/140/150	ms,	as	well	as	the	corresponding	ventilation-weighted	(b)	and	perfusion-weighted	(c)	
images.	
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2.4	 Discussion	
	
In	this	work,	the	recently	proposed	ufSSFP	framework	was	adapted	and	optimized	for	FD-MRI.	
The	major	benefits	from	ufSSFP	as	compared	to	standard	bSSFP	used	in	previous	FD-MRI	studies	
mainly	originate	from	minimal	TR	times	that	can	be	achieved	by	pushing	the	sequence	building	
blocks	to	the	hardware	limits	of	the	MR	scanner.	The	reduction	in	TR	by	23%	(from	1.90	ms	to	
1.46	ms	for	the	standard	matrix	size	of	128´128)	resulted	in	an	overall	decrease	of	banding	arti-
facts	and	image	acquisition	time	used	to	reduce	the	parallel	imaging	acceleration	factor	from	3	
to	2.	Furthermore,	 the	decreased	TE/TR	times	 in	combination	with	a	reversed	 linear	RF	pulse	
ramp	at	the	end	of	the	image	acquisition	block	implemented	in	the	ufSSFP	pulse	sequence	re-
sulted	 in	 markedly	 improved	 signal	 intensities	 in	 the	 lung	 tissue	 (~	 19%)	 and	 successfully	
mitigated	banding	issues	at	1.	5T.	Eddy	currents	and	pulsation	artifacts	were	reduced	by	a	linear	
reordering	k-space	acquisition	scheme.		
	
Generally,	a	compromise	between	ufSSFP	FD	imaging	parameters	is	required	in	order	to	maintain	
both	a	sufficient	high	sampling	rate	for	respiratory	and	cardiac	cycles	and	appropriate	SNR	from	
the	lung	parenchyma.	To	this	end,	the	imaging	parameters	including	flip	angle,	waiting	time,	RF	
pulse	duration	and	spatial	resolution	were	optimized	in	order	to	achieve	both	the	maximal	pos-
sible	 signal	 intensity	 in	 the	 lung	 tissue	 as	 well	 as	 the	 sensitivity	 of	 FD-MRI	 to	 detect	 signal	
variations	caused	by	physiological	cycles.	In	the	experiments	performed	in	healthy	volunteers	we	
kept	a	constant	field-of-view	of	450´450	mm2	and	a	frame	rate	of	3.33	images	per	second.	Nev-
ertheless,	 parameters	 such	as	 field-of-view,	 acquisition	matrix	 and	waiting	 time	 should	 to	be	
adapted	for	 the	specific	patient	group.	Pediatric	patients	may	require	smaller	 field-of-view	or	
increased	spatial	resolution.	We	have	shown	that	the	decreased	ufSSFP	acquisition	time	can	be	
traded	for	an	increase	of	the	spatial	resolution	up	to	2.8´2.8	mm2,	without	notable	quality	loss	
in	the	derived	functional	lung	images;	even	in	adults.	In	contrast,	reduced	spatial	resolution	can	
be	used	for	diseases	heavily	affecting	the	density	of	the	lung	parenchyma,	such	as	emphysema	
or	COPD.	The	optional	fat	saturation	pulse	implemented	prior	the	image	acquisition	block	may	
prove	useful	in	obese	patients	or	in	presence	of	lesions	containing	fatty	tissue.		
	
After	 optimization,	 the	 ufSSFP	 pulse	 sequence	 provided	 functional	 Vw	 and	Qw	 images	 of	 in-
creased	 homogeneity	 across	 the	 lung	 tissue	 in	 the	 healthy	 volunteers	 at	 1.5T.	 Despite	 the	
significant	 improvements	 in	 the	 image	quality	at	1.5T,	 the	application	of	 the	ufSSFP	pulse	se-
quence	 for	 FD-MRI	 at	 3T	 still	 appears	 problematic.	 Major	 limitations	 arise	 from	 SAR,	 which	
reduces	the	maximal	achievable	flip	angle,	as	well	as	increased	susceptibility	effects,	resulting	in	
more	severe	banding.	As	a	result,	functional	lung	images	obtained	at	3T	using	ufSSFP	FD-MRI	are	
of	markedly	inferior	quality	as	compared	to	1.5T.	Unfortunately,	the	achievable	TR	is	not	short	
FD-MRI	with	ufSSFP	
	40	
enough	to	reduce	the	banding	artifacts	to	an	acceptable	level,	and	from	hardware	limitations,	
no	further	reduction	in	TR	can	be	currently	achieved.	As	an	alternative,	the	application	of	the	
spoiled	gradient	echo	sequence	for	FD-MRI	was	recently	proposed	[132].	
	
	
2.5	 Conclusion	
	
In	this	work,	we	adapted	and	optimized	the	recently	proposed	ufSSFP	scheme	for	FD-MRI	of	the	
lung	at	1.5T.	The	optimized	ufSSFP	sequence	profits	from	the	overall	reduced	TR	values	and	im-
proves	the	image	quality	by	increasing	the	signal	intensity	in	the	lung	tissue	while	reducing	the	
amount	of	banding	artifacts	at	1.5T.	In	addition,	ufSSFP	offers	the	possibility	to	acquire	functional	
lung	data	with	higher	spatial	resolution	as	compared	to	standard	bSSFP	imaging	used	in	previous	
FD-MRI	studies,	which	can	lead	to	an	increased	sensitivity	for	the	detection	of	functional	lung	
pathologies.	
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A	modified	version	of	this	chapter	has	been	published	as:	
Pusterla	O,	Bauman	G,	Wielpütz	MO,	Nyilas	S,	Latzin	P,	Heussel	CP,	Bieri	O.	Rapid	3D	in	vivo	1H	
human	lung	respiratory	imaging	at	1.5	T	using	ultra-fast	balanced	steady-state	free	precession.	
Magn	Reson	Med,	2017,	78:1059–1069.	
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CHAPTER	ABSTRACT	
	
	
Purpose:	To	introduce	a	reproducible	non-enhanced	1H	MRI	method	for	rapid	 in	vivo	
functional	assessment	of	the	whole	lung	at	1.5T.		
	
Methods:	At	different	 respiratory	volumes,	 the	pulmonary	 signal	of	ultra-fast	 steady-
state	free	precession	(ufSSFP)	follows	an	adapted	sponge	model,	characterized	by	a	res-
piratory	 index	 α.	 From	 the	model,	 α	 reflects	 local	 ventilation-related	 information,	 is	
virtually	 independent	 from	 the	 lung	density	and	 thus	 from	 the	 inspiratory	phase	and	
breathing	amplitude.	Respiratory	α-mapping	is	evaluated	for	healthy	volunteers	and	pa-
tients	with	obstructive	 lung	disease	 from	a	 set	 of	 five	 consecutive	 three-dimensional	
ufSSFP	scans	performed	in	breath-hold	and	at	different	inspiratory	volumes.	For	the	pa-
tients,	α-maps	were	compared	to	CT,	dynamic	contrast-enhanced	MRI	 (DCE-MRI)	and	
Fourier	decomposition	(FD).	
	
Results:	 In	 healthy	 volunteers,	 respiratory	 α-maps	 showed	 good	 reproducibility	 and	
were	homogeneous	on	iso-gravitational	planes	but	showed	a	gravity-dependent	respir-
atory	 gradient.	 In	 patients	 with	 obstructive	 pulmonary	 disease,	 the	 functional	
impairment	 observed	 in	 respiratory	 α-maps	was	 associated	with	 emphysematous	 re-
gions	present	on	CT	images,	perfusion	defects	observable	on	DCE-MRI,	and	impairments	
visualized	on	FD	ventilation	and	perfusion	maps.	
	
Conclusion:	Respiratory	α-mapping	derived	 from	multi-volumetric	ufSSFP	provides	 in-
sights	into	functional	lung	impairment	and	may	serve	as	a	reproducible	and	normative	
measure	for	clinical	studies.	
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3.1	 Introduction	
	
Periodical	bidirectional	airflow	is	the	primary	process	taking	place	in	the	lung,	enabling	gas	ex-
change	in	the	alveoli	[57].	As	a	result,	the	measurement	of	both	global	and	local	ventilation	is	a	
key	parameter	not	only	to	diagnose	and	understand	pathophysiology	in	lung	diseases,	but	also	
for	monitoring	the	progression	and	the	response	to	therapeutic	procedures	[11].	
	
A	global	measure	of	 lung	ventilation	can	be	obtained	by	conventional	whole-lung	spirometry,	
plethysmography	or	multiple-breath	washout	tests	[7].	The	strength	of	these	pulmonary	function	
tests	(PFTs)	relies	on	their	low	costs	and	in	the	standardization	of	normative	results	(e.g.,	gender,	
body	size,	age)	for	a	comparison	of	disease	severity	and	progression.	Conventional	PFTs,	how-
ever,	cannot	provide	information	about	regional	lung	processes	which	add	fundamental	insights	
into	pathophysiologic	mechanisms	or	improve	therapies	by	tailoring	to	specific	lung	regions	and	
disease	phenotypes	[10,	11].	
	
A	broad	spectrum	of	imaging	modalities	is	available	to	assess	the	regional	lung	ventilation.	Single-
photon	emission	computed	tomography	(SPECT),	planar	scintigraphy	and	positron	emission	to-
mography	 (PET)	 are	nuclear	medicine	 imaging	modalities	based	on	 radioactive-labeled	 tracer	
administration.	Despite	their	relatively	poor	spatial	and	temporal	resolution,	SPECT	and	PET	are	
commonly	used	 in	 clinical	 routine	 for	 lung	 functional	 imaging	 [16].	More	 recently,	 xenon-en-
hanced	dual-energy	computed	tomography	(CT)	[133]	and	the	novel	four-dimensional	CT	[134,	
135]	have	been	shown	to	provide	high	spatial	resolution	ventilation	imaging	in	short	scanning	
times.	Despite	 the	constant	progress	of	nuclear	medicine	and	CT	 in	 reducing	radiation	doses,	
exposure	to	any	 ionizing	radiation	 is	still	of	concern	[22,	23];	especially	for	children,	pregnant	
women,	or	patients	who	require	frequent	follow-up	examinations	[25].	
	
Alternatively,	magnetic	resonance	imaging	(MRI)	is	an	attractive	radiation-free	imaging	modality,	
and	over	the	last	decade	a	variety	of	powerful	methods	have	been	developed	for	the	evaluation	
of	both	lung	morphology	and	function.	Among	them,	for	the	assessment	of	pulmonary	perfusion	
and	indirectly	evaluate	lung	respiratory	obstructions	[75,	136],	dynamic	contrast-enhanced	(DCE)	
MRI	is	a	well-established	technique	[4,	29],	but	it	requires	the	injection	of	contrast	agents.	For	
ventilation	assessment,	non-proton	based	lung	 imaging	with	hyperpolarized	(HP)	noble	gases,	
such	as	Helium-3	or	Xenon-129,	has	demonstrated	 the	ability	 to	measure	 various	pulmonary	
functional	biomarkers	[35];	furthermore,	pulmonary	ventilation	can	be	visualized	in	MRI	using	
inert	fluorinated	gas	tracers	which	have	recently	generated	high	quality	images	similar	to	those	
from	HP	gases	[36].	As	 it	requires	specific	equipment,	broad	clinical	roll	out	of	gas	ventilation	
MRI	is	challenging,	requiring	a	dedicated	commitment.		
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	In	contrast,	non-invasive,	proton-based	imaging	of	regional	lung	function	is	possible	in	vivo	using	
a	technique	known	as	Fourier	decomposition	(FD)	[102]	MRI.	This	approach,	although	relatively	
new,	was	already	validated	 in	animal	and	human	studies	 [105,	106,	123].	FD	utilizes	dynamic	
balanced	steady	state	free	precession	(bSSFP)	imaging	in	free-breathing	with	subsequent	image	
registration	 and	 voxel-wise	 spectral	 analysis	 to	 extract	 local	 ventilation	 and	 perfusion	 infor-
mation.	 Nevertheless,	 due	 to	 the	 required	 time-resolution	 to	 separate	 perfusion	 from	
ventilation,	FD-MRI	is	a	single	slice	method.	As	a	result,	a	stack	of	coronal	two-dimensional	(2D)	
slices	must	be	acquired	 to	cover	 the	whole	 lung	volume,	 thus	offering	 relatively	 low	 through	
plane	resolution.	
	
In	this	work,	we	introduce	a	novel	proton-based	and	contrast-agent-free	MRI	technique	which	
provides	 regional	 isotropic	 three-dimensional	 information	 related	 to	 pulmonary	 ventilation	
[137].	 The	 method	 acquires	 a	 range	 of	 3D	 ultra-fast	 balanced	 steady	 state	 free	 precession	
(ufSSFP)	[45]	chest	scans	at	different	inspiratory	volumes	(multi-volume	3D	MRI)	to	derive	a	new	
volumetric	lung	functional	measure	termed	respiratory	index	α.	The	new	method	is	evaluated	at	
1.5T	in	healthy	volunteers	and	in	obstructive	pulmonary	disease	patients.	For	the	patients,	res-
piratory	 α-mapping	 is	 compared	 to	 dynamic	 contrast-enhanced	MRI	 (DCE-MRI),	 FD-MRI	 and	
computed	tomography	(CT).	
	
	
3.2	 Theory	
	
3.2.1	 The	adapted	sponge	model	and	the	respiratory	α-index	
	
The	 lung	parenchyma	can	be	compared	mechanically	to	sponge-like	tissue,	which	periodically	
expands	and	contracts	following	the	movement	of	the	diaphragm	and	chest	walls,	resulting	in	
bidirectional	air	flow	and	ventilation.		
	
In	a	simple	dry	sponge	model	[138]	where	the	sponge	mass	is	constant,	the	signal	intensity	(SI)	
is	inversely-proportional	to	the	lung	volume	V:	
	 SI 𝑉 	= 	Λ ∙ 𝑉<* + 	η																																																							(3.1)	
	
where	Λ	is	a	signal	intensity	scaling	factor	(related	to	parenchymal	“mass”),	and	η	is	the	SI	in	the	
limit	of	infinite	volume,	i.e.,	noise.	The	assumption	of	mass	preservation	in	the	dry	sponge	model,	
however,	 is	not	precise	enough	 to	model	 the	 lung	mechanics	 [138,	139]	due	 to	physiological	
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changes,	such	as	the	variability	of	blood	volume	during	breathing	[71],	or	due	to	ventilation	in-
homogeneities	or	regional	abnormalities.	As	a	result,	Equation	(3.1)	needs	to	be	modified	to	take	
the	form	 SI 𝑉 	= 	Λ ∙ 𝑉<S 	+ η																																																													(3.2)	
	
where	α	is	referred	to	as	respiratory	index,	which	maps	lung	expansion	and	changes	in	pulmonary	
blood	volume	during	breathing.		
	
In	the	limit	of	η ≪ Λ ∙ 𝑉<S,	the	adapted	sponge	model	[cf.	Eq.	(3.2)]	can	be	rewritten	to	yield	
	 log SI 	= 	 log Λ ∙ 𝑉<S	(1 + ηΛ ∙ 𝑉<S) ≈ log Λ ∙ 𝑉<S 	= 	 log Λ − α ∙ log 𝑉 											(3.3)	
	
and	the	respiratory	index	α	can	be	estimated	globally	considering	the	mean	SI	over	the	whole	
lung	volume,	SI,	using	 αglobal ∶	=	 − ∂ log SI∂ log 𝑉 	.																																																														(3.4)	
	
Similarly,	after	co-registration	of	multi-volumetric	acquisitions	using	a	deformable	registration	
algorithm,	the	respiratory	index	can	be	estimated	voxel-wise	(i.e.,	locally	at	the	position	𝑥)	
	
αlocal 𝑥 ∶	=	 − ∂ log SI 𝑥∂ log 𝑉 	.																																																								(3.5)	
	
3.2.2	 The	respiratory	α-index:	theoretical	formulation	and	interpretation		
	
In	the	following,	we	consider	a	physical	pulmonary	model	in	which	the	main	components	of	the	
lung	are	parenchyma	(tissue),	blood	and	air.	
	
During	breathing	the	whole	lung	volume	V	continuously	increases	or	decreases,	allowing	for	air-
flow.	For	small	enough	variations	in	the	total	lung	volume,	𝑉	 = 	𝑉1 ± δ𝑉,	the	average	density	in	
the	lung	(ρ)	is	assumed	to	become	a	function	of	the	global	variations	only,	i.e.,	
	 ρ(𝑉) ∶	=	 𝑀blood(𝑉) + 𝑀air 𝑉 + 𝑀tissue𝑉 ≈ ρblood ∙ 𝑉blood(𝑉) + ρtissue ∙ 𝑉tissue𝑉 													(3.6)	
	
where	V	 = 	Vblood + Vair + Vtissue,	 ρblood	 is	 constant,	 ρtissue	 is	 the	 average	 tissue	 density,	 and	
where	we	neglected	the	contribution	of	the	air	to	the	mass,	since	Mair	<<	Mblood,	Mtissue	.	
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Similarly,	if	ventilated,	the	volume	of	a	small	macroscopic	region,	𝑣	 = 	𝑣(𝑥),	expands	or	com-
presses	due	to	air	 inflow	or	outflow.	For	example,	while	the	region	inflates,	the	volume	of	air	
(𝑣air)	increases,	the	tissue	in	the	region	stretches	(but	preserves	its	mass),	and	the	blood	volume	
(𝑣blood)	might	be	altered	due	to	physiological	changes.	Analogous	to	Equation	(3.6),	we	assume	
that	 for	small	enough	variations	 in	the	total	 lung	volume	the	 local	volume	changes	become	a	
function	of	the	global	variations	only,	i.e.,	𝑣	 = 	𝑣(𝑥, 𝑉).	Thus,	the	local	density	becomes,	
	 ρ 𝑥, 𝑉 ≔ 𝑚blood 𝑥, 𝑉 + 𝑚air 𝑥, 𝑉 + 𝑚tissue 𝑥𝑣 𝑥, 𝑉 ≈	
	 ≈ ρblood ∙ 𝑣blood 𝑥, 𝑉 + ρtissue 𝑥 ∙ 𝑣tissue 𝑥𝑣 𝑥, 𝑉 																																			 3.7 	
	
where	again,	we	neglect	the	contribution	of	the	air	to	the	local	mass.	
	
Provided	that	there	is	no	or	only	a	limited	change	in	the	lung	T2/T1	during	breathing,	the	change	
in	the	steady-state	signal	of	multi-volumetric	ufSSFP	acquisitions,	ΔSI,	becomes	proportional	to	
the	change	 in	 the	proton	density,	Δ𝜌ghi.	From	the	model	 [cf.	Eq.	 (3.6)],	we	thus	 find	 for	 the	
global	index:	
	 αglobal 𝑉1 ≈ −∂ log ρ 𝑉∂ log 𝑉 j	K	jk 	= 	1 − 𝑉1𝑀1 ∙ ∂𝑀lmnno∂𝑉 j	K	jk 																						(3.8)	
	
where	the	second	term	reflects	the	change	in	whole	pulmonary	blood	mass	as	a	function	of	the	
whole	lung	volume	(note	 jkgk	is	simply	a	scaling	factor	and	𝑀1 ∶	=	 𝑀 𝑉1 	).	Simulations	indicate	
that	αglobal	is	almost	independent	of	the	breathing	position,	𝑉1,	that	is	 1 − Sglobal jqrjSglobal j<rj < 0.03	
for	variations	up	to	δ𝑉	 = 	 jku 	 (tidal	breathing,	e.g.,	2.4±0.4	L),	and	 vgwxyyzvj < 0.25 ∙ gkjk 	 (value	
elaborated	from	[71]	assuming	healthy	tissues	and	𝑀{|}}~ 	= 	𝑀lmnno 𝑉1 	).	
	
From	Equation	(3.8),	αglobal	measures	the	change	in	 lung	perfusion	as	a	function	of	the	whole	
lung	volume	change	(e.g.,	percentage	of	whole	lung	mass	change	divided	by	the	percentage	of	
the	 total	 lung	 volume	 change).	 Thus,	 αglobal 	 = 	1	 indicates	 no	 perfusion	 change,	 αglobal > 1	
means	that	the	blood	decreases	in	inspiration	and	αglobal < 1	the	opposite.	
	
In	analogy,	for	the	local	respiratory	index	[cf.	Eq.	(3.5)],	we	find	using	Eq.	(3.7)	
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αlocal 𝑣 𝑥, 𝑉1 ≈ − ∂ log ρ 𝑥, 𝑉∂ log 𝑉 j	K	jk 	=		
	 	= 	 𝑉1𝑣 𝑥, 𝑉1 ∙ ∂𝑣 𝑥, 𝑉∂𝑉 j	K	jk − 𝑉1𝑚 𝑥, 𝑉1 ∙ ∂𝑚lmnno 𝑥, 𝑉∂𝑉 j	K	jk .																										(3.9)	
	
From	Equation	(3.9),	the	local	respiratory	index	depends	on	two	main	components:	the	first	dif-
ferential	term	reflects	the	local	change	in	volume	as	a	function	of	the	total	lung	volume	change,	
thus	local	ventilation,	whereas	the	second	differential	term	describes	the	change	in	the	local	lung	
mass	(i.e.,	pulmonary	blood	volume)	as	a	function	of	the	total	lung	volume	change.	Note,	that	in	
Equation	(3.9),	the	terms	𝑉1/𝑣 𝑥, 𝑉1 	and	𝑉1/𝑚 𝑥, 𝑉1	 	are	scaling	factors.	
	
If	the	second	term	in	Equation	(3.9)	fulfills	
	 𝑉1𝑚 𝑥, 𝑉1 ∙ ∂𝑚lmnno 𝑥, 𝑉∂𝑉 j	K	jk ≪ 𝑉1𝑣 𝑥, 𝑉1 ∙ ∂𝑣 𝑥, 𝑉∂𝑉 j	K	jk 																			(3.10)	
	
the	respiratory	index	becomes	a	measure	of	local	ventilation	(e.g.,	percentage	of	the	local	vol-
ume	change	divided	by	the	percentage	of	the	total	lung	volume	change),		 	
	 αlocal 𝑣 𝑥, 𝑉1 ≈ 𝑉1𝑣 𝑥, 𝑉1 ∙ ∂𝑣 𝑥, 𝑉∂𝑉 j	K	jk .																														(3.11)	
	
The	premise	of	Equation	(3.10)	has	already	been	assumed	by	other	ventilation-weighted	imaging	
techniques	[102,	112,	123,	134,	140]	and	is	corroborated	by	recent	findings	[71,	141]	which	show	
a	not	statistically	significant	pulmonary	perfusion	change	over	the	whole	lung	and	no	significant	
lobar	perfusion	redistribution	for	breath-holds	in	the	tidal	volume	region.	As	a	result,	the	respir-
atory	index	αlocal 𝑥 	reflects	virtually	lung	ventilation	and	is	independent	of	the	lung	density	[see	
Eq.	(3.11)].	A	value	αlocal 𝑥 	= 	1	indicates	that	a	region-of-interest	(ROI)	expands	equally	to	the	
whole	 lung,	 αlocal 𝑥 > 1	 that	 the	 ROI	 expands	 at	 a	 rate	 higher	 than	 the	 whole	 lung,	 and	αlocal 𝑥 < 1	the	opposite.	
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3.3	 Methods	
	
3.3.1	 MRI	data	acquisition	
	
All	datasets	were	acquired	with	1.5T	clinical	whole-body	MR-scanner	(Siemens	Healthineers,	Er-
langen,	Germany).	A	12-channel	thorax	and	a	24-channel	spine	coil	were	used	as	receive-array;	
the	body	coil	as	transmitter.	Measurements	were	performed	in	a	total	of	ten	healthy	volunteers	
and	three	patients;	written	informed	consent	was	obtained	from	each	subject	prior	to	the	exam-
inations.	
	
Images	were	 acquired	 in	 breath-hold	 and	 in	 supine	 position	 using	 a	 3D	 balanced	 ufSSFP	 se-
quence,	offering	a	T2/T1	weighted	contrast	 for	TR	<	2	ms	at	1.5T	[45]	and	sensitive	enough	to	
depict	the	signal	intensity	modulations	of	the	lung	parenchyma	arising	at	diverse	inspiratory	lev-
els	 [137].	 For	 the	healthy	 volunteers,	 the	 sequence	parameters	were	 set	 as	 follows:	 TE/TR	 =	
0.47/1.19	ms,	flip	angle	23°	(optimized	for	highest	ufSSFP	lung	signal	intensity,	see	Eq.	(3.1)	in	
[117]	for	details),	RF	pulse	length	80	μs,	bandwidth	1563	Hz/pixel,	field-of-view	400	×	400	×	250	
mm3,	two	averages,	isotropic	resolution	3.1	mm3,	reconstruction	matrix	128	×	128	×	80,	parallel	
imaging	 GRAPPA	 factor	 2	 (phase	 encoding	 R-L),	 phase	 oversampling	 30%,	 asymmetric	 echo	
readout	(66%	of	full	echo),	total	acquisition	time	16	s.	The	protocol	was	shortened	to	11	s	for	the	
patients:	field-of-view	450	×	450	×	250	mm3,	isotropic	resolution	3.5	mm3,	reconstruction	matrix	
128	×	128	×	72,	no	phase	oversampling	and	otherwise	equal	protocol	parameters	as	for	the	vol-
unteers.	In	all	the	acquisitions	predefined	default	shim	settings	(tune	up)	were	used.	An	in	depth	
description	of	the	ufSSFP	pulse	sequence	and	technical	details	can	be	found	in	Bieri	[45].		
	
3.3.2	 The	adapted	sponge	model	
	
In	order	to	validate	the	adapted	sponge	model	[Eq.	 (3.2)],	3D	ufSSFP	 imaging	of	the	 lung	was	
performed	from	forced	expiration	(i.e.,	residual	volume,	RV)	to	forced	inspiration	(i.e.,	total	lung	
capacity,	TLC)	in	five	healthy	volunteers	(30	±	4	years	old,	males).	Typically,	around	14	scans	in	
inspiratory	breath-hold	were	recorded.	The	breathing	commands	were	given	vocally	to	the	vol-
unteers,	which	were	instructed	to	change	their	breathing	position	for	each	of	the	14	scans	(from	
RV	to	TLC).		
	
For	the	post-processing,	the	acquisitions	were	median	filtered	(filter	kernel	size	5	×	5	×	5	voxels)	
to	remove	the	vasculature	overlaying	the	pulmonary	tissue,	in	particular	vessels	smaller	than	4	
×	 4	 ×	 4	 voxels	 [142].	 The	 lungs	were	 segmented	 using	 a	 3D	 fast-marching	 algorithm	 using	 a	
standalone	software	 (MITK)	 [131].	The	consistency	of	 the	segmentation	was	verified	slice-by-
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slice	and	in	between	datasets	by	a	trained	observer;	if	needed,	the	regions-of-interest	were	cor-
rected	manually.	From	this,	the	volume	of	the	lung	and	the	corresponding	mean	signal	intensity	
in	each	acquisition	was	calculated.	Finally,	the	global	respiratory	index	αglobal	was	calculated	by	
fitting	the	observed	mean	signal	intensity	in	the	lung	parenchyma	as	a	function	of	the	lung	vol-
ume	to	the	adapted	sponge	model	[Eq.	(3.2)].	Fitting	was	performed	by	orthogonal	regression	
(singular	value	decomposition).		
Data	visualization	and	post-processing	was	performed	using	Python	2.7	(Anaconda	Python	dis-
tribution,	Continuum	Analytics,	version	2.5).		
	
3.3.3	 Respiratory	α-mapping	
	
Respiratory	α-mapping	[Eq.	(3.5)]	was	evaluated	in	ten	healthy	volunteers	(36	±	6	years	old,	four	
females	and	six	males),	five	of	which	were	already	scanned	for	the	adapted	sponge	model	pro-
tocol.	Respiratory	α-mapping	was	also	performed	in	three	patients	with	obstructive	pulmonary	
disease:	two	chronic	obstructive	pulmonary	disease	(COPD)	GOLD	III	(53	year	old	male	and	75	
year	old	female)	and	a	pediatric	patient	with	cystic	fibrosis	(CF)	(12	year	old,	female).	For	the	
COPD	patients,	respiratory	α-mapping	was	compared	with	clinically	indicated	CT	and	DCE-MRI,	
which	were	acquired	the	same	day	for	emphysema	treatment	planning.	The	CT	acquisitions	were	
post-processed	with	the	software	YACTA	(programmed	by	Oliver	Weinheimer,	Heidelberg,	Ger-
many)	[143]	to	generate	color-coded	emphysema	maps.	For	the	pediatric	CF	patient,	respiratory	
α-maps	were	compared	to	the	functional	information	derived	from	FD	[104,	144].	To	this	end,	
time-resolved	sets	of	coronal	images	were	acquired	in	free-breathing	using	TE/TR	=	0.68/1.54,	
flip	angle	60°,	field-of-view	400	×	400	mm2,	matrix	128	×	128	(interpolated	to	256	×	256),	slice	
thickness	12	mm,	bandwidth	2056	Hz/pixel,	GRAPPA	factor	2,	imaging	rate	4	images/s,	160	im-
ages	per	set,	for	an	acquisition	time	of	40	s	/	slice.		
	
The	scanning	protocol	for	the	calculation	of	respiratory	α-maps,	in	contrast	to	the	14	MR	scans	
performed	to	validate	the	adapted	sponge	model	(cf.	“Adapted	Sponge	Model”,	Section	3.2.1),	
consisted	of	only	five	3D	ufSSFP	lung	acquisitions.	The	acquisitions	were	recorded	at	different	
breathing	positions	around	the	tidal	respiratory	volume	region,	generally	from	functional	resid-
ual	capacity	(FRC)	to	tidal	inspiration.	To	this	end,	the	volunteers	and	patients	were	instructed	
either	to	“breathe-in,	breathe-out,	and	hold”	or	to	“breathe-in	and	hold”	before	the	respective	
FRC	and	tidal	inspiration	acquisitions.	The	three	scans	in	respiratory	phases	in	between	FRC	and	
tidal	inspiration	were	performed	with	the	following	breathing	commands:	“breathe-in,	breathe-
out,	one-sip	/	two-sips	/	three-sips	of	air,	and	hold”,	respectively.	
	
Scanning	in	the	tidal	breathing	region	facilitated	the	spatial	co-registration	of	the	limited	volume	
differences.	The	co-registration	was	performed	using	a	3D	deformable	B-spline	mass	preserving	
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image	registration	algorithm	implemented	in	elastix	(elastix	version	4.7,	University	Medical	Cen-
ter	Utrecht,	The	Netherlands)	[145].	The	registration	algorithm	aims	at	aligning	dense	and	high	
signal	intensity	landmarks	of	images,	such	as	lung	vessels	and	chest	cage.	For	the	registration,	
the	scan	with	a	mean	value	of	the	lung	volume	was	chosen	as	a	fixed	dataset	(baseline)	and	the	
remaining	four,	so-called	“moving”	datasets	were	co-registered.	After	registration,	the	images	
were	median-filtered	and	 the	 respiratory	 index	αlocal	was	 calculated	voxel-wise	by	orthogonal	
regression	estimation	of	the	observed	SI	as	function	of	the	lung	volume,	cf.	Equation	(3.5).	The	
lung	volume	of	each	scan	was	determined	on	native	datasets	(unregistered)	by	segmentation,	as	
described	above.	
	
3.3.4	 Reproducibility	
	
The	reproducibility	of	respiratory	α-mapping	was	assessed	in	three	healthy	volunteers.	Each	sub-
ject	 was	 scanned	 three	 times,	 but	 taken	 out	 and	 repositioned	 to	 mimic	 and	 enforce	 new	
measurement	conditions	(including	the	frequency	adjustments).	The	resulting	three	respiratory	
α-maps	of	each	subject	were	spatially	matched	by	co-registration	(elastix)	in	order	to	assess	the	
local	variability.	As	a	global	measure,	the	gamma-index	percent	passing	rate	[146]	was	calculated	
to	assess	the	voxel-to-voxel	similarity	between	the	maps	over	the	whole	lung.	The	gamma-index	
percent	passing	rate	was	derived	with	acceptance	criteria	of	5%	for	the	respiratory	α-index	de-
viation	 and	 a	 physical	 distance	 to	 agreement	 of	 10	mm.	 In	 contrast	 to	 a	 relative	 difference	
analysis,	the	gamma-index	tolerates	spatial	and	structural	misalignments	caused	by	differences	
in	the	lung	volume	of	the	baseline	datasets	(used	to	calculate	the	respiratory	α-maps).	
	
	
3.4	 Results	
	
3.4.1	 Validation	of	the	adapted	sponge	model		
	
Exemplary	3D	ufSSFP	images	obtained	in	a	healthy	volunteer	are	shown	in	Figure	3.1a	for	two	
different	inspiratory	volumes	(i.e.,	1.8	L	and	4.6	L).	As	a	result	of	the	very	short	TR,	no	banding	
artifacts	are	visible	and	airways	are	well	visualized	in	the	native	images.	The	difference	in	signal	
levels	in	the	lung	parenchyma	for	the	two	lung	volumes	are	clearly	noticeable;	especially	in	the	
dependent	(dorsal)	part	of	the	lung.	Median	filtering,	as	shown	in	Figure	3.1b,	is	used	to	remove	
the	 overlying	 vascular	 structure	 while	 preserving	 the	 underlying	 pulmonary	 signal	 variation	
[142].		
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The	observed	mean	parenchymal	signal	intensity	variation	(over	the	whole	lung;	see	yellow	out-
lines	in	Figure	3.1	for	definition	of	the	region-of-interest)	is	shown	in	Figure	3.2	as	a	function	of	
lung	volumes.	The	overall	SI	variation	of	the	lung	parenchyma	was	as	low	as	36	[a.u.]	in	forced	
inspiration	(V	=	6.31	L)	and	increased	about	4-fold,	up	to	147	[a.u.],	in	forced	expiration	(V	=	1.92	
L).	This	is	in	contrast	to	the	SI	in	the	liver,	remaining	constant	(304±4	[a.u.],	mean	±	SD).	In	com-
parison	to	the	signal	intensity	emanating	from	the	lung	parenchyma,	a	low	noise	level	of	about	
5±2	[a.u.]	was	measured	in	air	justifying	the	limit	of	η ≪ Λ ∙ 𝑉<S	and	thus	the	validity	of	Equation	
(3.3),	especially	for	respiratory	phases	in	the	tidal	breathing	region.	Overall,	the	signal	variation	
follows	the	adapted	sponge	model	[cf.	Eq.	(3.4)].	A	fit	of	the	adapted	sponge	model	yields	αglobal	
=	1.16	±	0.02	(mean	±	uncertainty)	in	combination	with	a	SI	scaling	factor	Λ	=	317	±	7	[a.u.].	The	
small	residual	deviations	of	the	experimental	data	from	the	linear	fit	in	the	double	logarithmic	
scale	corroborate	the	overall	 independency	of	 the	respiratory	 index	αglobal	 from	the	breathing	
phase.	Moreover,	 a	 respiratory	 index	αglobal	 deviating	 from	one	 indicates	 that	 the	dry	 sponge	
model	(α	=	1)	is	not	accurate	in	describing	the	lung	SI	modulations.	Similar	results	are	found	for	
all	five	volunteers	(cf.	Table	3.1).		
	
In	summary,	for	lung	volumes	ranging	from	RV	and	TLC,	the	respiratory	index	αglobal	varied	be-
tween	 1.04	 and	 1.16	 (uncertainty	 ±3%),	 indicating	 only	 residual	 contributions	 from	 blood	
changes	[cf.	Eq.	(3.8)].	The	orthogonal	regression	analysis	yields	coefficients	of	determinations	
R2	higher	than	0.996,	demonstrating	an	appropriate	description	of	the	experimental	data	based	
on	the	adapted	sponge	model.		
	
	
	
Figure	3.1.	(a)	Sagittal	and	coronal	3D	ufSSFP	chest	images	illustrating	end-expiration	(top)	and	full	inspi-
ration	 (bottom).	 (b)	Median-filtered	 images	with	 segmentation	 (yellow	outline)	used	 for	 estimation	of	
parenchymal	signal	intensity	and	lung	volume.	
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Figure	3.2.	Measured	mean	sig-
nal	intensity	of	the	parenchyma	
(red	 dots)	 as	 a	 function	 of	 the	
lung	volume	 in	double	 logarith-
mic	 scale.	 A	 fit	 of	 the	 adapted	
sponge	model	(black	line)	yields	
αglobal	=	1.16±0.02	(cf.	Table	3.1,	
Volunteer	#1).	
	
	
	
	
	
Table	3.1.	Demographic	information	(gender,	age,	height,	weight),	global	respiratory	index	(mean	±	uncer-
tainty),	 Pearson	 correlation	 coefficient	 (R2)	 and	 lung	 volume	 (mean	 ±	 SD,	 min,	 max)	 for	 the	 subjects	
examined	with	the	adapted	sponge	model	protocol	(lung	volumes	ranging	from	RV	to	TLC).	
	
Subject	
Gender,	Age,	Height	
(cm),	Weight	(kg)	
αglobal	 R2	
Lung	volume	[L]	
	mean±SD	 min	 max	
Volunteer	1	 M,	32,	179,	82	 1.16	±	0.02	 0.997	 3.73	±	1.52	 1.92	 6.31	
Volunteer	2	 M,	26,	190,	80	 1.11	±	0.03	 0.997	 3.67	±	1.40	 1.92	 6.66	
Volunteer	3	 M,	34,	175,	80	 1.14	±	0.02	 0.999	 3.09	±	0.91	 1.47	 5.32	
Volunteer	4	 M,	32,	178,	75	 1.07	±	0.03	 0.996	 4.38	±	1.41	 2.09	 6.39	
Volunteer	5	 M,	28,	185,	84	 1.04	±	0.02	 0.999	 3.39	±	1.09	 1.85	 5.53	
	
	
	
3.4.2	 Respiratory	α-mapping	in	healthy	subjects	
	
From	the	respiratory	mapping	protocol,	exemplary	coronal	views	of	the	five	native	datasets	ac-
quired	in	a	healthy	volunteer	at	different	inspiratory	levels	are	shown	in	Figure	3.3a.	The	datasets	
are	reordered	as	a	function	of	the	lung	volume	determined	by	segmentation,	from	FRC	to	tidal	
inspiration.	For	this	range	of	volumes,	the	mean	parenchyma	SI	varies	from	102±42	[a.u.]	(SImin	=	
53	[a.u.],	V	=	2.71	L,	FRC)	to	72±21	[a.u.]	(SImin	=	39	[a.u.],	V	=	3.78	L,	tidal	inspiration),	while	the	
noise	level	is	about	4±2	[a.u.].	A	global	respiratory	index	αglobal	=	1.04±0.03	is	recovered,	similar	
to	the	value	found	by	the	adapted	sponge	model	protocol	(cf.	Table	3.1,	Volunteer	#5,	αglobal	=	
1.04±0.02).	
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For	better	visualization	of	the	rather	marginal	differences	in	the	respiratory	phases,	relative	sig-
nal	intensity	difference	maps	are	calculated	and	shown	in	Figure	3.3b	(with	respect	to	the	scan	
taken	at	middle	respiratory	phase).	As	a	result,	the	diverse	lung	parenchyma	signal	levels,	lung	
structural	misalignments	and	through	plane	motion	due	to	slightly	different	inspiratory	volumes	
are	accentuated.	Finally,	in	Figure	3.3c,	relative	signal	intensity	difference	maps	are	shown	after	
image	registration.	Overall,	image	registration	does	not	affect	lung	signal	intensity,	and	resolves	
structural	mismatches,	such	as	vessels,	diaphragm	position	and	lungs	boundaries	and	corrects	
for	through	plane	motion.		
	
For	three	different	ROIs	 (4	×	4	×	4	pixels),	 the	mean	SI,	as	observed	 in	the	five	datasets	after	
image	co-registration,	is	shown	in	Figure	3.3d.	Local	respiratory	index	values	αlocal	of	0.88±0.07,	
0.93±0.07	and	1.13±0.05	are	found	with	an	R2	exceeding	0.976,	indicating	appropriate	descrip-
tion	of	the	experimental	data	by	the	adapted	sponge	model	after	image	registration	using	an	ROI	
analysis.	
	
	
Figure	3.3.	(a)	Exemplary	3D	ufSSFP	coronal	views	of	the	same	slice	acquired	at	five	different	tidal	volumes	
used	for	respiratory	α-mapping.	The	datasets	are	ordered	from	left	to	right	according	to	their	lung	volume	
(i.e.,	 from	FRC	to	tidal	 inspiration).	The	middle	volume	scan	served	as	a	baseline;	 i.e.,	was	chosen	as	a	
reference	image	during	the	registration	process.	(b)	Relative	signal	intensity	difference	maps	between	the	
baseline	and	the	target	images	(to	be	registered)	accentuating	differences	in	the	diaphragm	position	(e.g.,	
red	arrow),	lung	boundaries	and	arteries	due	to	the	respiratory	phase	mismatch.	(c)	Corresponding	relative	
signal	intensity	difference	maps	after	image	co-registration,	revealing	lung	structural	alignment	while	pre-
serving	the	signal	intensity.	(d)	Local	parenchymal	signal	(averaged	over	4	×	4	×	4	voxels)	as	a	function	of	
the	lung	volume	in	double	logarithmic	scale	for	three	selected	ROI	(for	position	of	ROI,	see	(a),	Vol	3).	A	fit	
of	the	adapted	sponge	model	yields:	α	=	0.81±0.07	(red	line),	α	=	0.93±0.07	(blue	line)	and	α	=	1.13±0.05	
(green	line).		
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Illustrative	respiratory	α-maps	for	two	volunteers	(a	male	and	a	female)	are	shown	in	Figure	3.4	
for	representative	slices	in	coronal,	sagittal,	and	axial	orientations.	Generally,	a	homogenous	res-
piratory	 index	 is	 observed	 on	 iso-gravitational	 planes,	 whereas	 the	 respiratory	 index	 values	
almost	double	in	the	caudal	part	(α	≈	1.4)	in	comparison	to	ventral	part	(α	≈	0.7).		
	
A	 side-by-side	comparison	of	 respiratory	α-maps	 for	a	volunteer	examined	 three	consecutive	
times	for	reproducibility	tests	is	presented	in	Figure	3.5,	revealing	a	striking	visual	similarity	in	
the	respiratory	α-maps.	This	is	corroborated	by	the	low	standard	deviation	(Fig.	3.5d)	and	by	high	
gamma-index	passing	rates	of	84%	and	87%.	As	a	result,	highly	similar	global	respiratory	indices	
αglobal	are	observed	for	the	three	examinations:	0.97±0.03,	0.98±0.04	and	0.95±0.03	(coefficient	
of	variation	cv	=	1.6	%).	The	reproducibility	results	for	the	two	other	subjects	revealed	analogous	
results:	similar	global	respiratory	indices	for	the	three	examinations	(cv	=	1	%,	c.f.	Table	3.2)	and	
gamma-index	passing	rate	in	between	87%	and	94%.	
	
	
	
	
	
	
	
	
	
	
Figure	3.4.	Three-dimensional	respiratory	α-maps	overlaid	on	3D	ufSSFP	morphological	images	in	sagittal,	
coronal,	and	transverse	orientation	for	two	healthy	volunteers	[(a):	male	and	(b):	female].	A	global	respir-
atory	 index	 of	 αglobal	 =	 1.10±0.04	 (male)	 and	 of	 αglobal	 =	 0.91±0.04	 (female)	 was	 found	 (cf.	 Table	 3.2,	
Volunteers	2	and	8).	
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3.4.3	 Respiratory	α-mapping	in	patients	
	
Finally,	the	feasibility	of	respiratory	α-mapping	was	evaluated	in	the	clinical	setting.	Respiratory	
α-maps	obtained	in	two	COPD	patients	are	shown	in	Figure	3.6	and	compared	to	CT	and	DCE-
MRI.	Respiratory	α-mapping	is	compared	to	DCE	which	is	a	robust	and	well	established	clinical	
imaging	technique	[2,	31,	147–149]	for	the	assessment	of	obstructions;	DCE	perfusion-impair-
ments	 reflect	 the	 effects	 of	 hypoxic	 pulmonary	 vasoconstriction	 and	 this	 is	 regarded	 as	 a	
surrogate	for	lung	ventilation	[75,	136].	Similarly,	for	COPD,	it	has	been	shown	the	emphysema-
tous	destruction,	as	quantified	with	CT	densitometry,	 leads	 to	a	 significant	 increase	of	 closed	
volume,	thus	a	decreased	ventilation	of	those	regions	and	subsequent	hypoxic	vasoconstriction	
[148,	150].	CT	emphysema	maps	reveal	different	 impairments	for	the	two	COPD	patients:	the	
	
Figure	3.5.	(a-c)	Reproducibility	of	respiratory	α-mapping	evaluated	in	a	healthy	subject	(Table	3.2,	Volun-
teer	#6)	scanned	three	consecutive	times	and	(d)	the	resulting	standard	deviation	map.	
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first	has	 localized	 large	emphysematous	 regions	 (Fig.	3.6	 in	 the	upper	 row,	53	year	old	male)	
while	the	second	patient	has	a	more	diffuse	form	of	emphysema	(in	the	bottom	row,	75	year	old	
female).	Similar	abnormalities	are	seen	on	DCE	perfusion	images.	Overall,	structural	emphysem-
atous	tissue	destruction	and	perfusion	defects	visually	correlate	with	the	location	of	conspicuous	
functional	 impairment	 indicated	on	 the	 respiratory	maps	 (e.g.,	αlocal	<	0.3).	Global	 respiratory	
indexes	αglobal	 =	1.07±0.03	 and	αglobal	 =	0.66±0.05	 are	 found	 (comparable	with	 literature	 results	
from	CT	measurements	[139]).	
	
Respiratory	α-maps	 for	a	CF	patient	are	 compared	 to	FD	ventilation-	and	perfusion-weighted	
maps	 in	Figure	3.7.	The	 three	 functional	 imaging	modalities	visually	 correspond,	 showing	 the	
same	major	functional	defect	 in	the	middle	 lobe,	 less	severe	 impairments	and	similar	healthy	
pulmonary	regions.	The	global	respiratory	index	for	the	CF	patient	is	αglobal	=	0.91±0.04.	
	
	
	
	
	
	
Figure	3.6.	Intraindividual	scans	in	COPD	patients	performed	the	same	day:	CT	emphysema	maps	(a,	b),	
DCE-MRI	subtraction	maps	(c,	d)	and	respiratory	α-maps	(e,	f).	The	arrows	indicate	exemplary	functional	
defects	on	respiratory	α-maps	(e.g.,	αlocal	<	0.3)	that	correlate	with	both	emphysematous	regions	on	CT	
images	(colored	in	yellow)	and	perfusion	defects	in	DCE-MRI	(blue	regions).	
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Table	3.2	summarizes	the	respiratory	index	values	for	the	volunteers	and	the	patients	examined	
with	the	respiratory	α-mapping	protocol	(lung	volumes	from	FRC	to	tidal	inspiration).	For	healthy	
male	volunteers,	respiratory	index	αglobal	varied	between	0.95	and	1.14	(1.07±0.06,	mean	±	SD),	
while	for	female	volunteers	it	varied	from	0.91	to	1.05	(0.95±0.06,	mean	±	SD);	the	volunteers	
average	was	αglobal	=	1.02±0.07.	For	the	five	volunteers	scanned	with	both	the	adapted	sponge	
model	protocol	(lung	volumes	ranging	from	RV	to	TLC)	and	the	respiratory	α-mapping	protocol	
(lung	volumes	from	FRC	to	tidal	inspiration),	the	respiratory	values	αglobal	between	the	two	ex-
periments	 differ	 less	 than	 2%	 and	 show	 a	 strong	 correlation	 (Lin’s	 Concordance	 correlation	
coefficient	ρc	=	0.93).	For	all	examined	subjects,	coefficients	of	determinations	R2	higher	than	
0.972	 are	 found,	 indicating	 an	 appropriate	 description	 of	 the	 experimental	 data	 using	 the	
adapted	sponge	model.	
	
	
	
	
Figure	3.7.	Fourier	decomposition	(a)	perfusion-weighted	and	(b)	ventilation-weighted	maps	compared	to	
(c)	α-maps	for	a	pediatric	CF	patient.	A	major	functional	defect	of	the	middle	lobe	(red	arrows)	and	other	
less	severe	impairments	(blue	arrows)	are	clearly	visible	on	all	the	three	imaging	modalities.	
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Table	3.2.	Demographic	information	(gender,	age,	height,	weight),	global	respiratory	index	(mean	±	uncer-
tainty),	Pearson	correlation	coefficient	(R2)	and	lung	volume	for	the	subjects	examined	with	the	respiratory	
α-mapping	protocol	(lung	volumes	from	FRC	to	tidal	inspiration).	
	
Subject	 Gender,	Age,	Height	
(cm),	Weight	(kg)	
αglobal	 R2	 									Lung	volume	[L]	
mean±SD	 min	 max	
Volunteer	1(*)	 M,	32,	179,	82	 1.14	±	0.04	 0.973	 2.85±0.28	 2.72	 3.23	
Volunteer	2(*)	 M,	26,	190,	80	 1.10	±	0.04	 0.994	 2.69±0.24	 2.41	 2.99	
Volunteer	3(*)	 M,	34,	175,	80	 1.12	±	0.02	 0.996	 1.99±0.27	 1.69	 2.29	
Volunteer	4(*)	 M,	32,	178,	75	 1.05	±	0.02	 0.997	 2.79±0.28	 2.38	 3.08	
Volunteer	5(*),	scan	1	 M,	28,	185,	84	 1.04	±	0.03	 0.996	 2.92±0.41	 2.71	 3.78	
									“														,	scan	2	 “	 1.02	±	0.03	 0.995	 3.20±0.44	 2.40	 3.65	
									“														,	scan	3	 “	 1.03	±	0.02	 0.999	 3.13±0.39	 2.64	 3.69	
Volunteer	6,	scan	1	 M,	29,	175,	75	 0.97	±	0.03	 0.996	 2.59±0.40	 2.21	 3.34	
									“										,	scan	2	 “	 0.98	±	0.04	 0.997	 2.43±0.35	 2.08	 3.03	
									“										,	scan	3	 “	 0.95	±	0.03	 0.998	 2.48±0.42	 2.16	 3.25	
Volunteer	7,	scan	1	 F,	49,	164,	58	 1.04	±	0.02	 0.984	 2.72±0.27	 2.40	 3.10	
									“										,	scan	2	 “	 1.05	±	0.03	 0.986	 2.62±0.23	 2.37	 2.95	
									“										,	scan	3	 “	 1.03	±	0.02	 0.989	 2.63±0.21	 2.34	 2.89	
Volunteer	8	 F,	30,	168,	53	 0.91	±	0.04	 0.995	 1.84±0.27	 1.53	 2.28	
Volunteer	9	 F,	30,	170,	54	 0.92	±	0.03	 0.994	 2.49±0.19	 2.28	 2.75	
Volunteer	10	 F,	34,	170,	60	 0.94	±	0.02	 0.996	 2.31±0.39	 1.89	 2.83	
Patient	1,	COPD	 M,	53,	186,	78	 1.07	±	0.03	 0.989	 7.13±0.44	 6.66	 7.84	
Patient	2,	COPD	 F,	75,	158,	67	 0.66	±	0.05	 0.972	 3.93±0.37	 3.39	 4.40	
Patient	3,	CF	 F,	12,	157,	42	 0.91	±	0.04	 0.991	 1.48±0.34	 1.29	 1.98	
(*)	volunteers	1	to	5	were	scanned	with	both	protocols	(cf.	Table	3.1)	and	the	two	measurements	correlate	
(Lin's	Concordance	correlation	coefficient	ρc	=	0.93).	
	
	
	
3.5	 Discussion	
	
In	this	work,	we	introduced	a	novel	proton-based	MR	method	for	volumetric	whole	lung	func-
tional	imaging	on	1.5T,	applicable	in	the	clinical	setting	not	requiring	contrast	application	of	any	
sort	or	experimental	hardware.	The	adapted	sponge	model	is	used	to	derive	respiratory	α-maps	
from	a	set	of	ufSSFP	scans	acquired	around	the	tidal	volume	region.	Similarly	to	well-established	
ventilation	techniques	such	as	SPECT	[67],	3He	[68]	and	PET	[69],	respiratory	α-maps	in	healthy	
subjects	exhibited	the	expected	iso-gravitational	homogeneity,	and	showed	a	marked/distinctive	
gravitation-related	respiratory	gradient.	In	accordance	with	literature	[70],	respiration	from	the	
non-dependent	(ventral)	to	the	dependent	(dorsal)	lung	regions	was	almost	doubled.	In	patients	
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with	obstructive	lung	diseases,	the	functional	impairments	associated	with	emphysematous	re-
gions	on	CT	images,	perfusion	defects	on	DCE-MRI	and	ventilation	/	perfusion	abnormalities	on	
FD-maps	coincided	well	with	the	defects	identified	on	the	respiratory	α-maps.		
	
For	healthy	volunteers,	the	respiratory	index	αglobal	(which	is	a	measure	for	the	change	in	lung	
perfusion	during	the	breathing	cycle,	cf.	“Theory”	Section	3.2.2)	was	on	average	1.02±0.07,	 in	
accordance	with	literature	results	(data	elaborated	from	[71],	αglobal	=	1.04).	Interestingly,	αglobal	
appears	to	be	different	for	male	and	female	(1.07	and	0.95,	respectively),	but	a	larger	collective	
of	volunteers	would	be	required	for	conclusive	results.	
	
Multi-volumetric	proton-based	lung	MRI	using	spoiled	gradient	echo	was	already	introduced	by	
Pennati	et	al.	[112]	as	a	biomarker	for	regional	ventilation.	In	their	work,	lung	acquisitions	at	two	
different	 inspiratory	volumes	were	used	to	calculate	by	subtraction	proton	density	difference	
maps.	It	was	demonstrated	that	the	maps	positively	correlate	with	hyperpolarized	3He	imaging	
in	healthy	volunteers	and	in	patients	affected	by	asthma	and	emphysema.	The	derivation	of	ven-
tilation-weighted	information	by	simple	subtraction	or	by	taking	the	relative	difference	between	
a	variety	of	breathing	phases	(e.g.,	using	Fourier	decomposition,	cf.	 [123,	140]),	however,	de-
pends	on	the	 lung	proton	density	and	thus	on	the	breathing	phase	 (cf.	Fig.	3.3	and	 [151]).	 In	
contrast,	based	on	3D	ufSSFP	multi-volumetric	acquisitions,	the	respiratory	index	αlocal	assesses	
regional	ventilation	from	a	physical	lung	model	taking	into	account	the	lung	volume	which	mod-
ulates	the	regional	signal	intensities	in	the	lung.	From	the	model,	the	resulting	respiratory	index	
α	becomes	rather	insensitive	to	the	lung	density	and	thus	to	the	breathing	phase	[cf.	Eq.	(3.11)].	
This	provides	respiratory	α-mapping	with	high	reproducibility,	as	demonstrated	by	a	low	stand-
ard	deviation	and	high	gamma-index	passing	rate.		
	
Respiratory	α-maps	were	shown	to	yield	comparable	ventilation-related	information	as	Fourier	
decomposition	(cf.	Fig.	3.7).	Contemporary	FD	imaging	typically	requires	the	acquisition	of	8	–	12	
coronal	 image	 time	series	 (each	 series	 contains	about	160	 images	acquired	within	40	–	50	 s)	
acquired	in	free-breathing	to	cover	the	whole	lung	[104].	This	yields	a	total	scan	time	of	6	–	10	
min	for	a	typical	slice	thickness	of	12	–	15	mm.	Generally,	chest	wall	expansion	during	breathing	
can	cause	through-plane	motion	(anterior-posterior)	leading	to	image	artifacts	and	image	regis-
tration	issues	[102].	In	contrast,	respiratory	α-mapping	requires	breath-holding	maneuvers	and	
is	only	able	to	capture	ventilation-related	information	but	provides	an	isotropic	assessment	of	
the	whole	lung	from	just	five	multi-volumetric	acquisitions	that	can	be	acquired	in	about	3	min	
scan	time.	Furthermore,	the	respiratory	index	is	virtually	independent	from	the	inspiratory	phase	
and	breathing	amplitude,	thus	providing	high	reproducibility.	
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Similarly	to	other	proton-based	ventilation	techniques	[112,	123,	140],	respiration-related	signal	
modulations	were	assumed	to	reflect	density	changes	in	the	lung	(cf.	“Theory”	Section	3.2.2).	
Lung	relaxation	times,	however,	might	be	affected	by	breathing,	which	in	turn	may	lead	to	a	bias	
in	the	observed	signal	modulations.	To	investigate	the	influence	of	the	lung	relaxation	times,	a	T1	
change	of	less	than	10%	[152]	in	combination	with	a	presumably	substantially	overvalued	100%	
variation	in	T2	is	considered.	The	induced	T1/T2	variations	based	on	these	assumptions	affect	the	
bSSFP	signal	by	less	than	one	order	in	magnitude	as	compared	to	the	observed	signal	variation	
between	full	inspiration	and	forced	expiration.	Considering	a	T1	change	of	less	than	10%	[152],	in	
combination	with	a	presumably	considerably	overvalued	100%	variation	in	T2,	however,	leads	to	
T1/T2	variations	that	affect	the	bSSFP	signal	by	less	than	one	order	in	magnitude	as	compared	to	
the	observed	signal	variation	between	 full	 inspiration	and	 forced	expiration.	This	 justifies	 the	
assumption	that	the	signal	variations	between	diverse	respiratory	phases	reflect	predominantly	
proton	density	changes.	
	
Generally,	respiratory	α-maps	were	derived	from	MR	scans	taken	around	tidal	respiratory	vol-
umes	 to	 mimic	 tidal	 respiration	 and	 to	 avoid	 possible	 registration	 issues	 related	 to	 the	
requirement	of	large	deformations	fields,	e.g.,	if	scans	were	performed	from	forced	expiration	
to	total	lung	capacity.	Thus,	excellent	registration	accuracy	could	be	achieved,	as	confirmed	by	
whole	lung	SI	preservation	measurements	(not	presented)	and	by	qualitative	visual	assessment	
of	selected	landmarks.	Moreover,	for	scanning,	the	tidal	volume	region	rather	than	the	inspira-
tory	phase	was	selected	to	achieve	close	to	maximum	parenchymal	signal	levels.	However,	we	
recognize	that	our	method	still	depends	on	the	accuracy	of	the	deformable	image	registration,	
which	is	a	common	issue	for	several	lung	ventilation	imaging	techniques.	Another	limitation	is	
the	 requirement	 for	 manual	 lung	 segmentation.	 An	 automatic	 lung	 segmentation	 algorithm	
would	be	required	to	reduce	the	manual	burden	for	large-scale	studies	or	to	enroll	the	method	
into	the	daily	clinical	routine.	Recently	proposed	algorithms,	such	as	the	ones	presented	by	Kohl-
mann	et	al.	[153]	and	by	Tustison	et	al.	[154],	might	be	suitable,	but	their	applicability	needs	to	
be	investigated.	Another	potential	limitation	refers	to	the	ability	of	patients	to	perform	breath-
holding	maneuvers.	Nevertheless,	from	the	initial	experience	the	heavily	compromised	patients	
could	perform	breath-holds	of	11	seconds.	However,	especially	for	infant,	a	free-breathing,	self-
navigating,	3D	bSSFP	method	is	necessary	and	can	be	adopted	[155,	156].		
	
As	shown	for	the	patients,	on	respiratory	α-maps	under-ventilated	and	incompressible	lung	re-
gions	 (e.g.,	 bullae,	 obstructions,	 air-trapping,	 emphysematous	 destructions	 and	 hypoxic	
vasoconstrictions)	expand	less	than	healthy	tissues.	Overall,	respiratory	α-mapping	may	also	be	
a	sensitive	measure	for	assessing	the	functionality	of	lungs	in	other	categories	of	pulmonary	ob-
structive	 diseases,	 such	 as	 asthma,	 primary	 ciliary	 dyskinesia	 and	 bronchiolitis	 obliterans.	
Moreover,	it	might	be	used	to	evaluate	disease	progression	and	to	assess	lung	functionality	in	
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impaired	regions	before	and	after	therapeutic	interventions	(e.g.,	drug	administration,	surgery,	
broncoscopically	implanted	valves,	and	bronchial	thermoplasty).		
	
	
3.6	 Conclusions	
	
We	have	 introduced	a	 fast	and	reproducible	contrast	agent-free	volumetric	method	 for	 func-
tional	lung	imaging	using	proton-based	MRI	at	1.5T	that	is	applicable	in	the	clinical	setting	even	
in	patients	with	shortness	of	breath	and	children.	Based	on	an	adapted	sponge	model	for	lung	
tissue,	the	deduced	respiratory	index	α	may	serve	as	a	reproducible	and	normative	measure	to	
evaluate	disease	progression	and	for	repeated	monitoring	of	therapeutic	responses	of	function-
ally	impaired	lung	regions.		
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A3.1	 Purpose	
	
To	evaluate	3D	respiratory	a-mapping,	a	new	method	 for	native	whole-lung	pulmonary	 func-
tional	 imaging	 at	 1.5T	 derived	 from	 1H	multi-volumetric	 ultra-fast	 balanced	 steady-state	 free	
precession	(ufSSFP)	breath-hold	scans	[45,	157],	in	pediatric	patients	with	cystic	fibrosis	(CF)	in	
comparison	to	functional	parameters	derived	from	nitrogen	multiple-breath	washout	(N2-MBW).	
	
	
A3.2	 Materials	and	methods		
	
A3.2.1	 Theory	
	
At	every	breath	the	lung	tissue	undergoes	compression/expansion	and	its	physical	mass	density	
varies	(ρ	 = 		 gj ).	
The	observed	ufSSFP	signal	intensity	variation	at	diverse	inspiratory	volumes	(Fig.	A3.1)	is	in	ex-
cellent	 agreement	 with	 the	 adapted	 sponge	 model	 (see	 Section	 3.4),	 predicting,	 similar	 to	
physical	mass	density	(ρ	 = 		 gj ),	the	signal	intensity	(SI)	to	scale	inversely	proportional	to	the	lung	
volume	V:	
	
SI 𝑉, 𝑥 	= 	Λ 𝑥 ∙ 𝑉<S  	+ η 𝑥 								⟹ 					α 𝑥 	=	 − ∂ log SI 𝑉, 𝑥∂ log 𝑉 																		(A3.1)	
	
where	𝑥	is	the	position	of	a	voxel,	Λ 𝑥 	is	a	SI	scaling	factor,	η 𝑥 	the	SI	in	the	limit	of	infinite	
volume,	i.e.,	noise,	and	α 𝑥 	maps	lung	expansion	during	breathing,	referred	to	as	respiratory	a-
index.	The	 index	a	 reflects	a	ventilation-weighted	pulmonary	measure	 (the	acronym	“a”	was	
chosen	after	Aeolus,	mythical	divinity,	ruler	of	the	winds!)	and	is	virtually	independent	from	re-
gional	lung	density,	as	well	as	from	the	inspiratory	phase	and	breathing	amplitude	(cf.	Fig.	A3.1b	
and	Section	3.2.2).	From	the	model,	a	value	α 𝑥 	= 	1	indicates	that	a	region-of-interest	(ROI)	
expands	equally	to	the	whole	 lung	mean	expansion,	whereas	α 𝑥 < 1	 indicates	that	the	ROI	
expands	less	[for	α 𝑥 > 1,	more]	than	the	whole	lung	mean	expansion.	Generally,	functionally	
impaired	under-ventilated	lung	regions	have	low	respiratory	α-values	(e.g.,	α	<	0.3-0.5).	
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A3.2.2	 Subjects	and	measurement	protocol	
	
Respiratory	a-mapping	was	evaluated	in	24	pediatric	patients	with	CF	(13±3	years,	range	6-17	
years)	and	compared	to	the	lung	clearance	index	(LCI)	from	N2-MBW	measurements,	acquired	at	
the	same	day.	This	prospective	study	was	approved	by	the	local	Ethics	Committee	and	all	partic-
ipants/legal	guardian	provided	informed	consent.		
	
	
Multi-volumetric	ufSSFP	scans	of	the	lung	were	performed	in	breath-hold	(<	12	seconds)	and	in	
supine	position	at	1.5T	(Aera,	Siemens	Healthineers).	Scanning	was	repeated	at	five	breath-hold-
ing	positions	comprised	in	the	tidal	respiratory	region	with	an	isotropic	resolution	of	3.1	mm,	a	
TE/TR	=	0.47/1.19	ms,	and	a	flip	angle	of	19°	(for	technical	details	and	other	parameters	cf.	Sec-
tion	3.3).	Clinical	acquisition-time	for	a-mapping	was	less	than	3	minutes.	
	
	
	
	
Figure	A3.1.	For	ufSSFP	imaging	the	measured	pulmonary	SI	(red	dots)	as	a	function	of	the	lung	volume	
(e.g.,	measured	in	an	ROI	as	indicated	in	Fig.	A3.2d)	follows	the	adapted	sponge	model	(solid	lines).	(a)	The	
sponge	model	visualized	on	a	linear	scale	shows	that	classical	SI-regressions	analysis	(slope	=	 ij ,	e.g.,	pink	
and	green	dashed-lines,	or	Fractional	Ventilation	FV	=	 i
SIexpiration
)	will	depend	on	the	lung	volume	and	inspir-
atory-level	(and	slope	=	 ij 	from	local	proton-density	as	well!).	(b)	The	sponge	model	visualized	on	double-
logarithmic	scale	highlight	that	the	respiratory	index	𝛼	 = 	− 	(i) (j) ,	in	contrast,	is	virtually	independent	
on	the	lung	volume.	
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A3.2.3	 Image	post-processing	and	analysis		
	
Figure	A3.2	summarizes	the	principal	steps	to	calculate	respiratory	a-maps,	i.e.,	semi-automatic	
segmentation	of	the	lung	volume,	3D	deformable	image	registration	(Elastix),	median	filtering	to	
remove	the	vasculature	[142],	and	voxel-wise	calculation	of	the	respiratory	indexes	α 𝑥 	[cf.	Eq.	
(A3.1)]	 .	Due	to	the	ventral-to-dorsal	respiratory-gradient	characteristic	e.g.,	 in	the	a-maps	of	
healthy	volunteers	(cf.	Fig.	A3.2e),	respiratory	impairments	were	analyzed	iso-gravitationally	and	
automatically	associated	with	an	a-value	less	than	0.75	of	the	observed	median	a-value	distri-
bution	in	each	coronal	plane.	From	this,	a	respiratory	percent	defect	ratio	was	calculated	from	
the	number	of	impaired	voxels	divided	by	the	total	number	of	voxels	enclosing	the	whole	lung.		
	
	
	
Figure	A3.2.	Illustrative	summary	of	the	framework	used	for	respiratory	a-mapping.	(a)	Imaging	is	per-
formed	at	5	different	inspiratory	levels.	(b)	As	a	result	of	the	compression/expansion,	the	pulmonary	signal	
intensity	variates	and	is	modulated	depending	on	the	lung	volume	(cf.	Fig.	A3.1).	The	5	lung	volumes	are	
assessed	 by	 semi-automated	 segmentation.	 (c)	 Image	 registration	 resolves	 structural	 misalignments	
caused	by	the	different	inspiratory	levels,	while	preserving	the	signal.	(d)	Median	filtering	removes	vascu-
lature	and	resolves	parenchyma	signal.	 (e)	The	a-index	is	calculated	voxel-wise.	The	a-maps	represents	
normal	appearing	lung	tissue	of	an	healthy	subject.	
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A3.3	 Results	
	
From	the	24	patients	enrolled	in	the	study,	breath-holding	was	feasible	for	22,	and	images	were	
artifact-free	in	20	patients.	Illustrative	morphological	ufSSFP	images	and	a-maps	in	a	CF	patient	
(15	y,	male)	are	shown	in	Figure	A3.3.	In	contrast	to	the	characteristic	iso-gravitational	homoge-
neity	 and	 the	 physiological	 ventral-to-dorsal	 respiratory-gradient	 present	 in	 the	a-maps	 of	 a	
healthy	volunteer	(Fig.	A3.2e),	respiratory	a-maps	of	the	CF	patient	(Fig.	A3.3b)	revealed	under-
ventilated	regions.	The	a-impairments	are	mainly	associated	with	heavily	atelectatic	areas	of	the	
lung	in	this	case	(Fig.	A3.3a).	Overall,	in	the	cohort	of	patients,	the	percentage	of	respiratory	a-
impairments	determined	by	a-mapping	revealed	a	highly	significant	(p-value	<	10-6)	and	strong	
correlation	(Spearman	r	=	0.88)	with	the	LCI,	as	shown	in	Figure	A3.4.		
	
	
	
	
Figure	A3.3.	Morphological	ufSSFP	imaging	(a)	and	respiratory	a-maps	(b)	in	a	CF	patient	(male,	15	years	
old).	Lung	impairments	with	reduced	ventilation	[black	regions	in	(b),	a<0.3]	correspond	well	to	regions	of	
atelectasis	and	mucus	observed	on	morphological	images	[red	arrows	in	(a)].	
	
Figure	A3.4.	Plot	of	the	assessed	respiratory	defects	from	a-mapping	and	the	lung	clearance	index	(LCI)	
from	multiple-breath	washout	measurements.	 The	 functional	parameters	 show	a	highly	 significant	 (p-
value	<	10-6)	and	strong	correlation	(Spearman	r	=	0.88).	
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A3.4	 Discussion		
	
In	this	work,	we	evaluated	the	recently	introduced	respiratory	a-mapping	method	in	a	small	co-
hort	 of	 pediatric	 patients	 with	 CF.	 Respiratory	 α-mapping	 allows	 for	 regional	 respiratory	
assessment	of	the	whole	lung,	and	the	percentage	of	automatically	detected	respiratory	defects	
showed	a	pronounced	correlation	with	LCI	from	N2-MBW	measurements.		
The	index	α	is	derived	from	a	multi-volumetric	physical	compression	model	of	lung	tissue,	and	
since	it	is	virtually	independent	from	the	respiratory	phase	(cf.	Fig	A3.1b),	the	breathing	ampli-
tude	and	from	regional	lung	density	(cf.	Sections	3.2	and	3.3),	respiratory	α-mapping	may	serve	
as	a	reproducible	and	normative	measure	to	quantify	and	evaluate	patho-physiological	impair-
ments,	 and	 can	 be	 potentially	 used	 to	 compare	 measurements	 between	 different	 subjects	
and/or	changes	in	the	disease	progression,	such	as	in	CF	patients.	In	conclusion,	respiratory	a-
mapping	shows	good	prospects	as	a	quantitative	outcome	measure	for	monitoring	respiratory	
impairments	or	to	assess	the	effect	of	therapeutic	or	clinical	interventions.	
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Three-dimensional	oxygen-enhanced	MRI	
of	the	human	lung	at	1.5T	with	ultra-fast	
balanced	steady-state	free	precession	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	 	
A	modified	version	of	this	chapter	has	been	published	as:	
Pusterla	O,	Bauman	G,	Bieri	O.	Three-dimensional	oxygen-enhanced	MRI	of	the	human	lung	at	
1.5T	with	ultra-fast	balanced	steady-state	free	precession.	Magn	Reson	Med,	2018,	79:246–255.	
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CHAPTER	ABSTRACT	
	
	
Purpose:	To	assess	the	feasibility	of	three-dimensional	(3D)	oxygen-enhanced	(OE)	MRI	
of	the	lung	at	1.5T	using	multi-volumetric	ultra-fast	balanced	steady-state	free	preces-
sion	(ufSSFP)	acquisitions.	
	
Methods:	 Isotropic	 imaging	 of	 the	 lung	 for	 OE-MRI	was	 performed	with	 an	 adapted	
three-dimensional	 ufSSFP	 sequence	 using	 five	 breath-hold	 acquisitions	 ranging	 from	
functional	residual	capacity	to	tidal	inspiration	under	both	normoxic	(room-air)	and	hy-
peroxic	 (100%	O2)	 gas	 conditions.	 A	 sponge	model,	which	 captures	 the	 parenchymal	
signal	intensity	variation	as	a	function	of	the	lung	volume,	for	each	O2	concentration	was	
fitted	to	the	acquired	multi-volumetric	datasets	after	semi-automatic	lung	segmentation	
and	deformable	image	registration.	From	the	retrieved	model	parameters,	3D	oxygen-
enhancement	maps	were	calculated.	
	
Results:	For	OE	ufSSFP	 imaging,	the	maximum	parenchymal	signal	 is	observed	for	 flip	
angles	around	23°	under	both	normoxic	and	hyperoxic	conditions.	 It	 is	found	that	the	
sponge	model	accurately	describes	parenchymal	signal	at	different	breathing	positions,	
thereby	mitigating	the	confounding	bias	in	the	estimated	oxygen-enhancement	from	re-
sidual	density	modulations.	From	the	model,	in	the	healthy	volunteers	an	average	lung	
oxygen-enhancement	of	7.0%±0.3%	was	found,	and	the	oxygen-enhancement	maps	in-
dicate	a	ventral	to	dorsal	gravitation-related	gradient.	
	
Conclusion:	The	study	demonstrates	 the	 feasibility	of	whole-lung	OE-MRI	 from	multi-
volumetric	ufSSFP	in	healthy	volunteers.	
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4.1	 Introduction	
	
With	the	development	of	dedicated	pulse	sequences	and	optimized	acquisition	schemes,	mag-
netic	 resonance	 imaging	 (MRI)	 has	 become	 an	 attractive	 radiation-free	 modality	 for	
morphological	and	functional	imaging	of	the	lung	[4,	29].	For	the	assessment	of	pulmonary	per-
fusion,	dynamic	contrast-enhanced	(DCE)	MRI	is	a	well-established	technique	that	provides	high	
spatial	and	temporal	resolution,	but	requires	the	intravenous	injection	of	contrast	agents.	For	
ventilation	imaging,	non-proton-based	MRI	with	inhaled	hyperpolarized	3He	or	129Xe	gases	yields	
a	direct	measure	of	pulmonary	ventilation	and	has	demonstrated	compelling	results	[38,	119].	
However,	its	broad	application	is	hindered	by	the	requirement	of	dedicated	equipment.	
	
An	interesting	alternative	to	hyperpolarized	gas	imaging	may	be	found	in	oxygen-enhanced	(OE)	
proton-based	MRI	[95]	since	it	does	not	require	additional	equipment	and	is	based	on	the	para-
magnetic	properties	of	oxygen	itself.	When	breathed,	oxygen	acts	as	a	weak	contrast	agent	in	
the	lung,	shortening	the	longitudinal	relaxation	time	(T1)	and	the	apparent	transverse	relaxation	
time	(T2*)	[158].	The	observed	decrease	 in	T1	under	hyperoxic	condition	 is	attributed	to	an	 in-
creased	concentration	of	dissolved	O2	in	the	parenchyma,	blood	vessels	and	lung	tissue	[99].	OE-
MRI	 is	 usually	 considered	 an	 indirect	measure	 for	 ventilation,	 diffusion	 and	 perfusion	 on	 T1-
weighted	images	[96].	If	only	one	of	the	three	functions	is	regionally	hampered,	a	lower	signal	
intensity	(SI)	enhancement	is	detected	locally.	In	contrast,	the	T2*	shortening	effect	in	the	lungs	
while	breathing	oxygen	can	be	attributed	to	the	mesoscopic	magnetic	susceptibility	changes	at	
the	 tissue/gas	 interfaces	 in	 the	alveoli	and	 reflects	a	measurement	 for	pulmonary	ventilation	
[99].	
	
Oxygen-related	signal	enhancement	 in	the	 lung	 is	commonly	derived	voxel-wise	based	on	the	
relative	difference	of	images	acquired	in	hyperoxic	(100%	O2)	and	normoxic	(room-air,	21%	O2)	
conditions	and	has	shown	promising	results	for	patients	with	diseases	such	as	cystic	fibrosis,	pul-
monary	embolism,	and	emphysema	[115,	159].	Moreover,	the	technique	was	recently	applied	to	
monitoring	the	severity	of	asthma,	evaluating	pharmacological	treatment	in	COPD,	and	defining	
candidates	 for	 lung	volume	 reduction	 surgery	 [98,	160,	161].	Generally,	however,	 the	overall	
magnitude	of	the	signal	enhancement	from	oxygen	is	weak,	i.e.,	5%-10%	[99,	158].	As	a	result,	
the	oxygen-enhancement	is	typically	inferior	to	the	natural	SI	variations	of	the	lung	parenchyma	
induced	by	different	but	similar	inspiratory	volumes	(e.g.,	in	expiration)	and	OE-MRI	can	be	easily	
flawed	[162].	Consequently,	a	strategy	to	take	 into	account	the	SI	modulations	of	 the	 lung	at	
diverse	inspiratory	phases	appears	mandatory.	Moreover,	most	of	the	OE-MRI	methods	are	con-
fined	to	2D	acquisitions	and	are	thus	limited	either	in	speed	and/or	chest	coverage.	
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Here,	we	investigate	the	feasibility	of	3D	oxygen-enhanced	MRI	using	ultra-fast	balanced	steady-
state	 free	 precession	 (ufSSFP)	 imaging,	 recently	 introduced	 for	 improved	morphological	 and	
functional	lung	imaging	[45,	157].	Based	on	multi-volumetric	ufSSFP	lung	scans	(acquired	at	dif-
ferent	inspiratory	phases),	we	propose	a	new	framework	for	robust	volumetric	OE-MRI	that	takes	
into	account	signal	intensity	variations	of	the	lung	parenchyma	using	an	adapted	sponge	model	
(see	Chapter	3	and	Ref.	[157]).	
	
	
4.2	 Methods	
	
Four	healthy	subjects	 (29	±	3	years	old,	 three	males	and	one	 female)	underwent	ufSSFP	 lung	
imaging	on	a	1.5T	whole-body	MR-scanner	(MAGNETOM	Avanto,	Siemens	Healthineers,	Erlan-
gen,	Germany)	using	a	12-channel	thorax	and	a	24-channel	spine	receive-array.	Written	informed	
consent	was	obtained	from	each	subject	prior	to	the	examinations.	All	measurements	were	per-
formed	in	breath-hold	and	in	supine	position.	Normoxic	scans	were	acquired	first.	Subsequently,	
after	a	5	min	100%	O2	wash-in	phase,	hyperoxic	imaging	was	performed.	The	gases	were	deliv-
ered	through	a	non-rebreathing	face-mask	with	a	1.5	L	reservoir	bag	at	a	flow	rate	of	20-25	L/min.	
	
4.2.1	 Oxygen-related	signal	enhancement	for	balanced	SSFP	
	
The	oxygen-enhancement	between	scans	acquired	under	normoxic	(room	air,	21%	O2)	and	hy-
peroxic	(100%	O2)	conditions	is	defined	as	a	relative	measure:	
	
OE	 ≔ SIO2 − SIAir
SIAir
																																																																				(4.1)	
	
where	the	subscripts	“Air”	and	“O2”	indicate	the	two	different	gas	phases,	respectively.	
	
For	ufSSFP	imaging,	the	theoretically	expected	O2-enhancement	can	be	estimated	using	the	com-
mon	bSSFP	signal	model	[163]	assuming	a	T2/T1	ranging	between	100	ms/1000	ms	to	about	40	
ms/1400	ms	in	normoxic	condition	[29,	99,	101,	164],	and	a	10%	decrease	in	T1	(but	constant	T2	
[101,	 164])	 for	 hyperoxic	 conditions	 [99,	 101,	 165].	 At	 on-resonance,	 bSSFP	 becomes	 T2/T1-
weighted,	and	thus,	similarly	to	the	oxygen-enhancement	with	T1	weighted	pulse-sequences	[96],	
OE-MRI	with	bSSFP	is	an	indirect	measure	for	ventilation,	diffusion,	and	perfusion	altogether.	
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4.2.2	 Respiratory-related	signal	modulation	in	bSSFP	-	The	sponge	model	
	
The	 lung	parenchyma	can	be	compared	to	sponge-like	 tissue,	which	periodically	expands	and	
contracts	following	the	movement	of	the	diaphragm	and	chest	walls,	resulting	in	bidirectional	air	
flow	and	ventilation.	It	has	been	previously	hypothesized	that	for	two	volumetric	CT	images	the	
signal	intensity	modulations	resulting	from	contraction	/	expansion	of	the	lung	can	be	described	
by	a	sponge	model	[166].	This	model	has	recently	been	reformulated	for	ultra-fast	bSSFP	imaging	
(see	Chapter	3	and	Ref.	[157]),	based	on	the	observation	that	the	pulmonary	bSSFP	signal	scales	
inversely	proportional	with	the	total	lung	volume	V	(similarly	to	mass	density	r	 = 	gj ),	yielding	
the	adapted	sponge	model:	
	 SISponge 𝑉 	= 	Λ ∙ 𝑉<S + η	 (4.2)	
	
where	Λ	(>0)	is	a	scaling	factor	(reflecting	parenchymal	spin	density).	In	Equation	(4.2),	η	refers	
to	 the	 SI	 in	 the	 limit	 of	 infinite	 volume,	 i.e.,	 noise,	 and	α	 (≈1)	maps	 the	 lung	 expansion	 and	
changes	in	pulmonary	blood	volume	during	breathing.	Overall,	Λ,	η,	and	α	are	assumed	to	be	
constant	over	the	breathing	cycle.	
	
For	shallow	breathing	(small	volume	variations),	e.g.,	in	the	tidal	respiratory	volume	region,	we	
approximate	the	adapted	sponge	model	as	a	Taylor	series	expansion	around	an	arbitrary	refer-
ence	 volume	 𝑉ref	 (in	 the	 tidal	 volume	 region),	 which	 yields	 after	 short	 calculations	 and	
rearrangement	of	terms,	the	linear	relation	[167]:	
	 SISponge 𝑉 	= 	Λ ∙ 𝑉<S + η ≈ 1 + α ∙ Λ ∙ 𝑉ref<S + η − α ∙ Λ ∙ 𝑉ref<S<* ∙ 𝑉 ≡	
	 ≡ 	C1 − C* ∙ 𝑉																																																																	(4.3)	
	
4.2.3	 Calculation	of	oxygen-enhancement	maps	from	the	sponge	model	
	
After	estimation	of	the	sponge	model	parameters	[C0	and	C1;	cf.	Eq.	(4.3)]	for	both	normoxic	and	
hyperoxic	conditions	(e.g.,	by	orthogonal	regression	of	the	volume-signal	intensity	relationship	
of	the	 lung	parenchyma),	the	SI	can	be	derived	for	any	arbitrary	 lung	volume	𝑉	 (around	𝑉ref).	
From	this,	the	global	O2-enhancement	of	the	lung	is	given	by	inserting	Eq.	(4.3)	 into	Eq.	(4.1):	
	
OEglobal(𝑉)	 = 	 (C*,| − C*,+) ∙ 𝑉 + (C1,+ − C1,|)C1,| − C*,| ∙ 𝑉 		 (4.4)	
	
Similarly,	after	spatially	matching	the	lung	structures	of	the	multi-volumetric	acquisitions	by	a	
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deformable	 registration	algorithm,	 sponge	model	parameters	 [C0	and	C1;	 cf.	 Eq.	 (4.3)]	 can	be	
estimated	voxel-wise	(i.e.,	locally	at	the	position	x,	cf.	Chapter	3)	to	yield	a	voxel-wise,	i.e.,	local	
estimation	of	the	O2-enhancement,	
	
OElocal(x,𝑉)	 = 	 C*,|(x) − C*,+(x) ∙ 𝑉 + C1,+(x) − C1,|(x)C1,|(x) − C*,|(x) ∙ 𝑉 		 (4.5)	
	
4.2.4	 Imaging	
	
Imaging	was	performed	with	an	ultra-fast	SSFP	framework,	as	described	elsewhere	[45],	yielding	
a	TE/TR	of	0.47	ms/1.19	ms,	using	a	non-selective	RF	pulse	with	a	duration	of	80	μs,	a	readout	
bandwidth	of	1563	Hz/pixel,	and	a	field-of-view	of	400	´	400	´	250	mm3,	yielding	an	isotropic	
resolution	of	3.1	mm3	(128	´	128	´	80	imaging	matrix).	A	parallel	imaging	with	generalized	auto-
calibrating	partially	parallel	acquisition	(GRAPPA)	[128]	factor	2	and	40%	phase	oversampling	was	
used,	yielding	a	total	acquisition	time	of	16	seconds	for	an	acquisition	with	two	averages.	For	all	
scans,	predefined	default	shim	settings	(tune	up)	were	used.	
	
4.2.5	 Flip	angle	optimization	
	
Measurements	were	performed	for	both	normoxic	and	hyperoxic	gas	conditions	for	a	set	of	flip	
angles	(12°,	15°,	18°,	21°,	24°,	and	27°)	in	order	to	derive	an	adapted	ufSSFP	MRI	protocol	provid-
ing	optimal	bSSFP	signal	intensity.	To	this	end,	for	each	flip	angle	and	both	O2	concentrations,	
three	ufSSFP	 scans	were	 recorded	at	 functional	 residual	 capacity	 (FRC)	 to	bypass	 involuntary	
small	 discrepancies	 between	 the	 acquired	 end-expiratory	 phases.	 The	 volumetric	 scans	were	
then	randomized	in	order	to	mitigate	any	possible	bias	in	the	semi-automated	volume	segmen-
tation.	Furthermore,	the	datasets	were	median	filtered	(kernel	size	5	×	5	×	5)	to	reduce	sparse	
signals	from	vasculature	overlying	the	pulmonary	tissue	[142].	After	these	two	steps,	the	mean	
parenchymal	SI	was	derived	from	the	segmented	volume	and	logically	reordered	as	a	function	of	
the	associated	breathing	gas	and	flip	angle,	and	finally	averaged	for	each	flip	angle	and	for	each	
gas	condition.	
	
4.2.6	 Signal	intensity	variability	at	functional	residual	capacity	
	
Oxygen-enhanced	MRI	requires	at	least	two	datasets,	one	recorded	in	normoxic	and	one	in	hy-
peroxic	condition	[Eq.	 (4.1)].	Even	for	acquisitions	at	end-expiratory	breath-holding	(FRC),	 the	
two	datasets	will	show	small,	but	unavoidable,	differences	in	the	breath-hold	positions,	yielding	
volume-related	signal	modulations	which	are	on	the	same	order	of	magnitude	as	the	oxygen-
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related	signal	 increase.	To	illustrate	the	practical	 issue	of	equal	end-expiratory	breath-holding	
(FRC)	and	its	subsequent	possible	bias	on	oxygen-enhanced	MRI,	three	datasets	were	acquired	
in	normoxic	condition	(referred	to	as	A1,	A2,	A3)	and	three	datasets	in	hyperoxic	condition	(O1,	
O2,	O3).	Each	of	the	three	normoxic	acquisitions	can	be	combined	with	one	of	the	three	hyperoxic	
acquisitions	to	calculate	the	oxygen-enhancement,	resulting	in	a	total	of	9	combinations	to	cal-
culate	the	oxygen-enhancement	(A1O1;	A1O2;	A1O3;	A2O1;	A2O2;	A2O3;	A3O1;	A3O2;	A3O3).	For	each	
combination,	 the	whole	 lung	 oxygen-enhancement	 [Eq.	 (4.1)]	was	 calculated	 from	 the	mean	
parenchymal	SI,	determined	by	segmentation	as	explained	in	the	“Flip	angle	optimization”	Sec-
tion	 4.2.5	 (i.e.,	 specific	 steps	 include:	 randomized	 data	 sets,	 median	 filtering,	 segmentation,	
reordering).	
	
4.2.7	 OE-MRI	using	the	sponge	model	
	
A	series	of	five	3D	ufSSFP	lung	scans	in	normoxic	condition	were	obtained	at	different	breathing	
phases,	spanning	from	functional	residual	capacity	(FRC)	to	tidal	inspiration.	The	same	measure-
ments	were	 repeated	 for	 hyperoxic	 conditions.	 To	 ensure	 a	 relatively	 uniform	 range	 of	 lung	
volumes	(which	is	not	required,	but	desired),	the	volunteers	followed	breathing	commands.	For	
the	first	two	scans,	instructions	to	exhale	to	FRC	(breathe-out)	and	to	breathe-in	to	tidal	inspira-
tion	were	given.	The	three	scans	in	respiratory	phases	between	FRC	and	tidal	inspiration	were	
acquired	with	the	following	breathing	commands:	“breathe-in,	breathe-out,	one-sip	/	two-sips	/	
three-sips	of	air,	and	hold”,	respectively.	Determination	of	the	corresponding	lung	volumes	was	
achieved	by	semi-automated	volume	segmentation	after	randomizing	the	datasets,	median	fil-
tering	(kernel	size	5	×	5	×	5),	and	reordering,	as	described	before.	From	this,	the	average	oxygen-
enhancement	in	the	lung	tissue	[cf.	Eq.	(4.4)]	can	be	easily	retrieved	from	an	orthogonal	regres-
sion	analysis	of	the	adapted	sponge	model	[cf.	Eq.	(4.3)]	to	the	observed	volume-related	average	
signal	 variations.	A	 corresponding	outline	 is	 shown	 in	Figures	4.1a-c.	Uncertainty	 calculations	
were	performed	by	Gaussian	error	propagation	of	the	uncertainties	of	the	sponge	model	fitting	
parameters	(68%	confidence	interval	window).	
	
For	the	generation	of	the	OE-MRI	maps	[OElocal,	Eq.	(4.5)],	the	native	datasets	acquired	at	differ-
ent	 inspiratory	 phases	 were	 first	 spatially	 co-registered.	 Amongst	 the	 five	 chest	 acquisitions	
under	normoxic	condition,	the	one	closest	to	the	average	lung	volume	was	chosen	as	a	reference	
and	was	referred	to	as	baseline	acquisition	of	volume	V	[i.e.,	𝑉	 = 	V	in	Eqs.	(4.4)	and	(4.5)].	The	
four	remnant	air	datasets	as	well	as	the	five	O2	datasets	were	then	co-registered	to	the	baseline.	
All	datasets	were	subsequently	median	filtered	(kernel	size	5	´	5	´	5	voxels)	and	fitted	voxel-wise	
to	the	linear	sponge	model	[Eq.	(4.3)]	for	each	O2	concentration	using	orthogonal	regression	(the	
lung	volume	was	retrieved	in	the	aforementioned	segmentation	process	on	the	non-registered	
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images).	 The	 local	 oxygen-enhancement,	 OElocal(V),	 was	 then	 calculated	 voxel-wise	 [cf.	 Eq.	
(4.5)].	For	a	schematic	summary,	see	Figures	4.1d-f.	
	
The	effect	of	the	image	registration	on	OE-MRI	was	analyzed	from	a	direct	comparison	of	the	
whole	lung	oxygen-enhancement	before	and	after	image	registration.	Moreover,	as	a	negative	
control,	 the	signal	enhancement	obtained	from	two	normoxic	phases	of	 five	multi-volumetric	
acquisitions	each	was	calculated	for	one	subject	[cf.	Eq.	(4.4)	and	Eq.	(4.5)].	
	
For	data	visualization,	data	analysis,	and	simulations	Python	2.7	was	used	(Anaconda	Python	dis-
tribution,	 Continuum	Analytics,	 version	 2.0).	 Segmentation	 of	 the	 lung	was	 performed	 semi-
automatically	by	a	trained	observer	who	used	a	region	growing	tool	implemented	in	MITK	(The	
Medical	 Imaging	 Interaction	Toolkit	2014.03.0,	Heidelberg,	Germany).	The	 lung	datasets	were	
co-registered	using	a	mass	preserving	3D	deformable	B-spline	image	registration	algorithm	(elas-
tix	version	4.7,	University	Medical	Center	Utrecht,	The	Netherlands)	[145,	168].	
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Figure	4.1.	Schematic	of	the	oxygen-enhancement	calculation	process.	(a)	Two	multi-volumetric	sets	(five	
normoxic	and	five	hyperoxic	scans)	were	acquired	from	functional	residual	capacity	(FRC)	to	tidal	inspira-
tion.	(b)	The	datasets	were	subsequently	shuffled	(blinded	to	investigator),	median	filtered	(to	remove	the	
overlying	vascular	signal),	and	the	lung	volumes	were	determined	by	semi-automatic	segmentation.	 (c)	
The	segmented	and	median-filtered	datasets	were	ordered	with	respect	to	their	lung	volumes	(𝑉, 	for	air,	𝑉, 	for	oxygen).	The	whole	lung	mean	signals	(SI)	in	the	segmented	region	of	interests	(𝑉)	were	used	to	
calculate	the	whole	lung	oxygen-enhancement	OEglobal	(Eq.	(4.4),	unregistered	images),	using	the	sponge	
model	[Eq.	(4.3)].	 (d)	The	multi-volumetric	datasets	were	ordered	according	to	their	volumes	[using	the	
information	gained	in	(b)].	(e)	All	dataset	were	then	co-registered	to	the	normoxic	scan	of	volume	𝑉 ,	which	
is	the	one	with	minimum	volume	deviation	from	the	average	lung	volume.	(f)	After	median	filtering,	the	
oxygen-enhancement	(OElocal)	is	derived	voxel-wise	from	Eq.	(4.5),	as	well	as	the	whole	lung	mean	oxygen-
enhancement	(OEglobal,	registered	images)	
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4.3	 Results	
	
Illustrative	native	and	median	filtered	ufSSFP	lung	images	at	FRC	are	shown	in	Figure	4.2	under	
both	normoxic	and	hyperoxic	conditions	for	a	flip	angle	of	23°.	Because	of	the	very	short	TR,	no	
banding	artifacts	are	visible	in	the	lung	parenchyma	and	vasculature	is	well	recognizable	in	the	
native	images	(Figs.	4.2a	and	4.2b).	Median	filtering	removes	the	sparse	hyperintense	vascular	
signals	(Figs.	4.2c	and	4.2d)	to	recover	the	underlying	smooth	parenchymal	background	signal	
variation,	e.g.,	the	ventral	to	dorsal	density	variation	(cf.	sagittal	slices	in	Fig.	4.2)	due	to	gravita-
tional	effects	[65].	
	
	
4.3.1	 Flip	angle	optimization	
	
The	low	proton	density	and	consequently	low	signal-to-noise	ratio	(SNR)	of	the	lung	parenchyma	
makes	MR	imaging	challenging.	Moreover,	the	O2-related	signal	increase	while	breathing	pure	
oxygen	is	barely	recognizable	by	direct	visual	comparison	(cf.	Figs.	4.2c	to	4.2d).	As	a	result,	the	
flip	angle	of	ufSSFP	pulse	sequence	was	varied	to	find	its	optimal	value	providing	maximal	whole	
lung	signal	intensities	for	both	gas	conditions	(Fig.	4.3).	A	qualitatively	good	correspondence	be-
tween	 the	 measured	 signals	 and	 the	 bSSFP	 signal	 model	 [163]	 is	 observed.	 For	 both	 gas	
conditions,	the	signal	of	ufSSFP	is	maximal	for	flip	angles	around	20°	to	25°,	yielding	an	overall	
O2-enhancement	between	5%	±	3%	(mean	±	SD)	and	7%	±	3%.	As	a	result,	a	flip	angle	of	α	=	23°	
	
Figure	4.2.	(a,b)	Illustrative	sagittal	and	coronal	chest	images	obtained	using	3D	ufSSFP	scans	at	FRC	while	
breathing	(a)	air	and	(b)	100%	oxygen	(	α	=	23°).	(c,d)	Corresponding	images	after	3D	median	filtering	and	
segmentation	(yellow	outline)	for	estimation	of	the	parenchymal	mean	signal	intensity	and	lung	volume.	
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was	chosen	for	OE-adapted	ufSSFP	scans.	Similar	results	were	found	for	all	the	healthy	volun-
teers.	The	overall	observed	oxygen-related	signal	enhancement	is	in	agreement	with	simulations	
(cf.	 “Method”	 Section	 4.2)	 predicting	 an	 oxygen-enhancement	 of	 3%	 to	 8%	 for	 flip	 angles	 α	
around	20°-27°.	
	
	
Figure	 4.3.	 Observed	 average	 signal	 of	 the	 lung	 paren-
chyma	 as	 a	 function	 of	 the	 flip	 angle	 measured	 in	 a	
volunteer	for	both	air	and	100%	oxygen.	The	average	lung	
mean	SI	refers	to	the	average	of	three	acquisitions	and	the	
error	 bars	 represent	 its	 standard	 deviation.	 An	 analysis	
with	 the	 common	 bSSFP	 signal	model	 (solid	 lines)	 yields	
T1/T2	≈	26	for	air,	T1/T2	≈	24	for	oxygen,	and	M0	=	665	for	
both	gases.	The	relative	T1/T2	decrease	between	normoxic	
and	hyperoxic	conditions	is	8%.	
	
	
	
	
	
4.3.2	 Signal	intensity	variability	at	functional	residual	capacity	
	
Generally,	OE-MRI	requires	(at	least)	two	datasets,	recorded	under	different	gas	conditions.	As	a	
result,	the	scans	show	small,	but	unavoidable,	involuntarily	different	breath-hold	positions	even	
at	end-expiration,	as	outlined	in	Figures	4.4a	and	4.4b	for	normoxic	and	hyperoxic	breathing.	For	
the	six	scans,	the	observed	average	lung	signals	were	96	(arbitrary	units	[a.u.]),	101	[a.u.]	and	
102	[a.u.]	while	breathing	air,	and	103	[a.u.],	105	[a.u.]	and	108	[a.u.]	while	breathing	O2.	Since	
the	overall	O2-enhancement	is	small	(in	the	average	from	100	±	3	[a.u.]	for	air	to	105	±	3	[a.u.]	
for	O2),	even	marginal	 lung	volume	differences	will	 lead	 to	signal	modulations	of	comparable	
strength.	This	 leads	to	a	large	variability	and	thus	imprecise	quantification	of	the	O2-enhance-
ment	from	only	two	datasets,	as	exemplarily	demonstrated	in	Figure	4.4c.	For	all	nine	possible	
pairwise	 combinations	 resulting	 from	 the	 three	normoxic	 and	 the	 three	hyperoxic	 scans,	 the	
mean	whole-lung	O2-enhancement	spans	from	1.0%	to	12.5%	[with	an	average	O2-enhancement	
of	5.8%	±	3.7%	(mean	±	SD)].	For	reliable	and	reproducible	OE-MRI,	residual	SI-volume	modula-
tions	must	be	taken	into	account	and	can	be	addressed	by	the	sponge	model.	
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4.3.3	 OE-MRI	using	the	sponge	model	
	
Scanning	was	performed	for	five	variable	breath-hold	positions	around	the	tidal	volume	region,	
as	presented	in	Figure	4.5a.	For	better	visualization	of	the	differences	in	the	respiratory	phases,	
relative	SI	difference	maps	are	shown	in	Figure	4.5b	(with	respect	to	the	scan	taken	at	middle	
respiratory	phase,	volume	V).	The	relative	difference	maps	accentuate	the	diverse	lung	paren-
chyma	signal	levels	and	the	structural	misalignments	due	to	the	different	inspiratory	volumes.	In	
Figure	4.5c,	relative	signal	intensity	difference	maps	are	shown	after	image	registration.	Image	
registration	does	not	affect	lung	signal	intensity;	it	resolves	structural	mismatches	such	as	ves-
sels,	diaphragm	position,	lung	boundaries	and	corrects	for	through-plane	motion.	In	contrast	to	
the	moderate	SI	variation	observed	at	FRC	(cf.	Fig.	4.4a),	in	the	tidal	breathing	region	the	pulmo-
nary	signal	ranged	from	109	[a.u.]	to	83	[a.u.],	for	corresponding	lung	volumes	ranging	from	2381	
to	3075	cm3.	This	is	in	contrast	to	the	liver	SI	which	remains	constant	(240	±	3	[a.u.])	since	it	does	
not	expand	or	contract.	The	background	noise	level	[η,	cf.	Eq.	(4.2)]	was	about	3	±	2	[a.u.].	
	
	
Figure	4.4.	(a,	top)	Representative	3D	ufSSFP	sagittal	views	of	the	same	slice	acquired	three	times	consec-
utively	 in	 end-expiration	 (FRC)	while	 breathing	 air.	 (a,	 bottom)	 Relative	 difference	maps	 between	 the	
baseline	(A2)	and	the	target	 images	(A1	and	A3)	accentuating	the	respiratory	phase	mismatch	 (e.g.,	dia-
phragm	position	depicted	by	the	red	arrows	and	lung	boundaries)	as	well	as	the	modulation	of	the	lung	
signal	occurring	at	similar	but	different	FRC	volumes	(2550±80	cm3,	mean±SD	of	the	three	measurements).	
(b)	As	(a),	but	in	hyperoxic	conditions.	(c)	Nine	combinations	of	whole	lung	oxygen-enhancement	resulting	
from	 three	 scans	 in	normoxic	 (a)	 and	 three	 in	hyperoxic	 (b)	 conditions	at	 FRC	 (see	 “Methods”	Section	
4.2.6).	On	the	right,	the	mean	and	the	standard	deviation	resulting	from	the	nine	combinations	are	indi-
cated	using	a	red	color	bar.	
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Figure	4.5.	(a)	Representative	3D	ufSSFP	sagittal	views	acquired	at	five	different	tidal	volumes	in	normoxic	
condition.	The	datasets	are	ordered	from	left	to	right	according	to	their	lung	volume	(i.e.,	from	FRC	to	tidal	
inspiration;	cf.	Fig.	4.1d).	The	middle	volume	scan,	i.e.,	V3	(referred	to	as	volume	𝑉),	served	as	baseline	for	
the	registration	process	(cf.	Fig.	4.1e).	(b)	Relative	signal	intensity	difference	maps	between	the	baseline	
and	the	moving	images	(to	be	registered)	accentuating	the	parenchymal	signal	intensity	modulations,	dif-
ferences	 in	 the	 diaphragm	position	 (e.g.,	 red	 arrow)	 and	 lung	 structures	 due	 to	 the	 respiratory	 phase	
mismatch.	(c)	Corresponding	relative	signal	intensity	difference	maps	after	image	co-registration,	reveal-
ing	lung	structural	alignment	while	preserving	the	signal	intensity.	
	
	
The	average,	median-filtered,	lung	signal	is	shown	for	a	representative	volunteer	in	Figure	4.6	as	
a	 function	of	 the	 lung	volume	 for	both	normoxic	and	hyperoxic	conditions	and	 for	both	non-
registered	and	registered	datasets.	An	analysis	with	the	linear	sponge	model	yields	for	the	non-
registered	 datasets,	 C1,| 	= 	 197.4 ± 0.6 [𝑎. 𝑢. ],	 C*,| 	= 	 37.2 ± 0.2 [𝐿<* 	 ∙ 𝑎. 𝑢. ],	C1,+ 	= 	 209.6 ± 1.2 [𝑎. 𝑢. ],	 C*,+ 	= 	 39.4 ± 0.4 [𝐿<* 	 ∙ 𝑎. 𝑢. ],	 whereas	 for	 the	 registered	
datasets	C1,| 	= 	 191.6 ± 0.7 [𝑎. 𝑢. ],	C*,| 	= 	 35.4 ± 0.2 [𝐿<* 	 ∙ 𝑎. 𝑢. ],	C1,+ 	= 	 204.5 ±1.2 [𝑎. 𝑢. ],	C*,+ 	= 	 37.6 ± 0.4 [𝐿<* 	 ∙ 𝑎. 𝑢. ].	For	non-registered	datasets,	a	whole	lung	O2-en-
hancement	[OEglobal,	Eq.	(4.4)]	of	6.7%	±	2.0%	(mean	±	uncertainty)	was	observed	for	a	mean	lung	
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volume	V	of	2821	cm3	(see	“Methods”	Section	4.2.7	for	the	definition	of	V).	After	registration,	
the	whole	lung	oxygen-enhancement	was	7.3%	±	2.2%	(at	V	=	2821	cm3).	
	
It	 is	observed	that	the	oxygen-enhancement	values	from	the	sponge	model	were	nearly	 inde-
pendent	of	the	lung	volume:	for	the	volunteer	presented	in	Figure	4.6,	at	FRC	(V	=	2381	cm3),	the	
OEglobal	without	registration	was	6.6%	±	1.6%	(with	registration	7.2%	±	1.7%),	whereas	at	tidal	
inspiration	(V	=	3075	cm3),	the	oxygen-enhancement	without	registration	was	6.9%	±	2.4%	(with	
registration	7.5%	±	2.6%).	This	is	expected,	since	in	the	tidal	breathing	region	(e.g.,	𝑉 	=	 𝑉ref ±δ𝑉 ≈ 2.4	±	0.4	[L]),	 1 − OEglobal 	jref±rj
OEglobal 	jref < 	0.1	 for	 variations	 δ𝑉 < 	jrefu 	 using	 for	 example	C*,| ≈ C*,+ ≈ 36	[L-1	·	a.u.],	C1,| ≈ 190	[a.u.]	and	C1,+ ≈ 200	[a.u.].	
	
The	OEglobal	results,	determined	with	the	sponge	model	at	FRC,	V	and	tidal	inspiration,	are	sum-
marized	in	Table	4.1	for	the	four	healthy	volunteers	examined	(Volunteer	#4	refers	to	the	case	
analyzed	in	Figure	4.6).	Without	registration,	an	average	oxygen-enhancement	of	6.5%	±	0.2%	
(mean	±	intersubject	SD)	with	an	average	intrasubject	uncertainty	of	±2.1%	was	measured.	After	
registration,	the	four	volunteers	showed	an	average	oxygen-enhancement	of	7.0%	±	0.3%	with	
an	average	intrasubject	uncertainty	of	±2.3%.	In	all	the	volunteers,	the	oxygen-enhancement	is	
nearly	independent	from	the	lung	volume	(cf.	Table	4.1).	
	
	
	
Figure	4.6.	Mean	signal	intensity	of	the	lung	parenchyma	as	a	function	of	the	lung	volume	measured	in	a	
healthy	volunteer	for	both	normoxic	(blue	colors)	and	hyperoxic	(red	colors)	conditions	and	for	both	native	
median-filtered	datasets	(non-registered,	star	signs)	and	registered	median-filtered	datasets	(circles).	The	
lines	show	the	corresponding	fit	to	the	linear	sponge	model	(dashed	line:	non-registered	images,	solid	line:	
registered	 images).	 The	 lung	 volume	 of	 the	 acquisition	 used	 as	 baseline	 for	 the	 image	 registration	 is	
	𝑉	=	2821	cm3,	as	depicted	in	the	figure	
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Table	4.1.	Measured	lung	volumes	at	FRC,	𝑉	and	tidal	inspiration,	and	the	corresponding	whole	lung	oxy-
gen-enhancements	(mean	±	uncertainty)	for	both	non-registered	and	registered	datasets.	The	group	mean	
and	intersubject	standard	deviation	are	also	given.	Volunteer	#4	refers	to	the	subject	analyzed	in	Figure	
4.6.	
	
Subject	 	 Lung	volume	cm3	 OEglobal,	non-registered	data	[%]	OEglobal,	registered	data	[%]	
	 	 FRC	 V	 Tidal	Insp.	 OE(FRC)	 OE(V)	 OE(Insp.)	 OE(FRC)	 OE(V)	 OE(Insp.)	
#1	 Air	
O2	
2807	
2769	
3320	
	
3688	
3660	
6.3±1.7	 6.2±2.2	 6.1±2.5	 7.0±2.2	 6.8±2.5	 6.6±2.6	
#2	 Air	
O2	
2555	
2603	
2793	
	
3032	
3092	
6.2±1.5	 6.4±1.8	 6.6±2.4	 6.5±1.9	 6.6±2.0	 6.7±2.4	
#3	 Air	
O2	
2090	
2138	
2416	
	
2988	
2908	
6.7±1.8	 6.5±2.3	 6.1±2.7	 7.2±1.8	 7.1±2.5	 6.9±2.8	
#4	 Air	
O2	
2381	
2452	
2821	
	
3075	
3057	
6.6±1.6	 6.7±2.0	 6.9±2.4	 7.2±1.7	 7.3±2.2	 7.5±2.6	
Mean	 Air	
O2	
2458	
2495	
2837	 3196	
3179	
6.5±0.2	 6.5±0.2	 6.4±0.4	 7.0±0.3	 7.0±0.3	 6.9±0.4	
	
	
	
Finally,	exemplary	OE-MRI	maps	of	the	lungs	are	presented	in	Figures	4.7.	For	all	four	volunteers,	
coronal,	axial	and	sagittal	slices	are	shown.	Generally,	a	pronounced	increase	in	the	oxygen-en-
hancement	from	non-dependent	(ventral)	to	dependent	(dorsal)	lung	areas	is	observed,	as	well	
as	“patchy”	heterogeneities.	The	heterogeneities	are	increased	especially	in	regions	character-
ized	by	partial	volume	effects,	physiological	motion,	and	steep	proton	density	gradients	(e.g.,	in	
the	pericardial	areas,	at	the	periphery	of	the	lungs	next	to	the	rib	cage	or	near	vasculature	and	
airways).	Further	oxygen-related	signal	enhancement	can	be	located	in	the	pulmonary	veins,	left	
heart,	 aortic	 blood	 pool	 (O2-enhancement	 aortic	 arch	 ≈	 5%),	 renal	 cortex,	 and	 spleen	 (not	
shown).	 In	contrast,	no	signal	enhancement	emanates	venous	blood	(hypoxic)	 returning	from	
the	body,	such	as	in	the	vena	cava,	left	ventricle,	left	atrium,	pulmonary	arteries,	and	in	the	liver.	
	
The	specificity	of	the	proposed	approach	to	detect	O2-related	signal	enhancements	is	shown	in	
Figure	4.8,	reflecting	OE-MRI	maps	calculated	from	two	series	of	five	acquisitions	each,	but	per-
formed	both	in	normoxic	conditions.	As	expected,	the	observed	whole	lung	signal	enhancement	
is	almost	zero:	0.2%±2.0	%	(mean	±	uncertainty)	for	the	non-registered	datasets,	and	0.4%	±	2.3%	
(mean	±	uncertainty)	for	the	registered	datasets.	Consequently,	the	sponge	model	successfully	
removes	possible	volume-related	signal	modulations	from	multi-volumetric	data	acquisitions	as	
used	for	OE	imaging.	
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Figure	4.8.	Signal	intensity	enhancement	map	(absolute	value)	obtained	as	a	negative	control	from	two	
phases	while	breathing	air	(Volunteer	#4,	cf.	Fig.	4.7d).	The	mean	“enhancement”	OElocal	is	0.4%	±	2.3%.	
	
Figure	4.7.	Lung	oxygen-enhancement	maps	overlaid	on	structural	 images	 in	sagittal,	coronal,	and	axial	
views	obtained	in	two	healthy	volunteers.	The	whole	lung	oxygen-enhancements	(OEglobal,	registered	da-
tasets)	are	(a)	6.8%,	(b)	6.6%,	(c)	7.1%	and	(d)	7.3%	(cf.	Table	4.1,	Volunteers	1-4).	
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4.4	 Discussion	
	
In	this	work,	we	demonstrated	the	feasibility	of	3D	OE-MRI	of	the	lung	from	two	multi-volumetric	
sets	of	ultra-fast	SSFP	scans	acquired	in	normoxic	and	hyperoxic	gas	conditions.	A	sponge	model	
was	used	to	take	into	account	and	mitigate	oxygen-unrelated	signal	modulations	associated	with	
diverse	breath-hold	positions.	 In	agreement	with	 simulations,	a	mean	whole	 lung	oxygen-en-
hancement	 of	 6.5%	 ±	 0.2%	 (mean±SD,	 non-registered	 datasets)	 was	 observed	 for	 the	 four	
healthy	volunteers,	revealing	limited	intersubject	variability.	In	healthy	subjects,	the	derived	OE-
MRI	maps	exhibit	a	marked	gravitation-related	signal	enhancement	from	anterior	to	posterior	
lung,	in	accordance	with	2D	OE-MRI	[70]	and	similarly	to	well-established	functional	techniques	
such	as	SPECT,	DCE-MRI	or	arterial	spin	labeling	[66,	136,	169,	170].	Moreover,	the	signal	from	
oxygenated	blood	(e.g.,	aorta)	is	also	increased,	representing	the	physiological	validation	of	dis-
solved	molecular	O2	and	indicating	that	OE	lung	MRI	with	ufSSFP	is	weighted	by	both	perfusion	
and	ventilation.	
	
In	the	proposed	framework,	OE-MRI	 is	based	on	 lung	 images	acquired	 in	the	tidal	respiratory	
volume	region	to	achieve	close-to-maximum	parenchymal	signal	levels,	but	also	to	mitigate	reg-
istration	 issues	 related	 to	 the	 requirement	 of	 large	 deformations	 fields,	 e.g.,	 if	 scans	 were	
performed	from	forced	expiration	to	total	lung	capacity.	As	a	result,	good	registration	accuracy	
could	be	achieved	as	confirmed	by	the	qualitative	visual	assessment	of	selected	landmarks	(e.g.,	
diaphragm	position	 in	Fig.	4.5c)	and	by	the	whole	 lung	SI	preservation	(cf.	Fig.	4.6).	Overall,	a	
rather	marginal	lung	signal	intensity	change	due	to	image	registration	was	observed.	Neverthe-
less,	as	a	consequence	of	the	limited	oxygen-related	signal	enhancement	of	only	a	few	percent	
(6.5%	 for	 the	non-registered	datasets,	 cf.	Table	4.1),	 registration	 resulted	 in	a	detectable	but	
moderate	effect	on	the	whole	lung	oxygen-enhancement	(increased	from	6.5%	to	7.0%).	
	
The	feasibility	of	3D	OE-MRI	of	the	lung	has	been	recently	demonstrated	by	Kruger	et	al.	[158]	
and	Hemberger	et	al.	 [171]	using	 free-breathing	 respiratory-gated	3D	 radial	ultra-short	echo-
time	(UTE)	pulse	sequences.	In	this	approach,	the	OE-MRI	maps	are	derived	based	on	only	two	
matched	volumetric	sets,	one	set	for	each	O2	concentration	(21%	and	100%	O2).	In	comparison,	
the	use	of	 rapid	breath-hold	ufSSFP	acquisitions	at	different	 inspiratory	 levels	 in	combination	
with	the	sponge	model	mitigates	oxygen-unrelated	contributions	from	lung	density	modulations	
at	different	respiratory	positions	(lung	volumes),	thus	improving	the	overall	reliability	of	the	ox-
ygen-enhancement	 measure.	 As	 further	 advantage	 of	 the	 multi-volumetric	 approach,	 we	
consider	its	ability	to	provide	simultaneously	with	oxygen-enhancement	mapping	also	ventila-
tion-weighted	α-maps,	which	are	sensitive	to	ventilation	abnormalities	in	patients	as	presented	
in	Chapter	3.	Moreover,	especially	in	the	context	of	imaging	anatomical	regions	with	intrinsically	
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low	proton	density	like	the	lung,	the	ability	of	balanced	SSFP	[45]	to	provide	higher	SNR	com-
pared	to	spoiled	SSFP	sequences	(e.g.,	UTE)	is	beneficial.	
	
A	rigorous	assessment	of	the	repeatability	of	the	oxygen-enhancement	was	not	investigated	in	
this	work,	but	good	reproducibility	of	the	sponge	model	was	observed	for	normoxic	conditions	
(cf.	Chapter	3).	Although	the	sponge	model	requires	short	breath-holding	at	several	inspiratory	
levels,	these	maneuvers	are	well	tolerated	and	performed	by	patients	(cf.	Chapter	3	and	Chapter	
6).	As	a	result,	OE-MRI	with	the	sponge	model	should	be	feasible	also	in	the	clinical	setting	and	
specific	to	O2-related	signal	changes	in	impaired	lung	regions	(e.g.,	emphysema,	bullae,	air	trap-
ping,	fibrosis).	
	
Here,	we	used	the	sponge	model	to	capture	volume-related	balanced	SSFP	signal	modulations	in	
combination	with	the	administration	of	oxygen.	However,	the	proposed	methodology	could	be	
easily	adapted	to	other	contrast	agents	such	as	gadolinium-based	ones.	Furthermore,	the	meth-
odology	could	be	used	in	combination	with	other	basic	pulse	sequences	(e.g.,	UTE)	or	by	using	
self-navigated	 free	breathing	methods	 [155,	156]	being	able	 to	provide	multi-volumetric	 lung	
images;	these	imaging	acquisitions	might	be	required	in	patients	with	limited	breath-holding	ca-
pabilities	 or	 for	 infants.	 Moreover,	 currently,	 our	 method	 requires	 a	 semi-automatic	 lung	
segmentation	to	retrieve	the	lung	signal	volume-dependencies	for	the	sponge	model	analysis.	
Obviously,	for	large-scale	studies,	a	fully	automatic	lung	segmentation	algorithm,	such	as	the	one	
recently	presented	by	Kohlmann	et	al.	[153]	and	by	Tustison	et	al.	[154]	might	be	required,	but	
the	achievable	accuracy	needs	to	be	investigated.	
	
	
4.5	 Conclusions	
	
We	have	shown	that	simple	multi-volumetric	ufSSFP	breath-hold	scans	at	different	inspiratory	
phases	under	both	normoxic	and	hyperoxic	gas	conditions	in	combination	with	a	sponge	model	
provides	 improved	 reliability	 and	 accuracy	 for	 3D	 oxygen-enhancement	 mapping,	 since	 the	
parenchymal	volume-related	signal	modulations	are	taken	into	account.	This	might	ease	the	use	
of	OE-MRI	to	evaluate	disease	progression	and	monitor	therapeutic	responses.	However,	clinical	
evaluation	on	a	large	population	group	is	needed	to	further	validate	the	robustness,	reproduci-
bility,	and	diagnostic	potential	of	the	proposed	technique.	
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CHAPTER	ABSTRACT	
	
	
Purpose:	 To	 demonstrate	 the	 feasibility	 of	 oxygen-dependent	 relaxometry	 in	 human	
lung	using	an	inversion	recovery	ultra-fast	steady-state	free	precession	(IR-ufSSFP)	tech-
nique.	
	
Methods:	ECG-triggered	pulmonary	relaxometry	with	IR-ufSSFP	was	performed	in	seven	
healthy	human	subjects	at	1.5T.	The	data	were	acquired	under	both	normoxic	and	hy-
peroxic	conditions.	In	a	single	breath-hold	of	less	than	9	seconds,	30	transient	state	IR-
ufSSFP	images	were	acquired,	yielding	longitudinal	(T1)	and	transversal	(T2)	relaxometry	
parameter	maps	using	voxel-wise	nonlinear	 fitting.	Possible	spatial	misalignments	be-
tween	 consecutive	 IR-ufSSFP	 parameter	 maps	 were	 corrected	 using	 elastic	 image	
registration.	 Furthermore,	 dynamic	 relaxometry	 oxygen	 wash-in	 and	 wash-out	 scans	
were	performed	in	one	volunteer.	From	this,	T1-related	wash-in	and	wash-out	time	con-
stants	 (t,	t)	were	calculated	voxel-wise	on	 registered	maps	using	an	exponential	
fitting	model.	
	
Results:	For	healthy	lung,	observed	T1	values	were	1399±77	ms	and	1290±76	ms	under	
normoxic	and	hyperoxic	conditions,	respectively.	The	oxygen-related	reduction	of	T1	was	
statistically	significant	 in	every	volunteer.	No	statistically	significant	change,	however,	
was	observed	in	T2,	with	normoxic	and	hyperoxic	T2	values	of	55±16ms	and	56±17ms,	
respectively.	 The	 observed	 average	 t	was	 87.0±28.7	 s,	 while	 the	 average	 t	was	
73.5±21.6	s.	
	
Conclusion:	IR-ufSSFP	allows	fast,	steady-state	and	dynamic	oxygen-dependent	relaxo-
metry	of	the	human	lung.	
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5.1	 Introduction	
	
Introduced	already	in	the	mid-1990s,	oxygen-enhanced	(OE)	proton	magnetic	resonance	imaging	
(MRI)	of	the	lung	was	proposed	as	an	alternative	technique	for	the	assessment	of	lung	function	
[95].	In	contrast	to	the	hyperpolarized	gas	lung	MRI	[11,	37],	OE-MRI	does	not	rely	on	specialized	
hardware	and	can	be	easily	performed	using	a	standard	clinical	equipment.	OE-MRI	is	based	on	
the	paramagnetic	properties	of	O2,	changing	lung	tissue	relaxivity.	When	breathed,	oxygen	acts	
as	a	weak	contrast	agent	in	the	lung	by	shortening	the	longitudinal	relaxation	time	(T1)	[96]	and	
the	 apparent	 transverse	 relaxation	 time	 (T2*)	 [158].	 The	 observed	 reduction	 in	 T1	 under	 the	
pulmonary	hyperoxia	is	attributed	to	an	increased	concentration	of	dissolved	O2	in	blood	vessels	
and	 lung	 parenchyma	 [95],	 thereby	 reflecting	 oxygen	 uptake	 (wash-in).	 OE-MRI	 is	 usually	
considered	an	indirect	measure	for	ventilation,	diffusion	and	perfusion	using	T1-weighted	images	
[99].	If	one	of	those	functions	is	regionally	affected,	a	change	in	a	signal	enhancement	can	be	
detected	 locally.	 In	 contrary,	 no	 changes	 in	 the	 transverse	 relaxation	 time	 (T2)	 in	 the	 lung	
parenchyma	 are	 expected	 in	 the	 hyperoxic	 condition,	 since	 T2	 of	 the	 arterial	 blood	 remains	
unchanged	[164].	Furthermore,	an	increased	concentration	of	O2	has	been	shown	to	reduce	T2*	
in	the	lung	by	increasing	the	magnetic	susceptibility	of	gas	and	blood	in	alveoli	and	thus	can	be	
used	as	a	measure	of	ventilation	[99,	101].		
	
Hence,	oxygen-dependent	pulmonary	relaxometry	can	be	applied	to	measure	the	differences	in	
relaxation	times	between	the	normoxic	and	hyperoxic	conditions	or	to	observe	dynamic	changes	
of	tissue	relativity,	and	potentially	yield	a	useful	diagnostic	information.	Only	a	small	number	of	
studies	using	quantitative	oxygen-dependent	T1	 relaxometry	 in	patients	with	diseases	such	as	
cystic	 fibrosis	 [172],	 chronic	 obstructive	 pulmonary	 disease	 [114],	 chronic	 lung	 allograft	
dysfunction	[173]	or	asthma	[98]	have	been	reported	so	far.	
	
Most	 of	 the	 OE-MRI	 relaxometric	 techniques	 are	 based	 on	 either	 an	 inversion	 recovery	 (IR)	
snapshot	fast	low	angle	shot	(FLASH)	[93]	or	an	IR	half	Fourier	acquired	single	shot	turbo	spin	
echo	(HASTE)	[92]	method.	More	recently,	a	radial	acquisition	technique	with	ultra-short	echo	
(UTE)	times	has	been	presented	for	both	for	simultaneous	T1	and	T2*	mapping	of	the	lung	[99].	
The	UTE	approach	provides	improved	signal-to-noise	ratio	 in	the	lung	parenchyma	and	shows	
inherent	robustness	against	motion	and	pulsation	artifacts.	
	
As	 an	 advantage	 over	 spoiled	 gradient	 echo	 based	 sequences,	 balanced	 steady-state	 free	
precession	(bSSFP)	sequences	offer	the	highest	signal-to-noise	ratio	per	unit	of	time	amongst	all	
MRI	 techniques	 [108].	Hence,	 in	 the	 recent	 years,	bSSFP	 imaging	has	 found	an	application	 in	
structural	 as	 well	 as	 functional	 lung	 imaging	 [47,	 102,	 174–177].	 Specifically,	 an	 accelerated	
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implementation	of	the	bSSFP,	referred	to	as	ultra-fast	SSFP	(ufSSFP),	has	shown	to	be	well-suited	
for	pulmonary	imaging	[45].	Optimization	of	RF	pulse	excitation	timings	and	gradient	switching	
patterns	of	the	ufSSFP	pulse	sequence	as	well	as	application	of	partial	echo	readouts	and	ramp	
sampling	 techniques	 helped	 to	 substantially	 reduce	 the	 TR.	 Consequently,	 the	 shortened	 TR	
helped	to	mitigate	banding	and	motion	artifacts,	and	resulted	 in	a	substantial	 increase	 in	 the	
parenchymal	signal.	Recently,	a	derivate	of	the	pulse	sequence	termed	inversion	recovery	ultra-
fast	steady-state	free	precession	(IR-ufSSFP)	was	presented	for	pulmonary	relaxometry	[46].	The	
technique	 allowed	 for	 fast,	 simultaneous	 and	 automatic	mapping	 of	 T1,	 T2,	 and	 relative	 spin	
density	 M0	 in	 human	 lung	 at	 1.5T.	 In	 this	 work,	 we	 demonstrate	 the	 feasibility	 of	 oxygen-
dependent	 pulmonary	 relaxometry	 using	 IR-ufSSFP	 imaging	 and	 explored	 the	 influence	 of	
pulmonary	hyperoxia	on	relaxivity	of	the	lung	tissue	in	a	group	of	healthy	volunteers.	
	
	
5.2	 Methods	
	
5.2.1	 Pulmonary	relaxometry	with	IR-ufSSFP	
	
Recently,	 a	 technique	 termed	 inversion	 recovery	 ultra-fast	 steady-state	 free	 precession	 (IR-
ufSSFP)	technique	[46]	was	proposed	for	simultaneous	measurement	of	T1,	T2	and	M0	in	the	lung	
parenchyma.	The	acquisition	scheme	was	based	on	an	ECG-triggered	two-dimensional	(2D)	time-
resolved	 transient	 ufSSFP	 imaging	 preceded	 by	 a	 nonselective	 adiabatic	 hyperbolic-secant	
inversion	pulse.	Two	time-resolved	IR-ufSSFP	blocks	containing	a	user	defined	number	of	images	
were	acquired	during	a	single	breath-hold.	The	start	of	the	acquisition	was	triggered	by	patient’s	
ECG	signal	at	the	beginning	of	the	diastolic	phase.	The	imaging	blocks	were	separated	by	a	time	
interval	 (TW~3	 seconds)	 for	 the	 full	 recovery	 of	 the	 magnetization	 acquired	 during	 a	 single	
breath-hold.	Furthermore,	the	second	block	was	repeated	with	several	dummy	repetition	times	
between	 the	 inversion	 recovery	 and	 the	 start	 of	 the	 acquisition	 block.	 Thus,	 the	 acquisition	
scheme	produces	two	interleaved	sets	of	images	for	improved	sampling	of	the	transient	ufSSFP	
signal.	For	details	and	an	in-depth	description	of	the	IR-ufSSFP	technique,	cf.	Bauman	et	al	[46].	
	
5.2.2	 Imaging	procedure	
	
Experiments	were	performed	on	a	1.5T	MR-scanner	(MAGNETOM	Avanto-Fit,	Siemens	Healthi-
neers,	Erlangen,	Germany)	with	peak	gradient	amplitude	of	45	mT/ms	and	a	maximum	slew	rate	
of	200	T/m/s	using	a	12-channel	thorax	and	a	24-channel	spine	coil	receive-array.	All	scans	were	
performed	with	predefined	default	shim	settings	(tune-up	mode).		
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Seven	healthy	human	subjects	were	scanned	in	supine	position	using	ECG-triggered	2D	IR-ufSSFP	
sequence.	The	study	was	approved	by	the	ethics	committee.	Written	informed	consent	was	ob-
tained	from	all	volunteers.		
	
The	imaging	parameters	of	IR-ufSSFP	were	as	follows:	
	
• in-plane	resolution	=	2.8	mm	
• field-of-view	=	450	×	450	mm2,	slice	thickness	(ST)	=	10	mm	
• matrix	size	=	160	×	160	
• asymmetric	echo	sampling:	echo	time	(TE)	/	repetition	time	(TR)	=	0.71	/	1.63	
ms	
• two	acquisition	blocks	with	15	images	each,	acquisition	time	(TA)	per	image	=	
150	ms	
• time	between	acquisition	blocks	(TW)	=	3	seconds	
• total	scan	time	per	slice	=	9	seconds	
• 10	dummy	TRs	after	the	second	inversion	recovery	pulse	
• bandwidth	=	1955	Hz/pixel	
• sinc-shaped	radio-frequency	(RF)	pulse:	1.6	time-bandwidth	product,	400	μs	
duration	
• nominal	flip	angle	α	=	45°	
• parallel	imaging	with	generalized	auto-calibrating	partially	parallel	acquisition	
(GRAPPA)	[128]	factor	=	2	
	
The	 imaging	 protocol	 comprised	 three	 coronal,	 and	 two	 sagittal	 slices	 acquired	 in	 expiratory	
breath-hold.	Each	slice	was	acquired	during	a	separate	breath-hold.	Scanning	was	repeated	two	
times.	The	first	scan	was	performed	while	the	subjects	breathed	medical	air	with	21%	oxygen	
(normoxic	 condition),	 whereas	 the	 second	 scan	was	 acquired	 during	 supply	 of	 100%	 oxygen	
(hyperoxic	 condition).	 Medical	 air	 and	 oxygen	 was	 delivered	 at	 25	 L/min	 through	 a	 non-
rebreathing	ventilatory	mask	with	reservoir	placed	tightly	over	the	subject’s	nose	and	mouth.	
After	switching	to	100%	oxygen,	a	4	minute	 long	delay	was	used	prior	 to	 the	second	scan,	 in	
order	 to	 achieve	 steady-state	 conditions	 for	 the	 pulmonary	 IR-ufSSFP	 under	 hyperoxia.	
Furthermore,	to	assess	the	reproducibility	of	the	technique,	the	imaging	protocol	was	repeated	
on	5	consecutive	days	in	one	volunteer.		
	
In	one	volunteer	a	set	of	IR-ufSSFP	acquisitions	was	performed	during	the	dynamic	oxygen	wash-
in	 phase,	 during	 the	 steady-state	 of	 pulmonary	 hyperoxia,	 and	 during	 the	 oxygen	 wash-out	
phase.	Several	additional	acquisitions	were	performed	prior	to	the	wash-in	phase.	 In	order	to	
sample	each	phase,	 IR-ufSSFP	scans	were	performed	 in	expiratory	breath-hold	approximately	
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every	 30	 seconds	 for	 more	 than	 15	 minutes.	 Dynamic	 scanning	 was	 repeated	 separately	 in	
coronal	and	sagittal	orientation.	
	
5.2.3	 Generation	of	the	parameter	maps	
	
Only	images	acquired	in	the	diastolic	phase	were	selected	for	post-processing	based	on	the	time	
recorded	after	the	ECG-trigger.	The	number	of	images	acquired	in	the	diastolic	phase	was	in	the	
range	of	14-18.	Subsequently,	a	voxel-wise	nonlinear	fitting	of	the	transient	ufSSFP	signal	using	
a	model	proposed	by	Schmitt	et	al.	[178,	179],	was	performed	on	the	sorted	image	time-series	
obtained	from	both	acquisition	blocks.	As	a	result,	the	relative	spin	density	(M0),	and	T1	and	T2	
values	were	derived.	
	
For	improved	accuracy	of	the	parameter	maps,	a	correction	for	2D	slice	profile	effects	was	per-
formed,	as	presented	in	Ehses	et	al	[180]	and	subsequently	modified	by	Santini	et	al	[181],	using	
a	dictionary-based	approach.	Furthermore,	the	inversion	pulse	efficiency	was	taken	into	the	ac-
count	 as	 proposed	 by	 the	 Kellman	 et	 al	 [182].	 Post-processing	 and	 fitting	 procedures	 was	
performed	directly	on	the	scanner	using	IceLuva	scripting	framework	[183].		
	
Parameter	maps,	acquired	in	the	same	slice	position	during	different	gas-breathing	conditions,	
were	registered	to	eliminate	the	displacement	of	the	diaphragm	and	pulmonary	structures.	Such	
displacement	is	often	present	due	to	the	difficulty	to	reproduce	an	identical	breathing-holding	
position	during	all	scans.	Registration	was	performed	using	the	Advanced	Normalization	Toolkit	
[184],	using	a	symmetric	diffeomorphic	registration	algorithm	with	a	cross-correlation	metric.	
For	each	pair	of	images,	the	algorithm	estimated	a	deformation	that	maximizes	the	cross-corre-
lation	 metric	 between	 the	 reference	 and	 the	 uncorrected	 target	 image.	 For	 improved	
convergence	the	process	was	implemented	in	a	multi-scale	approach	from	coarse	to	fine	resolu-
tion.	Once	the	estimated	deformation	fields	were	calculated,	the	target	image	was	warped	and	
resampled	using	a	B-spline	interpolator.	
	
Maps	showing	regional	difference	in	T1	and	T2	relaxation	times	measured	during	the	hyperoxic	
condition	(𝑇1+	and	𝑇2+),	as	well	as	normoxic	conditions	(𝑇1|	and	𝑇2|),	were	calculated	for	
every	volunteer	using	registered	parameter	maps	from	corresponding	slices.	
	
5.2.4	 T1-related	oxygen	wash-in	and	wash-out	time	constants	
	
Sets	of	registered	T1	maps	were	used	to	assess	dynamic	changes	in	T1	during	the	oxygen	wash-in	
and	wash-out	phases.	A	conventional	asymptotic	exponential	wash-out	model	was	assumed	and	
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non-linear	fitting	of	an	exponential	function	was	performed	voxel-wise	on	the	sets	of	T1	maps	
acquired	during	each	phase.	The	three-parameter	wash-in	exponential	function	was	defined	as:	
	 𝑇1 𝑡 	= 	𝐴𝑒</t  + 𝐵																																																													(5.1)	
	
where	t 	 is	the	T1	wash-in	time	constant,	and	the	initial	values	of	remaining	two	parameters	
were	set	as	𝐴	 = 	𝑇1 0 − 𝑇1(𝑁)	and	𝐵	 = 	𝑇1(𝑁),	for	time-steps	𝑡	 = 	0… 	𝑁.		
Similarly,	the	wash-out	was	analyzed	with	the	exponential	function:	
	 𝑇1 𝑡 	= 	𝐴(1 − 𝑒</t¤) + 𝐵																																																		(5.2)	
	
where	t	is	the	T1	wash-out	time	constant	with	initial	fitting	parameters	set	as	𝐴	 = 	𝑇1 𝑁 −𝑇1(0)	and	𝐵	 = 	𝑇1(0).	
	
5.2.5	 Image	analysis	
	
The	lungs	were	segmented	in	every	volunteer	with	a	region	growing	algorithm	[131],	excluding	
the	 large	 vessels,	 using	 a	 dedicated	 software	 (The	 Medical	 Imaging	 Interaction	 Toolkit,	
Heidelberg,	 Germany).	 Segmentation	 masks	 were	 used	 for	 the	 analysis	 of	 the	 T1	 and	 T2	
distributions.	The	Mann-Whitney	U	test	was	used	to	test	for	the	intra-subject	difference	between	
distributions	of	relaxation	times	measured	in	hyperoxic	and	normoxic	conditions,	as	well	as	to	
test	 if	there	was	a	significant	difference	between	the	distribution	of	the	T1-related	O2	wash-in	
and	wash-out	time	constants.	Paired	two-sample	t-test	was	performed	to	assess	the	mean	values	
of	 relaxation	 times	 calculated	 for	 the	 whole	 group	 of	 subjects.	 The	 statistical	 tests	 were	
performed	on	the	significance	level	of	α	equals	0.05.	P	values	less	than	0.05	were	considered	to	
be	statistically	significant.	The	statistical	analysis	and	visualization	of	 the	data	was	performed	
using	Matlab	2012b	(MathWorks,	Natick,	MS,	US).	
	
	
5.3	 Results	
	
Illustrative	thoracic	coronal	and	sagittal	T1	and	T2	maps	of	a	healthy	volunteer	are	shown	in	Figure	
5.1	for	normoxic	and	hyperoxic	conditions.	Relaxometry	was	successful	over	the	whole	field-of-
view,	with	the	exception	of	regions	outside	the	body	which	were	subsequently	masked.	Overall,	
T1	maps	 appear	more	 homogenous	 than	 the	 ones	 of	 T2.	 This	 is	 due	 to	 lower	 difference	 in	 T1	
between	vessels	and	lung	parenchyma.	A	subtraction	of	registered	T1	and	T2	maps	from	the	same	
healthy	subject,	acquired	during	both	steady-state	gas-breathing	conditions	(room-air	and	100%	
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O2),	yields	O2-related	relaxometry	difference	maps,	i.e.,	∆T1	:	=	𝑇1+ − 𝑇1|	and	∆T2	:	=	𝑇2+ −𝑇2|	(see	Figure	5.2).	
	
Table	5.1	summarizes	the	means	and	standard	deviations	of	assessed	relaxation	times	measured	
during	hyperoxic	and	normoxic	conditions	in	the	lung	in	all	healthy	volunteers.	The	mean	𝑇1¥¦ 	
and	𝑇1+	in	healthy	volunteers	were	1399±77	ms	and	1290±76	ms,	respectively.	The	difference	
between	the	means	(𝑇1+ − 𝑇1¥¦)	for	the	whole	group	of	subjects	was	108	ms	(7.8%)	and	was	
statistically	 significant	 (P<10-4,	 paired	 two-sample	 t-test).	 The	 average	 difference	 between	 T1	
measured	 in	both	 steady-state	gas	 conditions	was	 in	 the	 range	of	previously	 reported	values	
	
Figure	5.1.	Coronal	(a,c)	and	sagittal	(b,d)	T2	maps	as	well	as	coronal	(e,g)	and	sagittal	(f,h)	T2	maps	of	the	
chest	acquired	under	normoxic	and	hyperoxic	conditions	in	Volunteer	#6.	A	reduction	of	T1	can	be	noticed	
in	the	lung	and	spleen	regions	on	coronal	images.	
	
Figure	5.2.	Maps	showing	the	difference	in	T1	and	T2	between	the	registered	maps	acquired	during	21%	O2	
and	100%	O2	gas-breathing	phases	in	coronal	(a,c)	and	sagittal	(b,d)	orientation.	
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[185].	 The	 mean	 𝑇2+	and	 𝑇2¥¦	in	 healthy	 volunteers	 were	 55±16	 ms	 and	 56±17	 ms,	
respectively.	The	difference	between	the	means	(𝑇2+ − 𝑇2¥¦)	was	-0.4	ms	(-0.8%)	and	was	not	
statistically	significant	(P	=	0.6,	paired	two-sample	t-test).	On	the	intra-subject	level	a	statistically	
significant	 difference	 between	𝑇1+	 and	𝑇1¥¦ 	 distributions	was	 observed	 for	 all	 volunteers	
(P<10-6,	Mann-Whitney	U	 test).	The	Mann-Whitney	U	 test,	however,	 showed	no	 intra-subject	
difference	between	𝑇2+	and	𝑇2¥¦ 	distributions	in	all	volunteers;	except	for	Volunteer	#5	(P<10-
4)	and	during	the	second	scan	of	Volunteer	#7	(P<10-3).	The	significant	T2	differences	in	those	two	
volunteers	were	influenced	by	the	imperfect	ECG	gating	during	those	scans	and	due	to	the	heart	
rate	variability	or	overestimated	length	of	the	acquisition	window.	The	T1	difference	in	those	two	
volunteers	was	not	affected	by	the	imperfect	ECG-gating	or	heart	rate	variability	in	the	same	way	
as	the	T2	difference	since	T1	of	blood	and	lung	parenchyma	are	similar.	The	coefficient	of	variation	
(cv)	calculated	for	repeated	measurements	in	Volunteer	#7	was	lower	for	T1	than	T2	relaxation	
times.	 For	 T1,	 the	 cv	was	0.0052	 and	0.0064,	whereas	 for	 T2,	 the	 cv	was	0.066	 and	0.049	 for	
normoxic	and	hyperoxic	conditions,	respectively.	
	
The	diagrams	 in	 Figure	5.3	 show	averaged	T1	 values	 in	 the	 segmented	 lung	parenchyma	of	 a	
healthy	 subject	 measured	 in	 coronal	 and	 sagittal	 orientation	 before	 the	 administration	 of	
oxygen,	during	the	oxygen	wash-in,	steady-state	of	pulmonary	hyperoxia,	and	oxygen	wash-out.	
From	the	observed	dynamic	T1	changes,	T1-related	O2	wash-in	and	wash-out	time	constants	are	
assessed	using	mono-exponential	exponential	 fitting	analysis,	as	 indicated	by	 the	solid	 line	 in	
Figure	5.3.	It	can	be	noticed	that	the	measured	T1	values	fit	the	exponential	model	function	better	
during	the	wash-out	than	the	wash-in	phase.	
	
Figure	 5.4	 presents	maps	 of	 T1-related	 oxygen	wash-in	 time	 constant	 t 	 and	wash-out	 time	
constant	t.	Mean	t	values	in	the	lung	were	smaller	than	mean	t 	values	estimated	for	the	
voxel	distributions	in	coronal	and	sagittal	scans.	Mean	t 	measured	in	the	segmented	lung	in	
the	coronal	and	sagittal	orientations	were	80.0±18.6	s	and	98.0±33.6	s,	respectively,	whereas	
mean	 t	 values	 calculated	 in	 the	 coronal	 and	 sagittal	 orientations	 were	 67.6±13.2	 s	 and	
84.0±24.7	s,	respectively.	Mann-Whitney	U	test	results	showed	that	the	differences	in	the	mean	
values	estimated	during	the	wash-in	and	wash-out	phases	were	statistically	significant	(P<10-4).	
Furthermore,	on	the	images	acquired	in	the	coronal	orientation	the	T1	change	cannot	only	be	
observed	 in	 the	 lung	 regions	but	 also	 in	 the	 kidneys	 and	 in	 the	 spleen,	 both	highly	 perfused	
organs.	The	calculated	wash-in	and	wash-out	time	constants	in	the	lung	parenchyma	are	larger	
than	the	mean	values	reported	by	Arnold	et	al.	[186].	In	his	study,	however,	a	large	inter-subject	
variability	of	the	measured	time	constants	was	observed.		
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Table	5.1.	Mean,	standard	deviation	of	T1	and	T2	relaxation	times	measured	using	IR-ufSSFP	in	the	lung	of	
healthy	volunteers	under	normoxic	and	hyperoxic	conditions,	as	well	as	differences	in	T1	and	T2	between	
the	 both	 gas	 conditions.	 Volunteer	 #7	 was	 scanned	 five	 times	 on	 different	 days	 for	 reproducibility	
assessment.	
	
	 	 Normoxic	condition	 Hyperoxic	condition	 Difference	
Volunteer	 Sex,	age	 T1	[ms]	 T2	[ms]	 T1	[ms]	 T2	[ms]	 ∆T1	[ms]	(%)	 ∆T2	[ms]	(%)	
	 	 	 	 	 	 	 	1	 M,	34	 1385±83	 48±11	 1273±80	 50±12	 112	(8.1)	 -2	(-4.2)	
2	 M,	35	 1346±74	 56±15	 1241±73	 55±14	 105	(7.8)	 1	(1.8)	
3	 F,	49	 1464±84	 58±18	 1368±91	 56±17	 96	(6.6)	 2	(3.5)	
4	 F,	31	 1428±90	 51±19	 1301±87	 52±23	 127	(8.9)	 -1	(-2.0)	
5	 M,	40	 1403±79	 54±15	 1312±62	 57±18	 91	(6.5)	 -3	(-5.6)	
6	 M,	27	 1416±53	 57±18	 1296±64	 56±18	 120	(8.5)	 1	(1.8)	
7,	scan	1	 M,	29	 1351±67	 66±20	 1244±62	 64±22	 107	(7.9)	 2	(3.0)	
7,	scan	2	 “	 1348±75	 62±16	 1237±65	 66±17	 111	(8.2)	 -4	(-6.5)	
7,	scan	3	 “	 1358±71	 66±21	 1252±72	 65±20	 106	(7.8)	 1	(1.5)	
7,	scan	4	 “	 1343±77	 64±20	 1239±69	 64±19	 104	(7.7)	 0	(0)	
7,	scan	5	 “	 1340±81	 60±18	 1231±79	 58±14	 109	(8.1)	 2	(3.3)	
	
	
Figure	5.3.	Diagrams	present	the	oxygen-dependent	change	of	T1	in	a	region-of-interest	located	in	the	lung	
parenchyma	measured	in	two	separate	acquisitions	performed	in	coronal	(a)	and	sagittal	(b)	orientation.	
T1-related	oxygen	wash-in	and	wash-out	time	constants	were	calculated	using	an	exponential	fit	model.	
The	time	period	where	100%	oxygen	was	delivered	is	marked	as	a	grey	area	on	the	diagram.	
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5.4	 Discussion	
	
In	 this	 work,	 we	 have	 shown	 the	 feasibility	 of	 a	 novel	 technique	 for	 oxygen-dependent	
pulmonary	relaxometry	in	human	subjects	at	1.5T.	The	technique	is	based	on	an	ECG-triggered	
acquisition	 of	 a	 series	 of	 images	 using	 an	 inversion	 recovery	 ultra-fast	 steady-state	 free	
precession	pulse	sequence	adapted	for	pulmonary	imaging	by	a	significant	shortening	of	the	TR.	
As	 a	 consequence	 of	 the	 TR	 reduction	 the	 signal-to-noise	 ratio	 in	 the	 lung	 parenchyma	was	
improved,	 which	 allowed	 us	 to	 produce	 high	 quality	 relaxation	 time	maps	 at	 good	 in-plane	
resolution	of	2.8	mm2	as	for	functional	lung	imaging.		
	
	
Figure	5.4.	T1	-related	oxygen	wash-in	time	constant	(t)	and	wash-out	time	constant	(t)	calculated	by	
voxel-wise	fitting	of	an	exponential	model	on	a	set	of	registered	parameter	maps	acquired	in	coronal	(a,c)	
and	sagittal	(b,d)	orientation	in	Volunteer	#7.	Oxygen	wash-in/wash-out	process	can	be	noticed	in	the	lung,	
spleen	and	kidneys	on	the	coronal	images	(a,c).	Voxels	located	outside	the	body	were	masked-out.	
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All	acquisitions	in	this	study	were	conducted	in	expiratory	breath-holding	and	lasted	no	longer	
than	nine	seconds	per	slice.	Hence,	it	is	possible	to	cover	the	whole	volume	of	a	subject	using	
multiple	breath-hold	acquisitions,	taking	no	more	than	a	couple	of	minutes	per	gas	condition.	As	
expected	the	global	T1	values	 in	the	 lung	measured	 in	all	volunteers	were	reduced	during	the	
pulmonary	hyperoxia	by	about	7.8%,	and	in	agreement	with	expectations	from	literature	[185].	
Overall,	no	significant	difference	between	T2	values	in	the	lung	measured	in	all	volunteers	during	
the	steady-state	conditions	was	found.	
	
For	the	calculation	of	the	relaxation	time	difference	maps	a	voxel-wise	subtraction	of	estimated	
values	 was	 required.	 Similarly,	 a	 voxel-wise	 analysis	 on	 a	 series	 of	 parameters	 maps	 was	
performed	 to	 study	 the	 oxygen	 wash-in	 and	 wash-out	 dynamics.	 Despite	 the	 fact	 that	 the	
volunteers	 were	 generally	 able	 to	 reproduce	 the	 respiratory	 volume	 in	 expiratory	 phase,	
application	 of	 non-rigid	 image	 registration	 was	 mandatory	 to	 correct	 for	 the	 misalignments	
between	the	lung	structures	acquired	in	the	normoxic	and	hyperoxic	conditions,	or	during	the	
dynamic	measurements.	Due	to	the	relatively	thick	slices	of	one	centimeter,	possible	residual	
through-plane	misalignments	should	marginally	affect	the	results	and	were	neglected.		
	
Dynamic	measurements	enabled	us	to	observe	regional	T1	change	during	the	oxygen	wash-in	and	
wash-out	phases	of	the	experiment.	We	used	a	simple	exponential	model	to	extract	voxel-wise	
the	 T1-related	wash-in	 and	wash-out	 time	 constants	 from	 the	 registered	 T1	 parameter	maps.	
Interestingly,	the	mean	oxygen	wash-in	time	constant	was	higher	than	the	oxygen	wash-out	time	
constant.	A	similar	fact	was	observed	by	Arnold	et	al.	[186]	using	rapid	dynamic	acquisition	of	T1-
maps	during	oxygen	enhancement	as	well	as	by	Chon	et	al.	[187]	in	a	study	where	a	mixture	of	
xenon	 and	 oxygen	was	 used	 as	 a	 gas	 tracer	 for	 CT	 in	 a	 large	 animal	 experiment.	 A	 regional	
difference	in	the	wash-in/wash-out	time	constants	along	the	anterior-posterior	direction	can	be	
noticed	on	sagittal	maps.	The	dorsal	lung	regions	are	characterized	by	lower	t 	and	t	values	
than	the	ventral	parts	of	the	lung.	This	was	also	observed	during	xenon	wash-out	experiments	
using	SPECT	[188].	For	both	scan	series	performed	in	coronal	and	sagittal	orientation	the	T1	values	
measured	 after	 oxygen	 wash-out	 failed	 to	 return	 to	 the	 baseline	 measured	 before	 the	
administration	of	100%	O2.	This	effect	can	be	caused	by	an	increased	pulmonary	perfusion	due	
to	hyperoxia	and	might	last	longer	than	the	oxygen	wash-out.	
	
As	shown	recently	by	Similarly	Zhang	et	al.	[98])	the	dynamic	T1	curves	could	also	be	converted	
to	the	dynamic	changes	in	the	partial	pressure	of	oxygen	dissolved	in	the	tissue	water	and	plasma	
of	the	lung	by	knowing	the	O2	longitudinal	relaxivity	in	water.	Similarly,	a	rate	of	change	of	oxygen	
partial	pressure	can	be	estimated	using	an	exponential	model.		
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One	of	main	limitations	of	the	presented	technique	is	the	possibility	of	acquiring	only	one	slice	
per	 breath-hold	 maneuver.	 Although	 volumetric	 ∆T1	 mapping	 can	 be	 performed	 in	 clinically	
feasible	scan	times	of	less	than	15	minutes,	dynamic	relaxometry	measurements	during	O2	wash-
in	and	wash-out	phases	would	require	the	experiment	to	be	repeated	for	every	acquired	slice.	
One	of	the	possibilities	to	accelerate	this	process	would	be	the	implementation	of	multiple-slice	
acquisition	technique	[189]	and	image	reconstruction	methods	taking	advantage	from	the	high	
spatial-temporal	redundancy	in	the	acquired	datasets	[190].	Another	limitation	was	related	to	
the	 lack	 of	 the	 direct	measurement	 of	 the	 oxygen	 concentration	 in	 the	 gas	 delivered	 by	 the	
breathing	mask	and	exhaled	by	the	subject.	A	well-controlled	experiment	using	the	proposed	MR	
methodology	and	additional	hardware	for	on-line	measurements	of	the	gas	concentration	would	
improve	the	accuracy	of	the	measurements	and	provide	further	 insight	 into	the	physiology	of	
the	 lung.	 Furthermore,	 our	 study	had	 an	 exploratory	nature	with	 the	main	 goal	 to	 show	 the	
feasibility	of	the	proposed	relaxometry	technique.	Hence,	the	study	involved	only	a	small	group	
of	healthy	subjects.	
	
	
5.5	 Conclusion	
	
We	demonstrated	the	feasibility	of	steady-state	and	dynamic	oxygen-dependent	relaxometry	of	
the	human	 lung	at	1.5T.	Our	method	 is	based	on	an	ECG-triggered	 IR-ufSSFP	pulse	 sequence	
adapted	for	 lung	 imaging	and	allows	for	simultaneous	and	automatic	estimation	of	relaxation	
time	 parameter	 maps.	 We	 have	 employed	 the	 method	 for	 measurements	 of	 T1	 and	 T2	
measurements	 in	 normoxic	 and	 hyperoxic	 conditions	 in	 healthy	 subjects	 as	 well	 as	 during	
dynamic	measurements	of	T1-related	oxygen	wash-in	and	wash-out	time	constants.	The	potential	
of	the	oxygen-dependent	pulmonary	relaxometry	using	IR-ufSSFP	should	be	evaluated	in	further	
studies	on	groups	of	patients	with	different	pulmonary	disease.	
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of	the	lung	parenchyma	with	ultra-fast	
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CHAPTER	ABSTRACT	
	
	
Purpose:	To	investigate	the	lung	signal	enhancement	ratio	(SER)	with	ultra-fast	steady-
state	free	precession	(ufSSFP)	after	Gd-administration.	
	
Methods:	ufSSFP	and	volume-interpolated	breath-hold	examinations	(VIBE)	imaging	of	
the	chest	was	performed	at	1.5T	before	and	three	minutes	after	i.v.	Gadobenate-Dime-
glumine	in	ten	subjects	with	healthy	lungs,	and	nine	patients	with	pulmonary	diseases	
(COPD,	lung	cancer,	pulmonary	fibrosis,	lung	contusion).	A	workflow	including	deforma-
ble	image	registration	and	median	filtering	was	used	to	compute	3D	SER	maps.	SER	was	
analyzed	in	the	lung,	blood	pool,	liver,	muscles,	and	fat.	In	the	COPD	patients,	ufSSFP-
SER	was	compared	to	99mTc-MAA-SPECT/CT	by	visual	scoring	of	lung	enhancement	defi-
cits.		
	
Results:	In	healthy	lungs,	ufSSFP-SER	(99%±23%,	mean±pooled	intrasubject	SD,	cv=23%)	
was	significantly	higher	(P<10-3)	and	more	homogeneous	(P<10-3)	than	VIBE	(47%±26%,	
cv=57%).	ufSSFP-SER	was	significantly	higher	(P<10-3)	for	the	lungs	(99%±9%,	mean±in-
tersubject	 SD)	 than	 for	 the	blood	 (81%±7%)	 and	other	 tissues	 (liver	 33%±8%,	muscle	
26%±5%,	fat	2%±1%).	In	the	lung	ufSSFP-SER	exhibits	homogeneity	on	iso-gravitational	
planes,	and	an	anterior-posterior	gradient.		
In	COPD	patients,	ufSSFP-SER	was	reduced	and	less	homogeneous	compared	to	the	con-
trol	group	(73%±33%,	mean±pooled	intrasubject	SD,	cv=42%).	ufSSFP-SER	had	moderate	
intermodality	agreement	with	SPECT/CT	(Cohen's	kappa	kq	=	0.64).	
	
Conclusion:	ufSSFP-SER	of	the	lung	is	a	rapid	and	simple	method.	Our	preliminary	data	
show	plausible	results	in	different	pulmonary	diseases,	motivating	further	evaluation	in	
larger	cohorts.	
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6.1	 Introduction	
	
Pulmonary	diseases	are	an	important	burden	to	public	health	[1,	2].	Functional	information	on	
pulmonary	perfusion	obtained	from	diagnostic	imaging	plays	a	pivotal	role	for	patient	manage-
ment,	both	in	terms	of	diagnosis	and	therapy	planning	[2,	4,	5].	Pulmonary	perfusion	is	commonly	
assessed	by	scintigraphy	and	hybrid	single	photon	emission	tomography/computed	tomography	
(SPECT/CT)	using	99mTc-labelled	macro-aggregated	albumin	(MAA)	[5].	Alternatively,	contrast-en-
hanced	dual-energy	CT	[191]	can	be	performed,	but	is	not	yet	fully	established	in	clinical	practice.	
Similarly,	magnetic	resonance	imaging	(MRI)	has	been	described	as	a	promising	method	to	assess	
pulmonary	morphology	and	function	[4,	28,	29,	33,	47].	Since	MRI	comes	without	an	associated	
radiation	burden	[29–31],	further	technical	development	of	pulmonary	MRI	is	of	interest	partic-
ularly	for	frequently	repetitive	imaging	investigations,	where	radiation	protection	is	an	issue.	
	
Functional	information	about	pulmonary	perfusion	is	commonly	assessed	by	MRI	from	a	heavily	
T1-weighted	spoiled	gradient	echo	(SPGR)	in	combination	with	the	intravenous	injection	of	a	con-
trast	agent	[28].	Using	rapid	volumetric	SPGR	imaging	during	the	wash-in,	peak-enhancement,	
and	wash-out	of	the	contrast	agent,	dynamic	contrast-enhanced	(DCE)	MRI	enables	to	measure	
both	blood-volume	and	flow	[192].	Moreover,	static	contrast-enhanced	imaging	is	convention-
ally	performed	with	SPGR,	such	as	volume	interpolated	breath-hold	examinations	(VIBE)	[4,	30].	
These	contrast-enhanced	MRI	methods	have	demonstrated	 to	 correlate	 reasonably	well	with	
99mTc-MAA-SPECT	[193],	however,	with	one	important	limitation:	while	99mTc-MAA-SPECT	repre-
sents	tracer	accumulation	in	the	pulmonary	arterioles	and	capillary	bed,	i.e.,	in	the	pulmonary	
parenchyma	itself	[194],	gradient	echo	imaging	is	mainly	sensitive	to	larger	vessels,	and	suffers	
from	low	signal-to-noise	ratio	(SNR)	in	the	lung	parenchyma	[195].	
	
In	contrast,	balanced	steady-state	free	precession	(bSSFP)	offers	the	highest	SNR	per	unit	of	time	
amongst	all	MRI	sequences	[108].	Banding	artifacts	that	typically	compromise	the	image	quality	
of	bSSFP	 in	 the	chest	have	been	 recently	mitigated	by	 the	development	of	an	ultra-fast	SSFP	
imaging	approach	(ufSSFP)	[45];	a	variant	of	bSSFP	with	ultra-short	repetition	times,	which	has	
already	demonstrated	potential	for	morphological	and	functional	assessment	of	the	lungs	[47,	
144,	157,	196].	Due	to	 their	mixed	contrast	behavior	driven	by	the	T2/T1	 relaxation	time	ratio	
[110],	bSSFP	sequences	are	frequently	regarded	as	being	rather	insensitive	to	gadolinium-based	
contrast	 agents,	 although	 their	 potential	 use	 after	 contrast	 administration	 has	 been	 demon-
strated	and	advised	[116,	117].	From	the	theory	[108],	the	signal	enhancement	for	SSFP	after	
contrast	administration	is	expected	to	be	higher	for	tissue	with	long	T1	and	short	T2,	such	as	the	
lung	(T1/T2	~	1375/66	[ms/ms]	at	1.5T,	cf.	[197]),	as	compared	to	the	blood	(T1/T2	~	1300/300)	and	
fluids	with	comparable	T1/T2.	
Signal	enhancement	ratio	imaging	with	ufSSFP	
	104	
The	purpose	of	our	work	is	to	investigate	the	static	signal	enhancement	ratio	(SER)	of	ufSSFP	and	
VIBE	from	two	sets	of	volumetric	scans,	acquired	before	and	after	the	administration	of	a	gado-
linium-based	contrast	agent.		
	
	
6.2	 Methods	
	
This	 study	was	approved	by	 the	 local	 institutional	 review	board	and	all	 subjects	gave	written	
informed	consent.	Imaging	examinations	were	performed	between	July	2015	and	Dec.	2016.	
	
6.2.1	 Study	subjects	
	
Pulmonary	SER	imaging	with	ufSSFP	and	VIBE	was	retrospectively	evaluated	in	10	consecutive	
patients	(4	males,	6	females;	mean	age	40±13	years,	range	25-64)	with	healthy	 lungs	who	re-
ceived	chest	MRI	with	contrast	agent	because	of	a	suspected	mediastinal	mass.	For	structural	
and	functional	examination	of	the	lung,	both	ufSSFP	and	VIBE	sequences	were	part	of	our	routine	
clinical	MRI	protocol.	Mediastinal	mass	was	excluded,	through	MRI	in	eight	cases.	One	subject	
had	thymic	hyperplasia,	another	subject	had	an	esophageal	duplication	cyst.	Since	no	disease	of	
the	lung	was	present,	these	10	patients	are	in	the	following	referred	to	as	the	“control	group”	of	
the	study.	
		
Static	ufSSFP-SER	 imaging	was	further	assessed	 in	nine	patients	with	common	pulmonary	dis-
eases	 showing	 a	 diversified	 spectrum	 of	 pulmonary	 pathologies.	 Seven	 patients	 (3	 males,	 4	
females;	mean	age	64±10	years,	range	45-74)	were	examined	as	part	of	an	ongoing	clinical	trial	
investigating	 the	potential	of	MRI	 in	 chronic	obstructive	pulmonary	disease	 (COPD).	Of	 these	
seven	COPD	patients,	three	patients	had	COPD	global	initiative	for	chronic	obstructive	lung	dis-
ease	(GOLD)	stage	II,	one	patient	GOLD	stage	III,	and	three	patients	GOLD	stage	IV;	three	of	the	
COPD	patients	had	evident	emphysema	and	four	had	non-small-cell	lung	cancer	(NSCLC).	In	these	
seven	COPD	patients,	recent	99mTc-MAA-SPECT/CT	exams	(delay	21±22	days,	interval:	1-51	days)	
were	available	for	comparison	to	SER	imaging.		
	
Two	further	patients	with	a	different	pulmonary	pathology	than	COPD	who	were	examined	with	
ufSSFP-SER	imaging	are	also	included	in	this	study	for	illustration	purposes.	The	first	patient,	a	
54-year-old	female	with	scleroderma	and	non-specific	interstitial	pneumonia	(NSIP),	received	the	
MRI	exam	for	routine	follow-up;	 in	this	patient,	the	morphological	MR	images	were	taken	for	
comparison	to	ufSSFP-SER	imaging.	The	second	patient	was	a	71	years	old	male	with	traumatic	
lung	contusion	who	underwent	CT	and	MRI	(interval:	8	days)	after	a	traumatic	accident.	
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6.2.2	 MR	imaging	
	
All	MRI	scans	were	performed	on	a	whole-body	1.5T	MR	scanner	(MAGNETOM	Avanto,	Siemens	
Healthineers,	Erlangen,	Germany)	using	a	24-channel	spine	and	a	12-channel	thorax	receive-ar-
ray	 centered	 on	 the	 lungs.	 Both	 ufSSFP	 [45]	 and	 VIBE	 scans	were	 acquired	 before	 and	 after	
intravenous	injection	of	Gadobenate	Dimeglumine	(MultiHance®,	Bracco	Imaging	S.p.A.,	Milan,	
Italy)	using	the	standard	dose	of	0.2	ml	per	kg	body-weight.	In	order	to	avoid	the	first	pass	(con-
centration	peak)	of	the	contrast	agent,	and	rather	have	a	static	distribution	of	contrast	[198],	
post-contrast	imaging	for	static	SER	mapping	was	performed	3	minutes	after	the	contrast	injec-
tion:	first	with	ufSSFP,	and	immediately	after	(ca.	30	s)	with	VIBE,	resulting	in	a	similar	contrast	
agent	concentration	for	the	two	imaging	modalities	[198].		
	
Imaging	 with	 both	 volumetric	 sequences	 was	 performed	 in	 inspiratory	 breath-hold.	 The	 se-
quence	 parameters	 were	 chosen	 to	 obtain	 a	 high	 spatial	 resolution	 to	 guarantee	 good	
morphological	details	for	the	radiological	diagnosis	(see	Heye	et	al.	[47])	and	similar	acquisition	
times	(~15	seconds).	If	necessary,	the	ufSSFP	acquisitions	could	be	shortened	by	the	technician	
to	11	seconds	to	minimize	the	respiratory	effort.	The	repetition	time	(TR)	of	the	ufSSFP	sequence	
was	minimal,	 to	avoid	banding	artifacts;	 the	TR	 for	VIBE	was	set	as	 recommended	elsewhere	
[199].	The	flip	angle	for	ufSSFP	and	VIBE	were	set	for	close-to-maximal	lung	signal	intensity	after	
contrast	 agent	 administration,	 following	 the	 theoretical	 signal-model	 [163]	 and	 as	 explained	
elsewhere	[117].	Due	to	radiological	image	preferences,	ufSSFP	was	acquired	with	coronal	and	
VIBE	with	transverse	image	orientation.	Detailed	parameters	for	ufSSFP	and	VIBE	are	available	in	
Table	6.1.		
	
6.2.3	 SPECT/CT	
	
Lung	perfusion	SPECT/CT	was	performed	in	the	seven	COPD	patients	as	part	of	the	routine	clinical	
workup	using	a	standard	administered	dose	of	111	MBq	99mTc-MAA.	The	scintigraphy	and	SPECT	
were	acquired	on	a	double-head	SPECT/CT	scanner	 (Symbia	 Intevo	16,	Siemens	Healthineers,	
Forchheim,	 Germany).	 Three-dimensional	 ordered	 subset	 expectation	 maximization	 (OSEM)	
with	4	subsets,	8	iterations	and	4	mm	Gaussian	filtering	was	used	for	reconstruction.	The	voxel	
size	was	isotropic	4.8	mm.	The	acquisition	time	for	SPECT	was	20	min.	The	CT	scans	followed	a	
low	dose	protocol	with	130	kV	and	30	mAs	reference	values	resulting	in	a	total	dose-length	prod-
uct	(DLP)	of	~100	mGycm.	CT-data	were	reconstructed	using	filtered	back	projection	with	a	B70s	
convolution	kernel.	The	slice	thickness	was	1.5	mm	and	the	in-plane	resolution	was	0.7×0.7	mm2.	
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6.2.4	 MR	image	post-processing	
	
Pre-	and	post-contrast	volumetric	datasets	were	first	co-registered	to	spatially	match	lung	struc-
tures,	 such	 as	 vessels	 and	 lung	 boundaries,	 using	 a	 mass	 preserving	 three-dimensional	
deformable	B-spline	image	registration	algorithm	(Elastix	version	4.7,	University	Medical	Center	
Utrecht,	 The	Netherlands)	 [145].	 Subsequently,	 the	 registered	 datasets	were	median	 filtered	
(kernel	radius	9×9×9	mm3).	Median	filtering	(see	Ref.	[142]	for	details),	a	common	edge-preserv-
ing	 noise	 reduction	 filter	 (cf.	 Figs.	 3.1	 and	 4.2),	 is	 particularly	 effective	 to	 remove	 “salt	 and	
pepper”	type	of	noise,	that	is	sparsely	occurring	white	and	black	pixels,	such	as	the	hyperintense	
vasculature	overlying	the	pulmonary	tissue	and	small	airways	(up	to	a	size	of	9×9×9	mm3	in	our	
post-processing).	Finally,	SER	images	were	calculated	voxel-wise	(at	position	𝑥)	from	the	signal	
intensity	before	[SIpre 𝑥 ]	and	after	[SIpost 𝑥 ]	contrast	agent	administration,	respectively,	using		
	
SER 𝑥 	= 	 SIpost 𝑥 − SIpre 𝑥
SIpre 𝑥 	.																																																										(6.1)	
	
Image	 post-processing	 was	 identical	 for	 ufSSFP	 and	 VIBE,	 and	 essentially	 similar	 to	 previous	
Table	6.1.	Pulse	sequences	parameters	for	ufSSFP	and	VIBE.	
	
Parameter	 ufSSFP	 VIBE	
TR	/	TE	 1.43	/	0.61	ms	 4.0	/	1.05	ms	
Flip	angle	α	 35°	 10°	
Bandwidth	 1563	Hz/pixel	 580	Hz/pixel	
Acquisition	plane	 Coronal	 Transversal	
Field	of	View	(FoV)	 400×400×280	mm3	 280×400×360	mm3	
Matrix	 160×160×112	 112×160×112	
Resolution	 2.5×2.5×2.5	mm3	 2.5×2.5×3	mm3	a	
Slice	resolution	 100%	 80%	
Phase	oversampling	 30%	 0	
Phase	partial	Fourier	 8/8	(6/8)	b	 6/8	
Slice	partial	Fourier	 8/8	 6/8	
GRAPPA	factor	 2	 2	
Acquisition	time	 15	s	(11	s)	b	 17	s	
a	Interpolated	to	1.25×1.25×3	mm3.	
b	Acquisition	time	can	be	shortened	by	technicians	for	patient	examination,	if	
necessary.	
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works	[157,	196].	Signal	preservation	by	the	image	registration	was	analyzed	by	comparing	the	
whole-lung	signal	before	and	after	 image	registration.	A	schematic	summary	of	 the	proposed	
method	is	shown	in	the	Figure	6.1.	
	
	
Figure	6.1.	Schematic	of	 the	post-processing	 for	
signal	enhancement	ratio	(SER)	imaging.	Pre-con-
trast	 (Vol1)	 and	 post-contrast	 (Vol2)	 volumetric	
datasets	are	first	registered	(a)	to	match	the	lung	
structures	(e.g.,	diaphragm	positions	and	vessels).	
Successively,	the	datasets	are	median	filtered	(b)	
to	 remove	 vasculature	 and	 to	 get	 access	 to	 the	
parenchymal	signal.	(c)	Pulmonary	SER-maps	are	
finally	calculated	(see	“Method”	Section	6.2.4).	
	
	
	
	
	
	
	
	
	
	
	
	
	
6.2.5	 Visual	and	quantitative	data	analysis	
	
To	analyze	the	difference	between	VIBE	and	ufSSFP-SER	imaging,	five	volumetric	regions	of	in-
terest	 (ROI)	were	manually	 segmented	 in	every	subject	comprising	 the	whole	 lung	 (excluding	
large	vessels),	the	aortic-arch	blood	pool,	the	whole	liver	(excluding	large	vessels),	muscles	(sub-
scapularis,	 pectoralis),	 and	 subcutaneous	 thoracic	 fat.	 Figure	 6.2	 shows	 an	 exemplary	
segmentation	of	these	ROIs.	For	every	ROI	and	every	individual,	the	mean	value	and	standard	
deviation	(SD)	of	the	SER	were	computed.	From	these,	the	group	mean,	the	intersubject	SD	(in-
terindividual	deviation	 from	the	group	mean)	and	pooled	 intrasubject	SD	 (square	 root	of	 the	
average	variance)	were	calculated.	The	coefficient	of	variation	(ratio	of	pooled	intrasubject	SD	
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and	group	mean)	was	also	calculated	for	the	lung	ROI.	Statistical	significances	were	determined	
using	Wilcoxon	signed-rank	paired	test.	
	
The	robustness	(artifact	behavior)	of	SER	imaging	was	assessed	in	the	control	cohort	by	a	board	
certified	radiologist	and	nuclear	medicine	physician	(G.S.,	9	years	of	clinical	experience).	The	ra-
diologist	scored	on	the	SER	images,	for	every	lung	lobe,	the	percentage	of	volume	affected	by	
artifacts	(score	0,	no	artifacts;	score	1,	1-25%	of	lobe	volume;	score	2,	26-50%;	score	3,	51-75	%;	
and	score	4,	76-100%).	Statistical	significance	between	ufSSFP-SER	and	VIBE-SER	artifact	scoring	
was	determined	using	Wilcoxon	signed-rank	paired	test.		
	
For	 the	 COPD	 patients,	 ufSSFP-SER	 of	 the	 lung	 was	 compared	 to	 99mTc-MAA-SPECT/CT.	
To	this	end,	a	radiologist	and	nuclear	medicine	physician	(G.S.)	visually	scored	on	SPECT/CT,	for	
every	lung	lobe,	the	extent	of	visible	perfusion	deficits	as	percentage	of	the	lobar	volume	(score	
0,	no	defects;	score	1,	1-25%	of	lobe	volume	affected;	score	2,	26-50%;	score	3,	51-75%;	score	4,	
76-100%).	The	same	scoring	was	performed	for	the	ufSSFP-SER	images	by	a	second	board	certi-
fied	radiologist	(J.B.,	20	years	of	clinical	experience).	Intermodality	agreement	was	calculated	by	
Cohen's	kappa	coefficient	using	both	linear	and	quadratic	weighting	(kl	and	kq,	respectively)	[200,	
201].	
For	the	NSIP	and	the	trauma	patients,	ufSSFP-SER	images	were	visually	correlated	with	morpho-
logical	MR	and	/	or	CT	by	a	radiologist	(G.S.).	
	
Image	post-processing	and	statistical	analysis	were	performed	with	Matlab	(Mathworks,	Natick,	
MA,	USA)	by	three	physicists	experienced	in	medical	imaging	(O.P.,	G.B.	and	F.S.,	with	3,	9	and	
11	years	of	experience).	
	
	
Figure	6.2.	Exemplary	ufSSFP	coronal	view	indicating	rep-
resentative	 volumetric	 region	 of	 interests	 of	 the	 lung	
(depicted	in	red,	volume	=	2716	cm3),	aortic	arch	(pink,	21	
cm3),	 liver	 (green,	 1322	 cm3),	muscle	 (yellow,	 174	 cm3)	
and	fat	(blue,	125	cm3).	
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6.3	 Results	
	
6.3.1	 Signal	enhancement	in	the	control	group	
	
In	all	subjects,	ufSSFP	and	VIBE	scans	provided	diagnostic	image	quality	and	allowed	the	deriva-
tion	of	static,	volumetric,	SER	images.	Imaging	was	performed	in	inspiratory	breath-holding	and	
thus	in	similar	breathing	phases.	As	a	result,	image	registration	was	successful	in	all	cases.	Lung	
signal	intensity	was	not	affected	by	the	registration,	deviating	by	-2.7%	to	2.9%	(min,	max)	for	
ufSSFP	(mean±SD	=	0.8%±1.9%),	and	by	-5.4%	to	6.2%	(0.3%±4.3%)	for	VIBE.	No	patient	was	ex-
cluded	from	the	analysis.	
	
A	side-by-side	comparison	of	ufSSFP	and	VIBE	pre-	and	post-contrast	images	(maximum	intensity	
projection)	 is	presented	in	Figure	6.3	for	a	representative	subject	from	the	control	cohort	(no	
lung	disease).	As	compared	to	non-enhanced	imaging	(Figs.	6.3a	and	c),	after	contrast	admin-
istration	 both	 VIBE	 and	 ufSSFP	 show	 a	 clear	 signal	 increase	 in	 the	 lung	 parenchyma	 and	
vasculature	 (Figs.	6.3b	and	d),	also	yielding	enhanced	morphological	details.	 In	both	pre-	and	
post-contrast	 imaging	with	ufSSFP	the	signal	of	 fine	vessels	and	parenchyma	 is	clearly	caught	
until	 the	very	periphery	of	 the	 lung	 (Figs.	6.3a	and	b);	especially	when	compared	 to	 the	dark	
background	signal	of	the	trachea.	In	contrast,	with	VIBE	almost	similar	signals	are	registered	in	
the	lung	periphery	and	trachea.	
	
Figure	6.4	shows,	for	a	subject	of	the	healthy	cohort,	native	ufSSFP	and	VIBE	images	pre-	and	
post-contrast	together	with	the	resulting	static	SER	images.	The	efficacy	of	median	filtering	on	
the	same	data	is	exemplary	shown	in	Figure	6.5.	In	this	subject	(Fig.	6.4),	the	average	lung	SER	
using	ufSSFP	(Fig.	6.4c)	was	96%±23%	(mean±SD),	appearing	homogeneous	on	iso-gravitational	
planes	(e.g.,	95%±13%	on	the	presented	coronal	slice	in	Fig.	6.4c),	but	revealing	an	increase	from	
non-dependent	(ventral,	e.g.,	83%±19%)	to	dependent	areas	(dorsal,	e.g.,	114%±19),	as	expected	
in	a	healthy	lung.	In	contrast,	VIBE-based	SER	images	of	the	same	subject	(Fig.	6.4f)	appear	highly	
inhomogeneous	with	a	considerably	lower	mean	whole	lung	SER	of	41%±28%.	Similar	results	are	
found	for	all	the	subjects	of	the	control	group	(three	of	them	exemplarily	shown	in	Fig.	6.6).		
	
For	the	ten	subjects	of	the	control	cohort,	group-averaged	SER	values	are	outlined	in	Table	6.2	
for	different	anatomical	regions.	For	ufSSFP,	the	SER	values	were	significantly	higher	in	the	lung	
parenchyma	(99%±9%,	mean±intersubject	SD)	than	in	the	blood	pool	(81%±7%,	P<10-3)	and	in	
other	tissues	(liver	33%±8%,	muscle	26%±5%,	fat	2%±1%).	As	a	consequence,	ufSSFP-SER	images	
reveal	an	improved	depiction	of	the	lung	parenchyma	(cf.	Fig.	6.4c).	In	contrast,	VIBE-based	SER	
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of	the	lung	was	significantly	lower	(P<10-3)	and	more	inhomogeneous	(mean	=	47%,	pooled	in-
trasubject	 SD	 =	 27%,	 cv	 =	 57%,	 P<10-3),	 as	 compared	 to	 ufSSFP-SER	 (mean	 =	 99%,	 pooled	
intrasubject	SD	=	23%,	cv	=	23%).	In	the	blood	pool,	however,	VIBE-SER	(164%±17%,	mean±inter-
subject	SD,	P<10-3)	was	twice	as	high	(ufSSFP-SER,	81%±7%).	
	
A	schematic	of	 the	artifacts	perceived	on	ufSSFP-SER	and	on	VIBE-SER	 images	 is	presented	 in	
Table	6.3.	Generally,	for	the	control	group,	ufSSFP-SER	images	were	broadly	homogeneous,	re-
vealing	only	limited	image	artifacts.	Overall,	for	ufSSFP,	none	of	the	SER	images	had	an	artifact	
scoring	above	2	(artifact	size	<50%	for	every	lung	lobe).	The	left	lower	lobe	of	the	lung	was	the	
region	most	prone	to	artifacts	caused	to	heart	beating	and	partial	volume	effects	(see	e.g.,	Fig.	
6.4c).	In	contrast,	VIBE-SER	of	the	lung	is	generally	prone	to	artifacts	and	signal	variations,	even	
in	the	absence	of	parenchymal	abnormalities.	The	average	score	of	the	artifacts	per	 lobe	was	
2.3±0.6	for	VIBE-SER,	and	0.6±0.4	for	ufSSFP-SER.	The	artifact	scoring	for	ufSSFP-SER	was	signifi-
cantly	lower	than	for	VIBE-SER	(P<10-12).	
	
Overall,	for	the	purpose	of	pulmonary	SER	imaging,	ufSSFP	outperformed	VIBE,	providing	an	ac-
centuated	 signal	 enhancement	 and	 visually	 homogeneous	 SER	 images	 (mean	 =	 99%,	 pooled	
intrasubject	SD	=	23%,	cv	=	23%)	with	a	reduced	intersubject	standard	deviation	among	the	col-
lective	of	subjects	with	healthy	lung	(mean	=	99%,	intersubject	SD	=	9%).	As	a	result,	only	the	
static	signal	enhancement,	as	observed	with	ufSSFP,	was	investigated	for	SER	imaging	in	patients.	
with	pulmonary	disease.	
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Figure	6.3.	Maximum	intensity	projection	(effective	slice	thickness	25	mm)	of	ufSSFP	(a,	b)	and	VIBE	(c,	d)	
before	(a,	c)	and	after	contrast	agent	injection	(b,	d)	in	a	26-year-old	male	subject	from	the	control	group.	
The	red	rectangles	indicate	regions	of	interests	in	the	lungs,	“zoomed”	on	the	right	of	the	figures;	in	blue	
is	marked	the	trachea,	“zoomed”	on	the	top-right	of	the	figures.	For	visual	comparison	of	the	signal	in-
crease	after	 contrast	administration,	 the	 same	windowing	 (logarithmic	 grey-scale)	 is	used	 for	pre-	and	
post-contrast	images	[(a,	b)	and	(c,	d)].	Both	sequences	allow	for	the	depiction	of	the	pulmonary	vascula-
ture.	The	 red	arrowheads	 (a)	 indicate	exemplarily	the	fissure	between	the	 lung	 lobes	[observable	 in	all	
images	a-d].	
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Table	6.2.	Comparison	of	the	observed	signal	enhancement	ratio	(SER)	for	ufSSFP	and	VIBE	for	different	
anatomical	regions	and	averaged	over	ten	subjects	from	the	control	group	(healthy	lung).	
	
SER,	mean	±	intersubject	SD	(pooled	intrasubject	SD)	[%]	
	 Lung	 Aorta	 Liver	 Muscle	 Fat	
ufSSFP	 99	±	9	(23)	 81	±	7	(8)	 33	±	8	(12)	 26	±	5	(6)	 2	±	1	(4)	
VIBE	 47	±	12	(27)	 164	±	17	(21)	 36	±	8	(5)	 22	±	3	(5)	 7	±	4	(3)	
	
	
Figure	6.4.	Comparison	of	ufSSFP	(a-c)	and	VIBE	(d-f)	for	a	representative	subject	from	the	control	group	
(female,	54	years	old).	Native	(non-registered)	pre-contrast	(a,	d)	and	post-contrast	datasets	(b,	e)	are	co-
registered	and	median-filtered	to	 calculate	signal	enhancement	 ratio	maps	 (c,	 f).	The	 same	windowing	
(grey-scale)	is	used	for	pre-	and	post-contrast	images	[(a,	b)	and	(d,	e)]	for	visual	comparison	of	the	signal	
increase	after	i.v.	contrast	administration.	SER	images	with	ufSSFP	appear	homogeneous	in	the	lung	[(c),	
SER	=	96%±23%,	cv	=	24%],	whereas	VIBE-based	SER	images	show	patchy	hyper-	and	hypo-intense	artifacts	
(e.g.,	green	and	blue	arrows)	[(f),	SER	=	41%±28%,	cv	=	86%].	SER	values	in	the	lung	increase	from	ventral	
to	dorsal,	as	depicted	 in	the	plots	[see	 left-lower	panel	 in	 (c,	 f)]	which	report	the	mean	SER	 in	the	 iso-
gravitational	planes	as	a	function	of	the	ventral-to-dorsal	distance.	Balanced	SSFP	“banding”	artifacts	are	
entirely	mitigated	 by	 the	 accelerated	 ufSSFP	 acquisition	 scheme	 (a,	 b).	 Different	 scaling	 was	 used	 for	
ufSSFP-SER	and	VIBE-SER	images	in	(c,	f);	in	(c),	the	yellow	arrowhead	shows	exemplarily	an	artifact	caused	
by	heart	pulsation.	In	both	VIBE	and	ufSSFP	 images	the	fissures	between	the	 lung	lobes	are	observable	
[e.g.,	sagittal	view	in	(b),	marked	by	red	arrowheads].		
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Figure	6.5.	Ultra-fast	SSFP	(a-d)	and	
VIBE	(e-h)	native	images	(a,	c,	e,	g)	
and	median	filtered	(b,	d,	 f,	h)	be-
fore	 (a,	 b,	 e,	 f)	 and	 after	 contrast	
agent	 injection	 (c,	d,	g,	h)	 in	a	54-
year-old	 female	 subject	 from	 the	
control	group.	Median	 filtering	 re-
moves	 vasculature,	 small	 airways	
and	noise	to	recover	the	underlying	
smooth	 parenchymal-background	
signal	variation.	The	same	window-
ing	 (greyscale)	 was	 used	 in	 (a-d)	
and	(e-h).		
	
	
	
	
	
	
	
	
	
	
Table	 6.3.	 Artifact	 evaluation	 (e.g.,	 pulsation,	 heart-beating,	 partial	 volume	 effects)	 per	 lung	 lobe	 for	
ufSSFP-SER	and	VIBE-SER	in	ten	subjects	from	the	control	group.	“No	artifact”	is	scored	0;	score	1	indicates	
that	1-25%	of	the	lobe	volume	is	affected	by	artifacts;	score	2,	26-50%;	score	3,	51-75	%;	and	score	4,	76-
100%.	No	scores	above	2	were	found	for	ufSSFP;	artifacts	in	the	lower	lobes	and	the	lingula	are	attributable	
to	cardiac	pulsation.	Average	score	of	the	artifacts:	2.3±0.6	for	VIBE-SER	and	0.6±0.4	for	ufSSFP-SER.	
	
Image	artifacts	for	ufSSFP-SER	and	VIBE-SER	divided	by	lung	lobe	(n	=	10	subjects).	
ufSSFP-SER	 	 VIBE-SER	
	 RU	 RM	 RL	 LU	 Lin	 LL	 	 	 RU	 RM	 RL	 LU	 Lin	 LL	
No	artifacts	 10	 7	 6	 9	 4	 –	 	 No	artifacts	 –	 1	 –	 –	 2	 –	
Score	1	 –	 1	 4	 1	 4	 5	 	 Score	1	 –	 –	 2	 –	 1	 2	
Score	2	 –	 2	 –	 –	 2	 5	 	 Score	2	 2	 7	 6	 3	 5	 5	
Score	3	 –	 –	 –	 –	 –	 –	 	 Score	3	 5	 1	 2	 6	 2	 3	
Score	4	 –	 –	 –	 –	 –	 –	 	 Score	4	 3	 1	 –	 1	 –	 –	
Abbreviations:	RU	=	right-upper	lobe;	RM	=	right-middle;	RL	=	right-lower;	LU	=	left-upper;	Lin	=	lingula;	LL	
=	left-lower.	
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Figure	6.6.	Side-by-side	comparison	of	signal	enhancement	ratio	imaging	with	ufSSFP	(a,	c,	e)	and	VIBE	(b,	
d,	f)	in	three	subjects	with	no	lung	disease	from	the	control	group	[(a,	b)	female	52	years	old,	(c,	d)	male	
28	years	old,	and	(e,	f)	male	43	years	old].	To	note,	the	color	maps	for	ufSSFP	and	VIBE	SER	are	differently	
scaled.	The	SER	in	the	lung	is	more	homogeneous	using	ufSSFP	than	using	VIBE	(cf.	Table	6.2).	Whole	lung	
mean	SER	values	were	97%±20%	[(a),	mean±SD],	116%±27%	(c),	101%±25%	(e)	for	ufSSFP;	55%±24%	(b),	
61%±31%	(d),	and	55%±27%	(f)	for	VIBE.	To	note,	in	the	region	of	the	heart,	due	to	pulsation	(and	thus	
partial-volume	effects	in	the	native	images)	the	SER	values	have	large	signal	variations	[cf.	sagittal	view	in	
(c)].	
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6.3.2	 Signal	enhancement	in	pathologic	lung	tissue	
	
The	radiological	potential	of	ufSSFP-SER	imaging	of	the	lung	was	evaluated	in	patients	with	pul-
monary	diseases	including	COPD,	lung	cancer,	pulmonary	fibrosis,	and	traumatic	lung	contusion.	
Imaging	with	ufSSFP	was	successful	for	all	patients,	who	could	perform	the	15s	long	breath-hold-
ing	maneuvers.		
	
Side-by-side	comparisons	of	morphological	ufSSFP,	ufSSFP-SER,	and	SPECT/CT	imaging	for	three	
representative	COPD	patients	are	shown	in	Figure	6.7,	Figure	6.8	and	Figure	6.9	(COPD	GOLD	II,	
COPD	GOLD	IV,	and	COPD	GOLD	III	with	lung	cancer,	respectively).	In	contrast	to	ufSSFP-SER	of	
the	control	group	(SER	=	99%±23%,	mean	±	pooled	intrasubject	SD),	ufSSFP-SER	of	the	lung	in	
the	seven	COPD	patients	was	characterized	by	an	overall	significantly	(P<10-3)	lower	signal	en-
hancement	and	significantly	 (P<10-3)	 larger	 inhomogeneities	 (SER	=	73%±33%,	mean	±	pooled	
intrasubject	SD,	cv	=	42%,	intersubject	SD	=	15%).	Visually,	there	was	a	moderate	to	strong	spatial	
correspondence	between	areas	of	 low	SER	and	regions	with	 low	radiotracer	uptake	on	99mTc-
MAA-SPECT	(see	Figs.	6.7,	6.8,	and	6.9).	Interestingly,	in	the	patient	with	NSCLC	(Figure	6.9)	the	
SER	in	the	tumor	(43%±8%)	was	lower	than	in	the	lung	parenchyma	(68%±24%).	
	
A	comparison	of	the	functional	defects,	assessed	for	the	COPD	patients,	with	ufSSFP-based	SER	
imaging	and	with	SPECT/CT	is	shown	in	Figure	6.10.	The	lobar	scoring	for	the	two	imaging	mo-
dalities	shows	that	SER	imaging	tends	to	underestimate	the	size	of	defects	in	COPD	compared	to	
SPECT/CT	(the	mean	score	of	defects	in	our	cohort	was	2.0±0.9%	for	ufSSFP-SER,	and	2.5±1.0%	
for	 SPECT);	 Cohen's	 kappa	 coefficients	 indicate	moderate	 intermodality	 agreement	 between	
SPECT/CT	and	ufSSFP-SER	(kl	=	0.41,	kq	=	0.64,	fair	agreement).	
	
The	clinical	potential	of	ufSSFP-based	SER	imaging	is	further	illustrated	in	a	NSIP	and	a	trauma	
patient	 in	Figures	6.11	and	6.12.	 In	 the	patient	with	NSIP	 (Fig.	6.11),	 the	 fibrotic	 lung	regions	
visible	on	the	morphological	MR	images	exhibit	a	streaky	decrease	in	SER	(67%±25%)	as	com-
pared	to	the	healthy	parenchyma	(99%±22%;	whole	lung	SER	=	96%±23%).	In	the	trauma	patient	
(Fig.	6.12),	a	hematoma	 is	visible	 inside	the	 lung	parenchyma	on	CT	and	post-contrast	ufSSFP	
images;	the	lesion	is	also	well	observable	on	ufSSFP-based	SER	maps,	and	reveals	a	strongly	re-
duced	SER	(34%±23%)	as	compared	to	the	healthy	lung	(110%±27%).	
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Figure	6.7.	Side-by-side	comparison	of	post-contrast	ufSSFP	(a),	ufSSFP-SER	(b),	and	99mTc-MAA	SPECT/CT	
fusion	images	(c)	in	a	61-year-old	male	patient	with	COPD	GOLD	II	and	emphysema.	There	is	an	extensive	
destruction	of	 the	right	 lung	of	 this	patient	by	emphysema	with	 large	confluent	bullae	 (green	arrows).	
Reduced	SER	is	also	seen	in	the	emphysematous	regions	in	the	left	lung	(blue	arrows)	with	apical	predom-
inance.	Spatial	coincidence	is	observed	between	areas	of	low	SER	in	ufSSFP	and	areas	of	low	radiotracer	
uptake	in	99mTc-MAA	SPECT.	The	whole	lung	SER	was	75%±42%	(mean±SD).	
	
	
	
	
	
	
Figure	6.8.	Comparison	of	post-contrast	ufSSFP	(a),	ufSSFP-SER	(b),	and	99mTc-MAA	SPECT/CT	fusion	images	
(c)	in	a	70-year-old	male	patient	with	COPD	GOLD	IV.	In	this	patient,	a	more	uniform	distribution	of	em-
physema	compared	to	the	patients	presented	in	Figure	6.7	and	Figure	6.9	was	observed.	A	homogenous	
but	still	patchy	decrease	in	SER	is	noted	(whole	lung	SER	=	57%±28%,	mean±SD).	Again	there	is	a	good	
visual	agreement	between	ufSSFP-SER	imaging	and	SPECT/CT,	e.g.,	in	the	regions	of	bullous	emphysema	
in	the	apices	(green	arrows).	In	(b),	a	pulsation	artifact	from	the	heart	is	indicated	by	the	yellow	arrowhead.		
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Figure	6.9.	Comparison	of	post-contrast	ufSSFP	(a),	ufSSFP-SER	(b),	and	99mTc-MAA	SPECT/CT	fusion	images	
(c)	in	a	57-year-old	female	patient	with	COPD	GOLD	III	and	an	NSCLC	in	the	right	upper	lobe	(green	arrows).	
There	is	extensive	inhomogeneity	of	SER	in	the	lung	parenchyma	of	this	patient	due	to	COPD	(exemplary	
impairments	depicted	by	blue	arrows)	with	spatial	coincidence	of	the	defects	observed	with	ufSSFP-SER	
and	99mTc-MAA-SPECT.	The	whole	lung	SER	was	68%±24%	(mean±SD).	To	note,	the	solid	tumor	in	the	right	
upper	lobe	of	this	patient	shows	lower	SER	than	the	surrounding	lung	parenchyma	(43%±8%).	In	(b),	the	
SER	scale	was	optimized	to	facilitate	visualizations	of	functional	impairments.	The	yellow	arrowheads	in	
(a,	b)	 indicate	a	blurring	artifact,	caused	by	a	minute	diaphragm	movement	due	to	non-perfect	breath-
holding	during	imaging.		
	
	
	
	
Figure	6.10.	Functional	defects	per	lung	lobe	in	seven	COPD	patients	evaluated	with	ufSSFP-SER	and	with	
99mTc-MAA	SPECT/CT.	Score	0	indicates	no	defects;	score	1,	1-25%	of	lobe	volume	is	affected;	score	2,	26-
50%;	score	3,	51-75%;	score	4,	76-100%.	The	lobar	scoring	for	the	two	imaging	modalities	differed	up	to	2	
units	and	showed	moderate	intermodality	agreement	with	SPECT/CT	(Cohen's	kappa	kl	=	0.41,	kq	=	0.64).	
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Figure	6.11.	Post-contrast	ufSSFP	images	(a),	and	ufSSFP-SER	images	(b)	in	a	58-year-old	female	patient	
with	scleroderma	and	NSIP.	A	streaky	decrease	in	SER	is	noted	in	both	lower	lobes	corresponding	to	fibrotic	
changes	seen	on	morphological	MRI	(green	arrows).	
	
	
	
	
	
Figure	6.12.	CT	(a),	post-contrast	ufSSFP	(b),	and	ufSSFP-SER	images	(c)	in	a	71-year-old	male	patient	after	
traumatic	lung	injury.	The	green	arrow	indicates	a	subpleural	hematoma	in	the	lung	parenchyma	of	the	
right	lower	lobe.	In	the	SER	images	(c),	in	comparison	to	the	normal	lung	(SER	=	110%±27%,	mean±SD)	the	
hematoma	shows	a	reduced	enhancement	(SER	=	34%±23%,	mean±SD).	The	red	arrowhead	on	the	SER	
map	(coronal	view)	indicates	an	artifact	caused	by	pulsation.	
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6.4	 Discussion	
	
From	the	shortened	TR,	as	compared	to	contemporary	bSSFP	methods	[108],	ufSSFP	[45]	offers	
banding-free	chest	imaging	at	1.5T	and	has	shown	promising	result	for	morphological	and	func-
tional	 investigations	 [33,	 45,	 47,	 144,	 157,	 196,	 197].	 In	 this	 work,	 we	 have	 extended	 the	
prospects	of	ufSSFP	imaging	to	the	diagnosis	of	functional	abnormalities	of	the	pulmonary	pa-
renchyma	in	combination	with	the	administration	of	an	intravenous	contrast	agent.	In	contrast	
to	 the	common	consensus	 that	bSSFP	sequences	are	 insensitive	 to	contrast	agents	 [108],	 the	
ufSSFP	signal	can	be	notably	increased.	In	fact,	in	the	post-contrast	ufSSFP	images,	the	signal	of	
lung	tissue	doubles,	revealing	the	highest	increase	amongst	all	captured	organs	and	the	blood	
pool.		
	
It	might	be	interesting	to	note	that	the	signal	of	coherent	SSFP,	such	as	balanced	SSFP	(and	thus	
ufSSFP),	scales	with	T1/T2	[45,	108,	163],	whereas	the	signal	of	incoherent	SSFP,	such	as	VIBE,	is	
predominantly	weighted	by	T1.	From	this,	especially	in	the	limit	of	large	T1/T2	as	for	the	lung	(T1/T2	
~	1375/66	[ms],	cf.	[197]),	a	similar	signal	enhancement	would	be	expected	for	both	methods.	
Overall,	ufSSFP,	however,	revealed	to	be	markedly	superior	to	VIBE.	This	is	most	likely	caused	by	
the	low	SNR	of	VIBE	for	lung	tissue,	as	a	result	of	the	rather	long	echo	time	(TE)	for	DCE-MRI	not	
being	adapted	to	the	short	T2*	of	the	lung.	As	a	result,	VIBE	acquisitions	with	considerably	short-
ened	TE,	or	alternatively	ultra-short	echo	time	sequences	[42,	43],	might	lead	to	an	improvement	
for	lung	SER	imaging;	especially	at	higher	field	strength	where	susceptibilities	effects	still	 limit	
the	applicability	of	ufSSFP	[144].	
	
Overall,	ufSSFP-SER	images	provide	a	highlighted	throughout	depiction	of	the	lung	parenchyma.	
This	is	in	contrast	to	SER	images	derived	from	VIBE	that	were	flawed	even	in	the	control	cohort	
of	subjects	with	no	pulmonary	disease	by	prominent	signal	variations	in	the	absence	of	paren-
chymal	 abnormalities.	 Moreover,	 ufSSFP-SER	 images	 of	 healthy	 lung	 tissue	 appeared	 iso-
gravitationally	homogeneous,	but	with	a	prominent	gravitational-related	gradient	increasing	the	
signal	from	ventral	to	dorsal	lung,	in	accordance	with	literature	[66,	136,	202].	In	the	COPD	pa-
tients,	ufSSFP-SER	images	were	characterized	by	marked	inhomogeneities,	that	coincided	with	
the	functional	defects	seen	on	99mTc-MAA-SPECT	(moderate	intermodality	agreement	k).	In	the	
NSIP	patient,	a	decrease	in	SER	values	was	noted	for	the	fibrotic	regions	of	the	lung,	correspond-
ing	well	to	morphological	MR.	Similarly,	in	the	trauma	patient,	the	SER	images	were	sensitive	in	
detecting	a	lung	hematoma.	
	
We	observed	a	moderate	intermodality	agreement	between	SPECT/CT	and	static	ufSSFP-SER	in	
the	lobe-by-lobe	evaluation	of	the	COPD	patients.	This	result	may	be	affected	by	the	fact	that	
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the	methods	of	image	acquisition	for	SPECT,	in	free	breathing,	and	for	ufSSFP,	in	breath-hold,	
differ	substantially.	Furthermore,	while	SPECT/CT	is	known	to	reflect	99mTc-MAA	lodged	in	the	
capillaries	(and	not	in	the	extravascular	parenchyma)	thanks	to	arterial	perfusion,	the	exact	an-
atomic	and	physiological	origin	of	the	signal	enhancement	observed	in	the	lung	with	ufSSFP	is	
unknown.	From	our	preliminary	data,	we	hypothesize	that	this	effect	is	primarily	related	to	the	
smaller	vasculature	of	both	the	arterial	and	venous	side	of	the	capillary	beds	and	may	addition-
ally	 include	 also	 parenchymal	 tissue	 contrast	 as	 a	 sort	 of	 “delayed	 enhancement”.	 The	 final	
answer	to	this	question,	however,	cannot	be	given	by	this	feasibility	study	and	requires	further	
investigation.		
	
While	 the	 obtained	 results	 with	 ufSSFP-SER	 imaging	 in	 patients	 appear	 promising,	 we	
acknowledge	that	the	administration	of	contrast	agent	might	not	be	indicated	for	some	catego-
ries	 of	 subjects	 (e.g.,	 in	 case	 of	 renal	 failure	 or	 allergy).	 Furthermore,	 the	 current	 approach	
requires	short	breath-holding	maneuvers,	which	sometimes	may	not	be	feasible	(e.g.,	in	infants),	
but	might	be	overcome	by	using	self-navigated	free-breathing	methods	[156].	Similarly,	residual	
motion	artifacts	 spotted	on	SER	 images	can,	 in	principle,	be	addressed	with	cardiac-triggered	
acquisitions,	but	only	at	the	cost	of	scanning	efficiency.		
	
It	may	be	perceived	as	a	limitation	of	the	present	study	that	the	signal	enhancement	of	ufSSFP	
was	not	 investigated	dynamically	at	several	time-points	after	contrast	agent	 injection,	as	per-
formed	with	traditional	DCE-MRI.	Resolving	dynamic	contrast	enhancement	with	ufSSFP	requires	
an	adaptation	of	the	sequence,	e.g.,	using	view-sharing	methods	[203].	This	will	be	subject	of	
future	investigation.	Another	focus	of	ongoing	development	will	be	attempting	to	suitably	stand-
ardize	the	measurement	(e.g.,	hardware,	parameters,	post	processing,	reproducibility).	 In	this	
context	quantitative	SER	imaging	might	automatically	identify	lung	defects	lobe-by-lobe,	for	in-
stance	 by	 using	 algorithms	 involving	 adaptive	 k-means	 thresholding	 [204]	 of	 the	 SER	 signal-
distributions,	and	segmentation	pipelines	as	presented	by	Tustison	et	al.	[154]	or	using	machine	
learning.		
	
Another	limitation	of	our	work	is	that	the	group	of	patients	with	pulmonary	pathology	is	small.	
Hence,	our	study	only	demonstrates	the	technical	feasibility	of	pulmonary	ufSSFP-SER	imaging	in	
some	of	the	most	common	pulmonary	disease	conditions	associated	with	respiratory	discomfort	
(eight	of	the	included	patients,	except	the	trauma	patient,	had	impaired	pulmonary	function	with	
an	FEV1	of	20%-75%	of	normal).	We	cannot	yet	provide	any	validation	of	ufSSFP-SER	imaging	in	
terms	of	its	diagnostic	role	for	specific	diseases.	To	this	end,	further	prospective	investigation	of	
the	method	in	a	larger	collective	of	subjects	and	against	standard	functional	imaging	methods,	
such	as	DCE-MRI	with	high	temporal	resolution	and	SPECT/CT,	is	required.	
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6.5	 Conclusion	
	
Following	intravenous	injection	of	gadolinium-based	contrast	agents	the	signal	of	ufSSFP	is	in-
creased	 in	 the	 lung	 parenchyma.	 In	 combination	 with	 a	 pre-contrast	 native	 acquisition	 and	
specific	post-processing,	ufSSFP-based	SER	imaging	offers	an	improved	depiction	of	the	pulmo-
nary	parenchyma.	Preliminary	findings	in	patients	show	plausible	patterns	of	signal	distribution	
for	different	pulmonary	diseases.	Added	as	a	complement	to	common	contrast-enhanced	MRI	
protocols	(e.g.,	DCE-MRI),	ufSSFP-SER	imaging	may	thus	provide	helpful	complementary	infor-
mation	about	the	functional	abnormalities	of	the	lung	parenchyma	from	only	two	rapid	breath-
hold	scans.	Its	clinical	benefit,	particularly	in	comparison	to	99mTc-MAA-SPECT/CT	and	DCE-MRI,	
remains	to	be	further	investigated.	
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7.1	 Summary	
	
Within	the	scope	of	this	thesis,	a	variety	of	methods	for	improved	pulmonary	functional	imaging	
using	ufSSFP	acquisition	schemes	have	been	developed.	These	techniques	have	been	evaluated	
in	proof-of-principle	studies;	in	healthy	subjects	and	patients	with	different	pulmonary	diseases.	
The	most	important	results	are	discussed	here	in	detail;	accentuating	the	potential	and	limita-
tions,	as	well	as	advantages	and	disadvantages	of	every	method.		
	
Chapter	2.	For	FD-MRI,	from	the	shortened	TR,	ufSSFP	yielded	considerable	signal	increase	com-
pared	to	conventional	bSSFP.	Furthermore,	the	proposed	protocol	demonstrated	mitigation	of	
artifacts	related	to	pulsation	and	off-resonance,	resulting	in	a	general	improved	image	quality.	
At	1.5	Tesla,	 FD-MRI	has	 reliably	provided	perfusion-	and	ventilation-related	maps	 in	healthy	
volunteers,	strengthening	the	potential	of	this	method	to	add	diagnostic	information	for	clinical	
imaging.	In	contrast,	at	3	Tesla,	residual	off-resonance	bandings	arising	from	increased	suscepti-
bility	effects	were	observed	to	affect	the	quality	of	the	acquired	images.	The	drawback	of	FD-
MRI	is	its	limitation	to	2D	acquisitions	and	as	a	consequence	the	out-of-plane	organ	motion	might	
reduce	the	quality	of	the	functional	maps.		
	
Along	with	an	ameliorated	algorithm	to	separate	the	signal	modulations	given	by	heart	pulsation	
and	 lung	 ventilation,	 denoted	Matrix	 Pencil	 (MP)	 decomposition	 [104],	 FD-MRI	 has	 recently	
shown	clinical	potential	[33]	for	quantifying	the	ventilation	and	perfusion	impairments	in	chil-
dren	with	cystic	fibrosis.	FD-MRI	 is	of	special	benefit	 for	the	 longitudinal	monitoring	of	young	
patients	since	it	 is	feasible	with	simple	free-breathing	acquisitions,	without	contrast	agent	ad-
ministration,	and	it	does	not	require	any	ionizing	radiation.		
	
Chapter	3.	Rapid	3D	α-mapping	has	shown	to	provide	quantitative	information	about	lung	ven-
tilation	with	an	isotropic	resolution,	suited	for	clinical	diagnostic.	As	expected	from	the	exploited	
lung	model	and	the	resulting	insensitivity	of	the	parameter	α	to	the	lung	breathing	phases	and	
lung	density,	α-mapping	showed	good	reproducibility	in	healthy	volunteers.	In	patients	with	pul-
monary	diseases	(CF	and	COPD),	the	functional	impairments	observed	on	α-maps	proved	to	be	
directly	associated	to	the	defects	present	on	FD-MRI,	DCE-MRI,	and	CT.	Furthermore,	in	the	Ad-
dendum	to	Chapter	3,	it	was	observed	that	α-mapping	is	feasible	in	children	with	CF	(6-17	years	
old)	and	that	the	percentage	of	respiratory	impairments	quantified	with	α-mapping	are	strongly	
correlated	with	the	lung	clearing	index	(LCI),	a	nitrogen	multiple-breath	washout	outcome	pa-
rameter	describing	whole-lung	ventilation	inhomogeneity	[118].		
	
Requiring	only	5	breath-hold	acquisitions,	α-mapping	offers	quantitative	3D	ventilation	imaging	
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with	scan	times	of	only	2-3	min.	Nevertheless,	the	clinical	applicability	of	α-mapping	is	hampered	
by	the	need	for	manual	lung	segmentation,	which	is	used	to	retrieve	the	lung	volume	and	thus	
required	to	calculate	α.	This	limitation	could	possibly	be	eliminated	by	developing	dedicated	au-
tomatic	segmentation	algorithms,	e.g.,	based	on	neural	networks	(deep	learning),	as	currently	
being	investigated	[205].		
	
The	 proposed	 approach	 for	 α-mapping	 requires	 short	 breath-holding	manoeuvres	 (10-15	 se-
conds),	which	may	not	always	be	feasible	for	all	patients.	Furthermore,	in	this	work,	α-maps	were	
calculated	from	5	volumetric	datasets	acquired	at	different	lung	inspiratory	breath-hold	levels	
(capacity).	However,	 the	calculation	of	 the	parameter	α	 from	even	more	 inspiratory	volumes	
would	 be	 statistically	 beneficial.	 Alternatively,	 free-breathing	 ufSSFP	 acquisitions	 could	 be	
adopted	for	α-mapping	[156,	206].	However,	to	date,	free-breathing	techniques	require	long	ac-
quisition	times	exceeding	5	to	15	minutes	for	multi-volumetric	imaging.	For	similar	scan	times,	
FD-MRI	provides	not	only	ventilation-weighted,	but	also	perfusion-weighted	imaging,	and	blood	
arrival	time	maps,	and	may	thus	be	preferred	over	free-breathing	α-mapping.	
	
Chapter	4.	Three-dimensional	oxygen	enhancement	maps	were	calculated	from	multi-volumet-
ric	ufSSFP	acquisitions	in	healthy	volunteers.	The	oxygen	enhancement	in	the	whole	lung	using	
ufSSFP	was	found	to	be	on	average	7%.	The	use	of	the	lung	model	proved	to	mitigate	residual	
density	modulations,	thus	offering	accurate	and	robust	oxygen	enhancement	quantification.	In-
terestingly,	a	similar	correction	for	residual	density	modulations	in	OE-MRI	has	successively	been	
proposed	for	3D	OE-MRI	using	UTE	imaging	[56].	
	
As	ufSSFP	OE-MRI	is	based	on	multi-volumetric	breath-hold	imaging,	the	limitations	are	similar	
to	the	one	previously	described	for	α-mapping	(Chapter	3).	In	general,	OE-MRI	requires	meas-
urements	 in	 both	 normoxic	 and	 hyperoxic	 conditions,	 therefore	 doubling	 the	 scan	 time	 and	
hampering	the	transition	to	clinical	settings.	Moreover,	oxygen	 is	delivered	with	a	 face	mask,	
which	might	not	be	well	tolerated	by	some	individuals.	Nevertheless,	the	use	of	oxygen	as	an	
endogenous	contrast	agent	remains	appealing	for	specific	physiological	studies.	
	
Chapter	5.	Dynamic	and	steady-state	oxygen-dependent	lung	relaxometry	using	IR-ufSSFP	was	
evaluated	in	healthy	subjects.	On	average,	oxygen-breathing	shortened	the	whole	lung	T1	by	8%	
(statistically	significant),	however,	no	significant	changes	in	T2	were	observed.	The	technique	al-
lowed	to	map	∆T1	(shortening	of	T1	after	hyperoxia),	as	well	as	the	oxygen	wash-in	and	wash-out	
time	constant,	related	to	the	T1	rate	of	change.		
	
A	limitation	of	the	technique	is	its	restriction	to	image	only	one	slice	per	breath-hold	(9	seconds).	
Nevertheless,	considering	that	8	coronal	slices	would	be	sufficient	to	cover	the	majority	of	the	
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lung,	it	appears	feasible	to	calculate	whole-lung	∆T1	maps	in	clinically	acceptable	times	(about	
10-15	min,	considering	5	min	of	oxygen	wash-in).	On	the	other	hand,	for	dynamic	oxygen-en-
hanced	relaxometry,	continuous	imaging	of	the	same	slice	(~15	min)	is	needed.	This	would	result	
in	an	intolerable	measurement	time	to	cover	the	whole	lung.	A	considerably	reduced	scan	time	
might	be	achieved	by	combining	IR-ufSSFP	with	simultaneous	multi-slice	imaging.	
	
OE-relaxometry	provides	maps	related	to	a	mixed	pulmonary	 function	comprising	ventilation,	
perfusion,	as	well	as	diffusion	(i.e.,	oxygen	uptake	from	the	alveolar	air	space	to	the	pulmonary	
blood).	It	has	thus	the	potential	to	add	additional	information	to	ventilation-weighted	and	per-
fusion-weighted	 imaging	modalities	 such	 as	 FD-MRI.	 Further	 evaluation	of	OE-relaxometry	 in	
large	cohorts	is	required	to	establish	its	radiological	value,	e.g.,	for	the	assessment	of	focal	de-
fects	and	the	quantification	of	lung	function	impairment.	
	
Chapter	6.	Static	SER-mapping	of	the	lung	with	ufSSFP	was	found	to	outperform	VIBE	and	deliv-
ered	high-quality	images	suited	for	diagnostic	radiology.	The	ufSSFP-SER	in	the	lung	(99%)	was	
higher	 than	 in	 the	 blood	 and	 other	 tissues,	 accentuating	 the	 visualization	 of	 the	 lung	 paren-
chyma.	 In	 healthy	 lung,	 SER-maps	 were	 homogeneous	 while	 in	 patients,	 the	 impairments	
quantified	 on	 SER-maps	 coincided	 well	 with	 the	 functional	 defects	 identified	 on	 99mTc-MAA-
SPECT	data	(fair	intermodality	agreement).	
	
Imaging	for	SER-mapping	was	performed	in	inspiratory	breath-hold;	once	before	and	once	after	
contrast	agent	administration.	Since	the	signal	increase	as	induced	by	the	contrast	agent	(~100%)	
is	at	least	one	order	of	magnitude	larger	than	possible	density	modulations	(<	5-10%)	caused	by	
the	non-perfect	 reproducibility	of	 the	breath-hold	 inspiratory	 levels,	density	corrections	were	
not	required	(cf.	Chapters	3	and	4).	As	many	other	techniques,	SER-mapping	is	not	a	quantitative	
measurement,	but	a	relative	measurement	and	hence	requires	normative	values	as	comparison.	
	
Three-dimensional	ufSSFP	requires	breath-holding	manoeuvres	that	might	be	challenging	or	im-
possible	to	perform	for	some	subjects	(e.g.,	infants),	but	this	limitation	might	be	overcome	by	
free-breathing	acquisitions	 (e.g.,	 self-navigated).	Another	disadvantage	of	SER-mapping	 is	 the	
need	for	Gadolinium-based	contrast	agents,	which	are	not	indicated	in	patients	with	renal	fail-
ure,	children,	pregnant	women,	or	when	 frequent	 follow-up	 imaging	 is	desired.	Furthermore,	
contrast	agents	might	cause	allergic	reactions	and	deposits	in	the	tissues,	with	yet	unknown	ef-
fects	 to	 the	 body	 [122,	 207].	 However,	 SER-mapping	 can	 easily	 be	 included	 into	 common	
contrast-enhanced	MR	protocols	and	has	clinical	potential	for	routine	application.	It	allows	map-
ping	perfusion-related	physiological	processes	of	 the	 lung	parenchyma	from	only	 two	breath-
hold	acquisitions	(each	taking	10-15	seconds),	which	in	turn	provide	3D	morphological	clinical	
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imaging	with	2.5	mm	isotropic	resolution	usable	for	the	differential	diagnosis	and	disease	assess-
ment	[47].	
	
	
7.2	 Future	work	
	
To	further	advance	functional	lung	MRI	based	on	ufSSFP,	future	investigations	are	required	with	
focus	on	the	implementation	of	improved	acquisitions	schemes	as	well	as	on	the	clinical	evalua-
tion	and	validation	of	the	proposed	techniques.	Particular	emphasis	needs	to	be	placed	on	the	
automatization	of	our	methods	for	the	online	quantification	of	functional	and	morpho-patholog-
ical	biomarkers.	
	
7.2.1	 Implementation	of	new	acquisition	schemes	
	
3D	ufSSFP	is	still	 limited	by	breath-holding	manoeuvres,	which	might	not	be	well	tolerated	by	
some	individuals.	To	overcome	this	limitation,	a	free-breathing	multi-slice	2D	ufSSFP	acquisition	
scheme	or	a	3D	self-navigated	stack-of-stars	ufSSFP	sequence	with	parallel	imaging	and	iterative	
reconstruction	 may	 be	 adopted	 for	 morpho-functional	 imaging.	 Preliminary	 results	 are	 pre-
sented	in	Refs.	[156,	206]	and	exemplarily	shown	here	in	Figure	7.1	for	the	case	of	free-breathing	
multi-slice	2D	ufSSP.	
	
SER-mapping	 has	 proven	 that	 the	 signal	 of	 ufSSFP	 sequences	 can	 be	 increased	 considerably	
through	gadolinium	injection.	It	is	thus	appealing	to	develop	a	three-dimensional	time-resolved	
ufSSFP	sequence	for	dynamic	contrast-enhanced	imaging,	e.g.,	using	k-space	undersampling	and	
view-sharing	[203].	
	
Particularly	for	3T	imaging,	field	inhomogeneities	might	adversely	affect	ufSSFP	image	quality	(cf.	
Fig.	2.4),	yielding	banding	artifacts	and	reduced	signal	due	to	off-resonances.	To	this	end,	 im-
proved	shimming	techniques	might	be	adopted,	as	well	as	new	acquisition	schemes	as	currently	
being	investigated	[208].	
CHAPTER	7	
	 129	
	
7.2.2	 Clinical	evaluation	and	validation	
	
FD-MRI	has	already	been	validated	against	3He-MRI	as	well	as	DCE-MRI,	and	is	becoming	a	rele-
vant	 clinical	 method	 for	 the	 longitudinal	 quantification	 of	 ventilation-perfusion	 defects	 in	
children	with	CF.	The	emphasis	of	future	studies	should	therefore	be	on	the	assessment	of	its	
reproducibility	and	broad	application	across	diverse	patient	groups.	Moreover,	FD-MRI	may	be	
applied	to	study	the	effects	of	drugs	such	as	bronchodilators.	
	
3D	α-mapping	has	shown	promise	to	quantify	ventilation	impairments	in	a	small	cohort	of	chil-
dren	with	CF	while	SER	mapping	showed	initial	potential	in	COPD	patients.	Future	work	may	thus	
concentrate	on	the	investigation	of	their	radiological	outcome	in	large	cohorts	of	patients	and	
against	other	functional	techniques	such	as	FD-MRI	or	DCE-MRI.	The	applicability	of	the	proposed	
methods	can	also	be	expanded	to	investigate	pulmonary	physiological	alterations	in	cardiac	dis-
eases	 (e.g.,	 congestive	 heart	 failure).	 Moreover,	 3D	 ufSSFP	 OE-MRI,	 and	 OE	 pulmonary	
relaxometry	may	be	studied	in	children	with	CF.	
	
	
Figure	7.1.	Sagittal	(maximum	intensity	projection,	MIP	=	10	mm)	and	coronal	(MIP	=	20	mm)	views	of	3D	
ufSSFP	(a)	in	breath-holding	(15	seconds)	and	2D	multi-slice	ufSSFP	(b)	in	free-breathing	(coronale	orien-
tation,	5	min	scan	time	to	obtain	48	volumetric	datasets).	Respiratory-maps	(a),	lung	deformation	field	(b)	
and	Jacobian	expansion	(c)	resulting	from	the	free-breathing	imaging.	The	respiratory	index	represents	the	
expansion	of	each	voxel	as	a	function	of	the	mean	lung	expansion	(cf.	Chapter	3).	The	deformation	field	
indicates	the	direction	and	strength	of	motion	dynamic	from	expiration-to-inspiration	phases.	The	deter-
minant	of	the	Jacobian	(Jac)	is	a	voxel-wise	estimation	of	lung	expansion/compression:	if	Jac>1,	the	local	
tissue	expands	(e.g.,	for	Jac	=	2,	its	size	was	doubled	from	expiration-to-inspiration),	and	Jac<1	represents	
tissue	contraction.	
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7.2.3	 Quantification	and	automatization	
Future	work	will	include	the	quantification	of	the	disease	with	the	presented	techniques	by	stud-
ying	the	extent	of	pathological	pulmonary	tissue	and	function	alterations.	To	this	end,	algorithms	
involving	adaptive	k-means	 thresholding	 [204]	 for	data	clustering	combined	with	multivariate	
data	analysis	[209]	may	be	investigated	to	evaluate	simultaneously	many	variables	and	patterns	
in	the	data.	
	
Of	particular	importance	for	future	studies	is	the	development	of	automatized	procedures	using	
deep	learning	approaches	with	both	recurrent	and	convolutional	neural	networks	[210,	211].	In	
preliminary	work,	an	approach	involving	a	neural	network	of	multi-dimensional	gated	recurrent	
units	 [212]	 is	 employed	 to	 automatize	 the	process	 of	 lung	 segmentation	 (see	 Fig.	 7.2)	 [205],	
which	is	required	to	quantify	the	percentage	of	defects	in	the	lung	with	FD-MRI	and	to	calculate	
α-maps.	The	ultimate	goal	for	the	future	is	to	implement	these	post-processing	steps	for	online	
evaluation	of	functional	images	(i.e.,	directly	at	the	scanner).	In	addition,	deep	learning	applied	
to	pulmonary	MR	imaging	may	be	extended	to	automatically	detect	and	quantify	functional	and	
morphological	abnormalities	 (e.g.,	ventilation	and	perfusion	defects,	mucus	plugs,	atelectasis,	
emphysema,	fibrosis,	and	lesions).	
	
	
	
	
Figure	7.2.	Lung	segmentation	of	2D	ufSSFP	(a)	and	3D	ufSSFP	(b)	datasets	of	a	patient	with	cystic	fibrosis	
performed	manually	by	a	human	observer	(green)	and	automatically	by	a	trained	neural	network	(red).	
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7.3	 Conclusion	
	
This	thesis	has	shown	novel	and	improved	techniques	to	assess	pulmonary	function	using	proton	
ufSSFP	MRI,	which	 is	widely	 available.	 The	 ufSSFP	 acquisition	 schemes	 have	 substantially	 in-
creased	the	image	quality	and	revealed	to	be	a	promising	strategy	for	clinical	applicability.	While	
OE-MRI	is	yet	hindered	in	a	clinical	context	by	a	rather	laborious	setup	and	may	be	employed	for	
specific	 research	 studies,	 FD-MRI,	 α-mapping,	 and	 SER-mapping	 have	 already	 demonstrated	
promise	for	clinical	applications	and	may	be	used	for	patient	monitoring.		
	
To	conclude,	I	hope,	this	work	will	inspire	other	scientists	and	improve	the	management	of	res-
piratory	diseases.	
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